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SUMMARY 
 
Intracranial pressure (ICP) is an important monitoring modality in the clinical management of 
several neurological diseases carrying the risk of fatal intracranial hypertension (ICH). 
However, this parameter is not always considered due to its invasive assessment. In this 
scenario, a non-invasive estimation of ICP (nICP) may be essential, and indeed it has become 
a Holy Grail in Clinical Neurosciences: extensively searched, albeit never found. This thesis is 
devoted to the assessment, applications and development of transcranial Doppler (TCD)-based 
non-invasive methods for ICP and cerebral perfusion pressure (CPP) monitoring.  
The thesis is divided into three sections: 
I) The accuracy of existing TCD-based nICP estimators in various scenarios of varying ICP 
(traumatic brain injury (TBI), rise of ICP during plateau waves, and rise in ICP induced by 
infusion of cerebrospinal fluid (CSF) during infusion test). The estimators of nICP consisted of 
a mathematical black box model, methods based on non-invasive CPP, and a method based on 
TCD pulsatility index.  
II) The feasibility of the best performing nICP estimator in clinical practice, including patients 
with closed TBI and brain midline shift, patients with acute liver failure during liver transplant 
surgery, and patients during non-neurosurgical surgery in the beach chair position. 
 III) The description and assessment of a novel methodology for non-invasive assessment of 
cerebral perfusion pressure (nCPP). 
The accuracy studies indicated that the black box model had the best performance to estimate 
ICP in TBI patients, and the overall confidence interval for ICP prediction presented by the 
TCD-based nICP methods was estimated around 10 mmHg. During infusion tests, ICP changes 
were estimated with only moderate correlations, and vasogenic components of ICP, like 
increases in cerebral blood volume, were better estimated with TCD-based nICP methods than 
the component related to increased CSF circulation during infusion test. During plateau waves, 
the nICP methods were remarkably accurate to replicate relative changes in ICP in the time 
domain, presenting correlations with direct ICP ranging from 0.62-0.80. Furthermore, they 
presented high performance to rule out intracranial hypertension and identify ICP changes of 
vasogenic origin during plateau waves, presenting prediction abilities around 80%. 
 iii 
 
For the feasibility studies, only the black box estimator was assessed since it provided the best 
estimation performance. It could identify an interhemispheric pressure gradient in TBI patients 
with closed head injury presenting midline shift, demonstrating that a greater CPP at the site of 
brain expansion was the driving force generating the pressure gradient. In patients with acute 
liver failure, different patterns of cerebral haemodynamics could be identified non-invasively 
during transplant surgery using a TCD-derived multiparameter approach englobing nICP, 
nCPP, and other cerebral haemodynamics parameters. The results indicated normal ICP and 
decreasing CPP during the procedure and an alteration of cerebral blood flow autoregulation. 
Also applying a multiparameter approach, the assessment of patients undergoing surgery in the 
beach chair position demonstrated significant cerebral haemodynamics changes in individuals 
with no indications of previous neurological impairment. The findings suggested that this 
surgical setting caused an alteration of cerebral haemodynamics, especially decrease in 
estimated CPP and impairment of cerebral autoregulation.  
The new method of nCPP estimation was based on spectral arterial blood volume accounting. 
It could identify changes in CPP across time reliably in conditions of decreasing and increasing 
CPP. It also presented a reasonable prediction ability to detect changes in CPP, with values 
around 70% for positive prediction power. 
These findings support the use of TCD-based nICP methods in a variety of clinical conditions 
requiring management of intracranial pressure and brain perfusion. Moreover, the low costs 
associated with nICP methods, since TCD is a widely available medical device, could 
contribute to its widespread use as a reliable alternative for ICP monitoring in everyday clinical 
practice. New methodologies should be tried and further developed (such as machine learning, 
artificial intelligence) since the absolute accuracy of estimation still needs improvement.  
 iv 
 
ACKNOWLEDGEMENTS 
 
 
I would like to thank my supervisor Professor Marek Czosnyka. I am indebted and grateful for 
the opportunity of having me under his supervision, and for his many efforts and time invested 
in this project and my academic career. Here, I would also like to thank Professor Sérgio 
Mascarenhas, for his early mentorship in my life and for providing me with support and 
inspiration in my academic career.  
I am grateful to Dr Peter Smielewski, for providing me with fundamental support regarding 
research software used for the development of this thesis and for contributing to my studies 
with constructive ideas. 
I would also like to thank Dr Bernhard Schmidt for his fundamental support on the development 
of this thesis and for critically reviewing my studies. 
I would like to thank Dr Zofia Czosnyka for teaching me how to conduct cerebrospinal fluid 
infusion tests and for contributing to my studies. I would also like to thank for her kind support 
over these years. 
I would like to thank my colleagues from the Brain Physics Laboratory for their friendship and 
for the many fruitful collaborations and discussions over the years, Chiara Robba, Joseph 
Donnelly, Manuel Cabeleira, Xiuyun Liu, Brenno Cabella, Cristine Sortica, Georgios Varsos, 
Dr Christina Haubrich, Aphroditi Lalou, Leanne Calviello, Dr Maxwell Damian. 
I am grateful for the constant support and encouragement from my friends Samuel Beserra, 
Ligia Kiyuna, Dr Gustavo Frigieri and Ligia Gomiero. 
I would like to thank the Cambridge Commonwealth, European & International Trust, 
University of Cambridge for the financial support. 
Finally, I would like to thank my family, Célia, Valter, Adélia, Ana Carolina, Lucas, Manuela, 
Evandro, for understanding my absence and for their constant motivation and support in the 
search for my dreams and goals in life. Muito obrigado!  
 
 
 
 v 
 
LIST OF PUBLICATIONS 
 
 
This is a current list (September, 2017) of manuscripts and presentations which have resulted 
from the work performed during the development of this thesis.  
 
 
Papers published 
 
Cardim, D., Robba, C., Donnelly, J., Bohdanowicz, M., Schmidt, B., Damian, M., Varsos, G. 
V, Liu, X., Cabeleira, M., Frigieri, G., Cabella, B., Smieleweski, P., Mascarenhas, S., and 
Czosnyka, M. (2015). Prospective study on non-invasive assessment of ICP in head injured 
patients: comparison of four methods. J. Neurotrauma. 
 
Cardim, D., Czosnyka, M., Donnelly, J., Robba, C., Cabella, B.C.T., Liu, X., Cabeleira, M.T., 
Smielewski, P., Haubrich, C., Garnett, M.R., Pickard, J.D., and Czosnyka, Z. (2016). 
Assessment of non-invasive ICP during CSF infusion test: an approach with transcranial 
Doppler. Acta Neurochir. (Wien). 158, 279–87. 
 
Cardim, D., Robba, C., Bohdanowicz, M., Donnelly, J., Cabella, B., Liu, X., Cabeleira, M., 
Smielewski, P., Schmidt, B., and Czosnyka, M. (2016). Non-invasive Monitoring of 
Intracranial Pressure Using Transcranial Doppler Ultrasonography: Is It Possible? Neurocrit. 
Care. 
 
Cardim, D., Schmidt, B., Robba, C., Donnelly, J., Puppo, C., Czosnyka, M., and Smielewski, 
P. (2016). Transcranial Doppler Monitoring of Intracranial Pressure Plateau Waves. Neurocrit. 
Care , 1–9. 
 
 
 
 
 
 
 
 
 
 vi 
 
Manuscripts in submission 
 
Cardim, D., Robba, C., Schmidt, B., Donnelly, J., Schmidt, E.A., Bohdanowicz, M., 
Smielewski, P., Czosnyka, M.: Midline shift in patients with closed traumatic brain injury may 
be driven by cerebral perfusion pressure not intracranial pressure. Journal of Neurological 
Research (2017).  
 
Cardim, D., Klinck, J., Robba, C., Schmidt, B., Donnelly, J., Schmidt, E.A., Smielewski, P., 
Czosnyka, M.: Transcranial Doppler non-invasive assessment of intracranial pressure, 
autoregulation of cerebral blood flow and critical closing pressure during orthotopic liver 
transplant. Liver Transplantation (2017). 
 
Cardim, D., Robba, C., Matta, B., Tytherleigh-Strong, G., Kang, N., Schmidt, B., Donnelly, J., 
Calviello, L., Smielewski, P., Czosnyka, M. Cerebrovascular assessment of patients undergoing 
shoulder surgery in beach chair position using a multiparameter transcranial Doppler approach. 
British Journal of Anaesthesia (2017). 
 
Cardim, D., Varsos, G.V., Uryga, A., Kaczmarska, K., Robba, C., Calviello, L., Bohdanowicz, 
M., Kasprowicz, M., Schmidt, B., Smielewski, P., Steiner, L.A., Czosnyka, M.: Spectral 
cerebral blood volume accounting for non-invasive estimation of changes in cerebral perfusion 
pressure using transcranial Doppler ultrasonography. Physiological Measurement (2017). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
 
Conference presentations 
 
Cardim, D., Cabella, B., Donnelly, J., Robba, C., Czosnyka, M., Garnett, M., Pickard, J.D., 
Czosnyka, Z.: Non-invasive assessment of ICP during infusion test using Transcranial Doppler 
Ultrasonography. Fluids and Barriers of the CNS 09/2015; 12 (Suppl 1): P6. 
 
Cardim, D., Schmidt, B., Robba, C., Donnelly, J., Cabella, B., Liu, X., Cabeleira, M., 
Bohdanowicz, M., Smielewski, P., Czosnyka, M.: Transcranial Doppler Non-invasive 
Assessment of ICP During Intracranial Hypertension of Vasogenic Origin. 16th International 
Symposium on Intracranial Pressure and Neuromonitoring, Cambridge, MA, USA, 2016. 
 
Cardim, D., Robba, C., Tytherleigh-Strong, G., Donnelly, J., Smielewski, P., Schmidt, B., 
Matta, B., Czosnyka, M.: The Effects of the Beach-chair Position on Cerebral Haemodynamics 
and Non-invasive ICP in Patients Undergoing Shoulder Surgery. 16th International Symposium 
on Intracranial Pressure and Neuromonitoring, Cambridge, MA, USA, 2016. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii 
 
Co-authored publications 
 
Robba, C., Cardim, D., Tajsic, T., Pietersen, J., Bulman, M., Donnelly, J., Lavinio, A., Gupta, 
A., Menon, D., Czosnyka, M. Ultrasound non-invasive measurement of intracranial pressure in 
neurointensive care: a prospective observational study. PLOS Medicine 07/2017 14(7): 
e1002356.  
Robba, C., Cardim, D., Donnelly, J., Bertuccio, A., Bacigaluppi, S., Bragazzi, N., Cabella, B., 
Liu, X., Matta, B., Lattuada, M., Czosnyka, M.: Effects of pneumoperitoneum and 
Trendelenburg position on intracranial pressure assessed using different non-invasive methods. 
British Journal of Anaesthesia 09/2016. 
Robba, C., Cardim, D., Sekhon, M., Budohoski, K., Czosnyka, M. Transcranial Doppler: a 
stethoscope for the brain - neurocritical care use. Journal of Neuroscience Research (in press). 
Robba, C., Bacigaluppi, S., Cardim, D., Donnelly, J., Bertuccio, A., Czosnyka, M.: Non-
invasive assessment of intracranial pressure. Acta Neurologica Scandinavica 10/2015. 
Liu, X., Maurits, N.M., Aries, M.J.H., Czosnyka, M., Ercole, A., Donnelly, J., Cardim, D., 
Kim, D.J., Dias, C., Cabeleira, M., Smielewski, P: Monitoring of optimal cerebral perfusion 
pressure in traumatic brain injured patients using a multi-window weighting algorithm. Journal 
of Neurotrauma 05/2017. 
Liu, X., Donnelly, J., Czosnyka, M., Aries, M.J.H., Brady, K., Cardim, D., Robba, C., 
Cabeleira, M., Kim, D.J. Haubrich, C., Smielewski, S.: Cerebrovascular Pressure Reactivity 
Monitoring Using Wavelet Analysis in Traumatic Brain Injury Patients: A Retrospective Study. 
PLOS Medicine 07/2017 14(7): e1002348.  
Donnelly, J., Czosnyka, M., Adams, H.A., Robba, C., Steiner, L.A., Cardim, D., Cabella, B., 
Liu, X., Ercole, A., Hutchinson, P., Smielewski, P.:  Individualising thresholds of cerebral 
perfusion pressure using estimated limits of autoregulation. Critical Care Medicine, Volume 
45(9), September 2017, p 1464–1471. 
Cabella, B., Donnelly, J., Cardim, D., Liu, X., Cabeleira, M., Smielewski, P., Haubrich, C., 
Hutchinson, P. Kim, D.J. Czosnyka, M.: An Association Between ICP-Derived Data and 
Outcome in TBI Patients: The Role of Sample Size. Neurocritical Care 11/2016. 
Donnelly, J., Czosnyka, M., Harland, S., Varsos, G.V., Cardim, D., Robba, C., Liu, X., Ainslie, 
P.N., Smielewski, P.: Cerebral haemodynamics during experimental intracranial hypertension. 
Journal of Cerebral Blood Flow & Metabolism 03/2016; 37(2). 
Robba, C., Bragazzi, N.L., Bertuccio, A., Cardim, D., Donnelly, J., Sekhon, M., Lavinio, A., 
Duane, D., Burnstein, R., Matta, B., Bacigaluppi, S., Lattuada, M., Czosnyka, M.: Effects of 
Prone Position and Positive End-Expiratory Pressure on Non-invasive Estimators of ICP: A 
Pilot Study. Journal of Neurosurgical Anesthesiology 02/2016. 
Robba, C., Bacigaluppi, S., Cardim, D., Donnelly, J., Sekhon, M., Aries, M.J.A., Mancardi, G., 
Booth, A., Bragazzi, N.L., Czosnyka, M., Matta, B.: Intraoperative non-invasive intracranial 
pressure monitoring during pneumoperitoneum: a case report and a review of the published 
cases and case report series. Journal of Clinical Monitoring and Computing 09/2015. 
 ix 
 
Robba, C., Donnelly, J., Bertuetti, R., Cardim, D., Sekhon, M., Aries, M.J.A., Smielewski, P., 
Richards, H., Czosnyka, M.: Doppler Non-invasive Monitoring of ICP in an Animal Model of 
Acute Intracranial Hypertension. Neurocritical Care 08/2015; 23(3).  
 x 
 
DISTINCTIONS 
 
 
This is a current list (September, 2017) of scholarship and grants that have been awarded for 
the work performed as part of this thesis. 
 
 
Scholarship 
 
Cambridge Commonwealth, European & International Trust Scholarship, University of 
Cambridge (2014-2017). 
 
 
Grants 
 
1. St. Catharine’s College, Travel and Research Grant, University of Cambridge (2015); 
2. St. Catharine’s College, Travel and Research Grant, University of Cambridge (2016); 
3. NIHR Brain Injury Healthcare Technology Cooperative, Cambridge, UK, Travel Grant 
(2016). 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
 
LIST OF FIGURES 
 
 
Figure 2.1. Representation of the systolic (FVs) and diastolic (FVd) components of the spectral 
cerebral blood flow (CBF) velocity (FV) waveform. ....................................................... 30 
 
Figure 2.2. Schematic representation of the acoustic windows for transcranial Doppler 
ultrasonography. ............................................................................................................... 31 
 
Figure 3.1. Extracted from Cardim et al., 2016 37. Systolic and diastolic flow velocities 
behaviour during a drop of cerebral perfusion pressure during a plateau wave increase of 
ICP observed in a TBI patient (source: Brain Physics Laboratory TBI Database, University 
of Cambridge). FVd component, in this case, indicates inadequate cerebral perfusion. .. 42 
 
Figure 3.2. Extracted from Cardim et al., 2016 37. Representation of the CrCP interaction with 
ICP and WT in a situation of intracranial hypertension observed in a traumatic brain-
injured patient (source: Brain Physics Laboratory TBI Database, University of 
Cambridge). During the increase of ICP, the CrCP also increases and WT decreases as an 
effect of preserved autoregulation. ................................................................................... 45 
 
Figure 3.3. Extracted from Cardim et al., 201637. Schematic representation of the black-box 
model for nICP estimation. A known transfer function (represented by a linear model) 
between ABP and FV, alongside modification TCD characteristics, are used as means to 
continuously find a relationship between ABP and nICP transformations (unknown 
transfer function – a linear model between ABP and ICP). ............................................. 50 
 
Figure 3.4. Extracted from Cardim et al., 2016 37. PI behaviour during drop in CPP observed 
in a traumatic brain-injured patient (source: Brain Physics Laboratory TBI Database, 
University of Cambridge). Dashed lines represent periods when PI increased due to 
increase in ICP, independently of changes in ABP. CPP (mmHg), cerebral perfusion 
pressure; PI (a.u.), pulsatility index; ICP (mmHg), intracranial pressure; ABP (mmHg), 
arterial blood pressure; TBI, traumatic brain injury. ........................................................ 60 
 
Figure 4.1. Organogram describing the utilisation of retrospective and prospective materials 
within the study categories. .............................................................................................. 63 
 
Figure 4.2. A representation of simultaneous recordings of ABP, ICP and FV. (A) Full range 
of recording; (B) representation of the signals waveforms. Source: Brain Physics 
Laboratory database, University of Cambridge. ............................................................... 66 
 xii 
 
Figure 5.1. Example of recording of nICP with four investigated methods in a case when ICP 
changed considerably. (A) ICP; (B) nICPBB; (C) nICPFVd; (D) nICPCrCP; (E) nICPPI. In this 
case, all nICP estimators could replicate changes in ICP in time reliably (R>0.60). ....... 78 
 
Figure 5.2. Linear regressions and Pearson correlation plots between ICP and nICP estimators 
for (A) nICPBB, (B) nICPFVd, (C) nICPCrCP and (D) nICPPI. nICPBB, nICPFVd, nICPCrCP 
presented moderate correlations with ICP. ....................................................................... 79 
 
Figure 5.3. Bland-Altman and error histograms plots showing bias and 95% CI for prediction 
of ICP for (A) nICPBB, (B) nICPFVd (B), (C) nICPCrCP and (D) nICPPI. The overall 95% CI 
ranged around 10 mmHg. ................................................................................................. 80 
 
Figure 5.4. Receiver operating characteristic analysis showing the area under the curve (AUC) 
for the averaged nICP estimator (nICPAv, AUC = 0.73). ................................................. 81 
 
Figure 5.5. Example of recording demonstrating the baseline and plateau phases of the infusion 
test and the parameters assessed (ABP, ICP, FV). ........................................................... 86 
 
Figure 5.6. Linear regressions and correlation plots considering the differences (∆) between 
plateau and baseline phases during infusion tests. (A) ∆nICPBB, (B) ∆nICPFVd, (C) 
∆nICPCrCP and (D) ∆nICPPI. Only nICPBB and nICPPI presented moderate significant 
correlations with direct ICP. ............................................................................................. 88 
 
Figure 5.7. Examples of good (A) and poor (B) recordings of nICP with the four investigated 
methods when ICP changed considerably during the infusion test. Correlation coefficients 
in the time domain (R) are depicted for each nICP method in each situation. ................. 89 
 
Figure 5.8. Modified from Cardim et al. 120. Examples of vasogenic waves during infusion test. 
(A) Shadowed area represents a plateau wave of ICP. (B) Shadowed area represents B 
waves of ICP. A noticeable positive correspondence between ICP and nICP methods are 
observed during the occurrence of vasogenic waves. ....................................................... 94 
 
Figure 5.9. Example of the algorithm used for identification of plateau waves: sudden and 
spontaneous increases in ICP and pulse amplitude of ICP during which CPP and FV 
dropped while ABP remained relatively stable. ............................................................... 96 
 
Figure 5.10. Modified from Cardim et al. 139. Example of recordings showing reliable and 
unreliable replications of ICP plateau waves by different TCD-based nICP methods 
(panels A and B, respectively). On Y axis, mean absolute values of ICP and nICPs are 
presented; and on X axis, relative changes of ICP and nICP in the time domain. ........... 99 
 xiii 
 
Figure 5.11. Linear regressions and Spearman correlation plots between ∆ICP and ∆nICP for 
(A) nICPBB, (B) nICPFVd, (C) nICPCrCP and (D) nICPPI. Only nICPBB and nICPCrCP 
presented statistically significant correlations with ICP. ................................................ 100 
 
Figure 5.12. Modified from Cardim et al. 139. Example of plateau wave recording with direct 
ICP and nICPBB. In comparison to baseline phase, at the top of plateau waves, ICP and 
nICPBB presented an increased pulse amplitude. The characteristic triangular shape of ICP 
waveform observed during plateau waves was replicated by nICPBB. ........................... 102 
 
Figure 6.1. Head CT scan illustrating a brain midline shift. In this example, the shift occurs 
from the right to the left brain hemisphere. .................................................................... 109 
 
Figure 6.2. An example of continuous recording of mean ABP, FV and nICP of a patient 
presenting a midline shift of -3.0 mm. It is possible to observe the asymmetry of nICP in 
this patient, in whom the mean left-right difference throughout the monitoring period was 
11.67 mmHg. .................................................................................................................. 115 
 
Figure 6.3. Correlation scatterplots between ICP and nICP. (A) Left nICP vs ICP (R=0.50, 
p<0.001); (B) Right nICP vs ICP (R=0.51, p<0.001). ................................................... 116 
 
Figure 6.4. Correlation scatterplot of the relationship between brain midline shift and the 
interhemispheric difference in nICP (R=0.34, p<0.01). Negative values for midline shift 
represent a brain expansion from the left to the right side; for positive values, an expansion 
from the right to the left side. When there is a midline shift, it is suggested that nICP was 
smaller on the side of brain expansion; therefore, nICP cannot be considered the driving 
force of the brain asymmetry demonstrated by a noticeable midline shift. .................... 117 
 
Figure 6.5. Scatterplot of the relationship between brain midline shift and the left-right 
difference in nCPP (R=-0.34, p<0.01). Similarly to Figure 6.4 negative values for midline 
shift represent a brain expansion from the left to the right side; for positive values, an 
expansion from the right to the left side. When there is a midline shift, it is suggested that 
nCPP is greater on the side of brain expansion. ............................................................. 118 
 
Figure 6.6. Representation of multiparameter monitoring performed with transcranial Doppler 
during orthotopic liver transplant. This figure depicts “patient 5”, in which is possible to 
observe the overall changes in cerebral haemodynamics among different surgical phases.
 ........................................................................................................................................ 127 
 
Figure 6.7. Longitudinal plots for (A) arterial blood pressure, (B) non-invasive intracranial 
pressure and (C) non-invasive cerebral perfusion pressure throughout OLT. Although all 
three parameters had a decreasing trend, only nCPP presented significant changes between 
phases (T0-T2 (p<0.03)). ................................................................................................ 129 
 xiv 
 
Figure 6.8. Longitudinal plots for (A) cerebral blood flow velocity and (B) pulsatility index 
throughout OLT. The patients presented low FV (<60 cm/s) and augmented PI (>0.8) in 
all phases during OLT. ................................................................................................... 130 
 
Figure 6.9. Longitudinal plot for autoregulation index throughout OLT. Mean Mxa 
demonstrates impaired cerebral autoregulation throughout OLT, with gradual worsening 
from T0-T1. .................................................................................................................... 130 
 
Figure 6.10. Longitudinal plots for (A) CrCP and (B) DCM throughout OLT. CrCP was never 
close to ABP in any phases. Therefore, DCM did not reach critical values (≤0 mmHg).
 ........................................................................................................................................ 131 
 
Figure 6.11. An example of an optimal curve for arterial blood pressure with corresponding 
recordings of ABP, ICP and nCPP throughout OLT. ..................................................... 132 
 
Figure 6.12. Optimal curves for arterial blood pressure obtained in different patients. ....... 133 
 
Figure 6.13. Longitudinal plots showing changes between supine (phase A) and beach chair 
position (phase B) for (A) ABPFINGER, (B) FV, (C) nICP and (D) nCPP. Mean ABP 
exhibited a decreasing trend, which was reflected in the other parameters. .................. 142 
 
Figure 6.14. Longitudinal plot showing changes between supine (phase A) and beach chair 
position (phase B) for cerebral autoregulation index (ARI). Mean ARI showed lower levels 
indicating impaired cerebral autoregulation (ARI <3). .................................................. 143 
 
Figure 6.15. Longitudinal plots showing changes between supine (phase A) and beach chair 
position (phase B) for critical closing pressure (A) and diastolic closing margin (B). CrCP 
did not approach diastolic ABP. Consequently, DCM did not reach critical values                     
(≤0 mmHg). .................................................................................................................... 143 
 
Figure 6.16. Example demonstrating the behaviour of ABP and FV during phases A (supine 
position) and B (beach chair position). Changes in ABP with correspondent changes in FV 
indicate disturbed cerebral autoregulation. ..................................................................... 145 
 
Figure 7.1. The electrical model of cerebral blood flow (CBF) and cerebrospinal fluid (CSF) 
dynamics, extracted from Czosnyka et al. 216. ................................................................ 150 
 
Figure 7.2. Example of signals of ABP, ICP, FV and estimators of pulsatile arterial blood 
volume calculated using constant flow forward (CaBVCFF) and pulsatile flow forward 
(CaBVPFF) methods. ........................................................................................................ 155 
 
 xv 
 
Figure 7.3. Example of individual cases (A, B, C) showing the correlation in the time domain 
between nCPPs and CPP (R) in patients with induced rises in ABP. Baseline and rise in 
ABP phases are distinguishable in the recordings. ABP (mmHg), arterial blood pressure; 
ICP (mmHg), intracranial pressure; CPP (mmHg), cerebral perfusion pressure; nCPPs 
(mmHg), non-invasive cerebral perfusion pressure according to the spectral method; R, 
correlation coefficient in the time domain. ..................................................................... 159 
 
Figure 7.4. Example of individual cases (A, B, C) showing the correlation in the time domain 
between nCPPs and CPP (R) in patients presenting ICP plateau waves. Baseline and 
plateau phases for these rises in ICP (and consequent decrease in CPP) are demonstrated 
in the recordings. ABP (mmHg), arterial blood pressure; ICP (mmHg), intracranial 
pressure; CPP (mmHg), cerebral perfusion pressure; nCPPs (mmHg), non-invasive 
cerebral perfusion pressure according to the spectral method; R, correlation coefficient in 
the time domain. ............................................................................................................. 160 
 
Figure 7.5. Correlation plots between the magnitude of changes (∆) of both CPP and nCPPs in 
the induced rises in ABP (A) and plateau waves (B) cohorts. In both cases, nCPPs  could 
detect the magnitude of changes in CPP reliably (R>0.70). ........................................... 161 
 
Figure 7.6. Receiver operating characteristic (ROC) curve for prediction of CPP changes using 
the combined threshold of 23.2 mmHg. AUC of 0.711 (95% CI: 0.543-0.878) demonstrates 
reasonable prediction ability for nCPPs. ......................................................................... 161 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xvi 
 
LIST OF TABLES 
 
 
Table 3.1. Modified from Cardim et al. 37. nICP methods based on TCD-derived pulsatility 
index (nICPPI). .................................................................................................................. 35 
 
Table 3.2. Modified from Cardim et al. 37. nICP methods based on non-invasive cerebral 
perfusion pressure estimation. .......................................................................................... 46 
 
Table 3.3. Modified from Cardim et al. 37. nICP methods based on mathematical models. ... 56 
 
Table 5.1. Physiological variables and nICP estimations assessed, presented and mean ± SD.
 .......................................................................................................................................... 75 
 
Table 5.2. Correlations between non-invasive ICP methods with invasive ICP in the time 
domain (mean±SD) and between ∆ICP and ∆nICP in cases when ∆ICP ≥7 mmHg (N=8). 
Correlation between ∆ICP and ∆nICP was not significant in any of the methods. .......... 76 
 
Table 5.3. Correlations between non-invasive methods with invasive ICP (R) (N=66 
recordings), bias (±SD), 95% CI for ICP prediction and AUC. The combination of the best 
performing estimators (nICPAv) resulted in better correlation with direct ICP and improved 
95% CI and AUC. ............................................................................................................. 77 
 
Table 5.4. Median values (IQR), bias (±SD) and 95% CI for ICP prediction are described for 
baseline and plateau phases. Spearman correlation between ∆ICP and ∆nICP and averaged 
correlation across time during ICP increase are described (N=53). At the 0.05 level, 
baseline and plateau distributions of nICP and ICP were significantly different. ............ 90 
 
Table 5.5. Median (IQR) values for all physiological variables estimated during baseline and 
plateau phases, with their corresponding ∆ correlations with ∆ICP and ∆ABP............... 91 
 
Table 5.6. Median values (IQR) of the differences between plateau and baseline phase (∆, in 
mmHg), ∆ correlations with ICP and correlations in the time domain for all nICP methods 
evaluated. ∆ICP and ∆nICP distributions were significantly different in all cases. AUC for 
each nICP method is presented considering the threshold of 35 mmHg. ......................... 98 
 
Table 5.7. Median (IQR) values for all physiological parameters estimated during baseline and 
plateau phases. ................................................................................................................ 101 
 
 xvii 
 
Table 5.8. Summary of the accuracy measures for TCD-based nICP methods in different 
clinical conditions. .......................................................................................................... 104 
 
Table 6.1. Median (IQR) of the assessed variables. .............................................................. 114 
 
Table 6.2. Patients demographics and acute liver failure aetiology. ..................................... 125 
 
Table 6.3. Variables assessed at each phase during OLT averaged by patient. Only nCPP 
presented statistically significant changes between surgery phases (T0-T2, mean decrease 
of 8.17 mmHg (p=0.03))................................................................................................. 125 
 
Table 6.4. Variables assessed at each phase during OLT considering individual cases. ...... 128 
 
Table 6.5. Patient’s demographic characteristics, medical history and type of surgical 
procedures performed (N=23). ....................................................................................... 139 
 
Table 6.6. Physiological and cerebral haemodynamics parameters assessed on phases A and B. 
Significant differences occurred in DCM (mean decrease of 6.43 mmHg (-34%) 
(p=0.009)) and PI (mean increase of 0.11 (+11%) (p=0.05)). ........................................ 140 
 
Table 6.7. Mean delta (magnitude) changes and correlation coefficients between FV and ABP.
 ........................................................................................................................................ 140 
 
Table 7.1. Values of the physiological variables and nCPPs estimator assessed for 
measurements at baseline and plateau phases. ............................................................... 158 
 
 
 
 
 
 
 
 
 
 
 
 xviii 
 
LIST OF EQUATIONS 
 
 
Equation 2.1, page 29 
Cerebral blood flow velocity derived from transcranial Doppler ultrasonography 
v =
(c ×fd)
2 ×f0 × cos θ
    (cm/s)  
 
Equation 3.1, page 40 
Non-invasive cerebral perfusion pressure estimation per Aaslid et al. 67 
nCPPAaslid = (FVm f1⁄ ) × a1  (mmHg)  
 
Equation 3.2, page 41 
Linear regression determined for nCPPAaslid estimation 
CPP = 1.1 nCPPAaslid-5  (mmHg)  
 
Equation 3.3, page 43 
Non-invasive cerebral perfusion pressure estimation per Edouard et al. 74 
nCPPEdouard = (
FVm
FVm- FVd
) × (ABPm-ABPd)  (mmHg)  
 
Equation 4.1, page 67 
Transcranial Doppler-derived pulsatility index per Gosling et al.49 
PI =  
FVs-FVd  
FVm
  (a. u. )  
 
Equation 4.2, page 68 
Critical closing pressure per Varsos et al.81 
CrCP = ABP- 
ABP
√(CVR ∙  Ca  ∙  HR ∙  2π)2 +  1 
  (mmHg)  
 
Equation 4.3, page 68 
Non-invasive approximation of cerebrovascular resistance 
    CVR =  
ABP
FV
  (mmHg/(cm/s))  
 
 
 
 
 
 xix 
 
Equation 4.4, page 68 
Compliance of the cerebral arterial bed 
Ca =  
CaBV1
a1
 (cm/mmHg)  
 
Equation 4.5, page 69 
Diastolic closing margin 
DCM =  ABPd-CrCP  (mmHg)  
 
Equation 4.6, page 69 
Non-invasive cerebral perfusion pressure estimator based on the diastolic cerebral flow velocity, per 
Czosnyka et al. 69 
nCPPFVd = ABP × 
FVd
FVm
 + 14  (mmHg)  
 
Equation 4.7, page 70 
Non-invasive cerebral perfusion pressure estimator based on critical closing pressure, per Varsos et 
al.76 
nCPPCrCP = ABP × [0.734- 
0.266
√(CVR ∙  Ca  ∙  HR ∙  2π)2 + 1
] -7.026  (mmHg)  
 
Equation 4.8, page 70 
Non-invasive intracranial pressure estimator based on the concept of critical closing pressure 
nICPCrCP = ABP- nCPPCrCP  (mmHg)  
 
Equation 4.9, page 70 
Non-invasive intracranial pressure estimator based on pulsatility index 
nICPPI = 4.47 × PI + 12.68   (mmHg)  
 
Equation 7.1, page 149 
Mathematical expression of cerebrovascular impedance based on cerebrovascular resistance, 
compliance and frequency 
Z(jω) =
CVR
jω ∙ Ca
CVR +
1
jω ∙ Ca
=
CVR
jω ∙ CVR ∙ Ca + 1
  (mmHg/(cm3/s)  
 
Equation 7.2,  page 150 
Modulus of impedance, derived from Equation 7.1 
|Z(ω)|  =  
CVR
√CVR2 ∙  Ca ∙  ω2  + 1 
  (mmHg/(cm3/s)  
 xx 
 
Equation 7.3, page 151 
Non-invasive cerebral perfusion pressure estimator based on the spectral volume accounting method 
(nCPPs) 
CPP =  
a1
sPI
 × √(CVR ∙ Ca)2 ∙ HR2 ∙ (2π)2 +  1   (mmHg)  
 
Equation 7.4, page 152 
Estimated changes of pulsatile cerebral blood volume over one cardiac cycle 
∆CBV(t) =  ∫ (CBFa(s) – CBFv(s))
t
t0
ds  (cm3)  
 
Equation 7.5, page 152 
Estimated changes of cerebral arterial blood volume over one cardiac cycle according to the 
continuous flow forward model 
∆CaBVCFF(t) =  ∫ (CBFa(s) – mean CBFa)
t
t0
ds   (cm3)  
 
Equation 7.6, page 153 
Estimated changes of cerebral arterial blood volume over one cardiac cycle according to the pulsatile 
flow forward model 
∆CaBVPFF(t) =  ∫ (CBFa(s) – 
ABP(s)
CVR
)
t
t0
ds  (cm3)  
 
Equation 7.7, page 153 
Compliance of the cerebral arterial bed according to the continuous flow forward model 
CaCFF =  
C1CFF
a1⁄   (cm/mmHg)  
 
Equation 7.8, page 153 
Compliance of the cerebral arterial bed according to the pulsatile flow forward model 
CaPFF =  
C1PFF
a1⁄   (cm/mmHg)  
 
Equation 7.9, page 154 
Non-invasive approximation of cerebrovascular resistance used for nCPPs estimation 
CVR1 =  
 ABP
FV
  (mmHg/(cm/s))  
 
Equation 7.10, page 154 
Cerebrovascular resistance according to the "resistance area product" method 
CVR2 =  
a1
f1
   (mmHg/(cm/s))  
 xxi 
 
Equation 7.11, page 155 
Amplitude of the first harmonic of heart frequency according to the continuous flow forward model 
C1CFF =
f1
ωHR
   
 
Equation 7.12, page 155 
Amplitude of the first harmonic of heart frequency according to the pulsatile flow forward model 
C1PFF =  
(f1-a1/CVR)
ωHR
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xxii 
 
LIST OF ABBREVIATIONS 
 
 
A ABP, arterial blood pressure 
ABPd, diastolic arterial blood pressure 
ABPs, systolic arterial blood pressure 
ACA, anterior cerebral artery 
ALF, acute liver failure 
ARI, autoregulation index 
ArLD, alcohol-related liver disease 
AUC, area under the curve 
B BCP, beach chair position 
BMI, body-mass index 
C Ca, compliance of the cerebral arterial bed 
CaBV, cerebral arterial blood volume 
CBF, cerebral blood flow 
CFF, continuous flow forward model 
CI, confidence interval 
CO2, carbon dioxide 
COx, correlation index between ABP and regional cerebral oxygen saturation 
CPP, cerebral perfusion pressure 
CPPopt, optimal cerebral perfusion pressure 
CrCP, critical closing pressure 
CSF, cerebrospinal fluid 
CT, computed tomography 
CVR, cerebrovascular resistance 
D DCM, diastolic closing margin 
E EEG, electroencephalogram 
ETCO2, end-tidal carbon dioxide concentration 
F FFT, fast Fourier transformation 
FV, cerebral blood flow velocity 
 xxiii 
 
FVd, diastolic cerebral blood flow velocity 
FVs, systolic cerebral blood flow velocity 
G GCS, Glasgow coma scale 
H HCC, hepatocellular carcinoma  
HCV, hepatitis C virus  
HR, heart rate 
I ICA, internal carotid artery 
ICH, intracranial hypertension 
ICP, intracranial pressure 
INPH, idiopathic normal pressure hydrocephalus 
IQR, interquartile range 
K KSR, kernel spectral regression 
L LP, lumbar puncture 
M MAD, mean absolute difference 
MCA, middle cerebral artery 
MRI, magnetic resonance imaging 
MS, midline shift 
Mx, mean flow cerebral autoregulation index based on cerebral perfusion pressure 
Mxa, mean flow cerebral autoregulation index based on arterial blood pressure 
N NA, not available 
NASH, non-alcoholic steatohepatitis;  
NCCU, Neurosciences Critical Care Unit 
nCPP, non-invasive cerebral perfusion pressure 
nCPPs, spectral non-invasive cerebral perfusion pressure 
nICP, non-invasive intracranial pressure 
nICPBB, non-invasive intracranial pressure based on the black box method 
nICPFVd, non-invasive intracranial pressure based on the diastolic cerebral blood flow 
velocity method 
nICPCrCP, non-invasive intracranial pressure based on the critical closing pressure 
method 
nICPPI, non-invasive intracranial pressure based on the pulsatility index method 
 xxiv 
 
NM, not measured 
NPV, negative predictive value 
O OLT, orthotopic liver transplant 
ONSD, optic nerve sheath diameter 
OR, odds ratio  
P PaCO2, partial pressure of carbon dioxide 
PCA, posterior cerebral artery 
PE, prediction error 
PECO2, pressure of expired carbon dioxide 
PFF, pulsatile flow forward model 
PI, pulsatility index 
PPV, positive predictive value 
PRx, pressure reactivity index 
PSC, primary sclerosing cholangitis  
R R, correlation coefficient 
R2, coefficient of determination 
RCSF, resistance to cerebrospinal fluid outflow 
REC, research ethics committee 
RI, resistance index 
ROC, receiver operating characteristic  
rSCO2, regional cerebral oxygen saturation 
S SAH, subarachnoid haemorrhage 
SCA, state of cerebral autoregulation 
SD, standard deviation 
SDE, standard deviation of the error 
SJO2, jugular bulb venous blood oxygen saturation 
SVM, support vector machine 
T TBI, traumatic brain injury 
TCD, transcranial Doppler ultrasonography 
W WT, cerebrovascular wall tension 
Aims & Hypotheses 
25 
 
1 AIMS AND HYPOTHESES  
 
This thesis is devoted to transcranial Doppler-based methods for non-invasive intracranial 
pressure and cerebral perfusion pressure monitoring. The structure of the thesis consists of 10 
chapters containing a comprehensive literature review of the existing methods for non-invasive 
intracranial pressure and cerebral perfusion pressure based on transcranial Doppler 
ultrasonography, the presentation of clinical material used for the author’s original projects and 
a method for non-invasive monitoring. The results are divided into three parts: I) accuracy of 
non-invasive intracranial pressure estimation; II) clinical feasibility of non-invasive 
monitoring; III) novel method for non-invasive cerebral perfusion pressure monitoring based 
on spectral arterial blood volume accounting. 
 
 
Hypotheses 
 
In the course of the thesis project, the following hypotheses were formulated and subsequently 
tested: 
 
Hypothesis I:  Transcranial Doppler-based non-invasive monitoring methods can reliably 
estimate intracranial pressure with a finite error. 
Transcranial Doppler ultrasonography consists of a technique with several possibilities for non-
invasive estimation of cerebral haemodynamics, including different methods for the 
assessment of intracranial pressure. Nevertheless, many of these methods have not been 
systematically compared in various clinical conditions presenting disturbed cerebral 
haemodynamics and increased intracranial pressure. To address this issue, this part of the thesis 
focuses on determining which transcranial Doppler approach offers the best reliability to assess 
intracranial pressure non-invasively in comparison with the standard invasive technique.   
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Hypothesis II:  Transcranial Doppler-based non-invasive monitoring can be used as a 
clinically feasible method to assess intracranial pressure and disturbed cerebral 
haemodynamics.  
In many clinical conditions, the assessment of intracranial pressure and cerebral 
haemodynamics using invasive methods cannot be performed. This part of the thesis focuses 
on assessing the feasibility of TCD-based non-invasive intracranial pressure monitoring in 
clinical conditions in which invasive monitoring was not considered or unachieved.  
 
 
Hypothesis III:  Cerebral perfusion pressure dynamics can be estimated using a model-based 
non-invasive method derived from transcranial Doppler and arterial blood pressure 
monitoring. 
A novel model-based method for cerebral perfusion pressure monitoring using transcranial 
Doppler-derided cerebral arterial blood volume accounting has been proposed in this thesis. 
This part of the thesis focuses on testing the performance of the method to replicate and predict 
changes in direct cerebral perfusion pressure.
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2 INTRODUCTION 
 
2.1 Intracranial pressure monitoring 
 
The concept of intracranial pressure (ICP) was first described in 1783 by the Scottish anatomist 
Alexander Monro, who described the skull as a rigid structure containing an incompressible 
brain and stated that a constant drainage of venous blood is required to allow continuous arterial 
supply 1,2. These assumptions were later confirmed in autopsy studies by George Kellie of Leith 
3, whose findings were postulated as the Monro-Kellie doctrine. The doctrine was modified 
throughout the years with contributions of Vesalius (description of fluid-filled brain ventricles), 
François Magendie (establishment of the concept of cerebrospinal fluid – CSF 4), George 
Burrows (the reciprocal relationship between the volumes of CSF and blood 5). However, 
Harvey Cushing, in 1926 6, formulated the classic explanation of the doctrine: with an intact 
skull, the volume of the brain, blood, and CSF are constant; an increase in one component will 
cause a decrease in one or both of the other elements. 
On the basis of the Monro-Kellie doctrine, intracranial pressure can be described as the 
summation of at least four elements, driven by different physiological mechanisms 7. The first 
element is associated with arterial blood inflow and volume of arterial blood. The most 
common phenomenon associated with this element is plateau waves of ICP. The second 
element of ICP is associated with venous blood outflow. Obstructions to the outflow of blood 
lead to elevation of ICP (like venous compression due to inadequate head position, but also 
venous thrombosis). The third component is related with cerebrospinal fluid (CSF) circulation 
derangements, as commonly seen in ‘acute hydrocephalus’ after traumatic brain injury (TBI) 
or subarachnoid haemorrhage (SAH). In neurocritical care, this component is commonly 
eradicated by extraventricular drainage. Finally, the fourth element relates to increasing brain 
volume (oedema) or volume of contusion (like haematoma). Osmotherapy or surgical 
decompression are therapeutical measures used to eradicate these complications. In clinical 
practice, it is important not only to monitor the absolute value of ICP but also to recognise 
which component is responsible for the pattern of intracranial hypertension observed, as 
different measures are appropriate for controlling different components 8. 
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ICP monitoring is one of the standard protocols that can guide patient management undergoing 
neurocritical care 9. In association with mean arterial blood pressure (ABP), ICP monitoring 
provides the knowledge of cerebral perfusion pressure (CPP = ABP - ICP), interpreted as the 
main force maintaining cerebral blood flow (CBF). However, ICP/CPP are not commonly 
considered in many clinical conditions outside neurocritical care settings or in non-specialized 
centres. The invasiveness of the standard methods for ICP monitoring (epidural, subdural, 
intraparenchymal and intraventricular monitors) and their associated risks to the patient (like 
infections, brain tissue lesions, haemorrhage) contribute to this scenario. Because of such 
complications, ICP monitoring has been prevented in a broad range of diseases, for instance in 
patients with risk of coagulopathy, as well as when invasive monitoring is not considered or 
outweighed by the risks of the procedure. Another downside is related to costs and availability, 
since invasive monitoring is an expensive technique, requires trained personnel and 
neurosurgical settings. The average cost of intraparenchymal microtransducer is around US$ 
600, additionally to US$ 6,000-10,000 for the display monitor 10, which makes it inaccessible 
in low to middle-income regions. Provided that knowledge of ICP can be crucial for the 
successful management of patients in many sub-critical conditions, non-invasive estimation of 
ICP may be helpful when indications for invasive ICP monitoring are not met and when it is 
not immediately available or contraindicated. 
Several methods for non-invasive assessment of ICP have been described so far: transcranial 
Doppler ultrasonography (TCD) to measure cerebral blood flow velocity indices 11; skull 
vibrations 12; skull deformation 13,14;  brain tissue resonance 15; transcranial time of flight 16; 
venous ophthalmodynamometry 17; optic nerve sheath diameter assessment (ONSD) 18; 
tympanic membrane displacement 19,20; otoacoustic emissions 21;  magnetic  resonance imaging 
(MRI) to estimate intracranial compliance 22; ultrasound-guided eyeball compression 23, and 
recordings of visual evoked potentials 24.  
Most of these methods are better suited for one-point assessment of the instant value of ICP 
rather than continuous monitoring. TCD, on the other hand, has been widely explored as a tool 
for non-invasive ICP monitoring 25–39 due to its ability to detect changes in CBF with ample 
time resolution. 
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2.2 Principles of transcranial Doppler ultrasonography 
 
Transcranial Doppler ultrasonography (TCD) technique is based on the phenomenon called 
Doppler effect, observed by the physicist Christian Andreas Doppler in the 19th century. Reid 
and Spencer popularised this principle applied to imaging of blood vessels in the 1970’s 40. The 
application of TCD in clinical practice was first described by Rune Aaslid and collaborators in 
1982 41, as a technique applying ultrasound probes for dynamic monitoring of CBF and vessel 
pulsatility in the basal cerebral arteries.  
The Doppler effect states that when a sound wave with a certain frequency strikes a moving 
object, the reflected wave changes its frequency (the Doppler shift, 𝑓𝑑) directly proportionally 
to the velocity of the reflector. When translated to medical applications, this principle has been 
applied to monitor erythrocyte motion inside an insonated blood vessel by measuring the 
difference in ultrasound frequencies between emission and reception 41. The equation derived 
from this principle is the basis for calculating cerebral blood flow velocity (FV, in cm/s) with 
TCD: 
Equation 2.1 
𝑣 =
(𝑐 ×𝑓𝑑)
2 ×𝑓0 × cos 𝜃
(2.1) 
 
where 𝑐 is the speed of the incident wave, 𝑓0 is the incident pulse frequency, fd is the Doppler 
shift and θ is the angle of the reﬂector relative to the ultrasound probe 42. 
TCD relies on pulsed wave Doppler to image vessels at multiple insonation depths. The 
received echoes generate an electrical impulse in the ultrasound probe and is processed to 
calculate 𝑓𝑑 and 𝑣, yielding a spectral waveform with peak systolic velocity (FVs) and end 
diastolic velocity (FVd) values (Figure 2.1). 
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Figure 2.1. Representation of the systolic (FVs) and diastolic (FVd) components of the spectral cerebral blood 
flow (CBF) velocity (FV) waveform. 
 
 
 
2.3 Assessment of cerebral circulation using transcranial Doppler 
 
The use of low-frequency ultrasound probes (≤2 MHz) allows insonation of basal cerebral 
arteries through different acoustic windows in the skull. These are regions presenting thin bone 
layers, through which ultrasound waves can be transmitted. There are four acoustic windows: 
transtemporal, transforaminal, transorbital and submandibular (Figure 2.2). The transtemporal 
window is the most frequently used, anatomically located above the zygomatic edge between 
the lateral canthus of the eye and auricular pinna. Through this window, it is possible to 
insonate the circle of Willis, specifically middle (MCA), anterior (ACA), posterior cerebral 
arteries (PCA), and terminal internal carotid artery (ICA) 43. Artery insonation is subject to 
probe angle, depth and appropriate acoustic window. However, inadequate transtemporal 
windows have been reported in 10-20% of patients 44,45, associated with patient age, female 
sex, and other factors affecting the bone thickness 46.  
In clinical practice, the MCA is the most frequently assessed artery. It is responsible for the 
greatest blood inflow to the brain (80%) 47,48; thus MCA measurement may represent the global 
blood flow. CBF represents the blood supply to the brain in a given period, and global changes 
in this parameter can be monitored continuously and non-invasively with TCD-derived FV 49. 
However, FV is only proportional to CBF when vessel cross-sectional area and angle of 
insonation are constant. The velocity detected by the probe as a fraction of the actual velocity 
depends on the cosine of the angle of insonation (Equation 2.1). 
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Figure 2.2. Schematic representation of the acoustic windows for transcranial Doppler ultrasonography. 
 
 
 
Consequently, at an angle of zero degrees, the erythrocytes’ velocities are equal (cosine of θ = 
1), whereas, at 90 degrees, no detection of velocity is possible. Anatomically, MCA insonation 
at the transtemporal acoustic window only allows signal capture at narrow angles (<30 
degrees), which approximates the detected velocity to the actual velocity (87% to 100%) 50. 
 
 
Non-invasive estimation of ICP and CPP 
TCD waveform analysis has been explored as a technique for non-invasive estimation of ICP 
(nICP) and CPP (nCPP). TCD-derived nICP/nCPP methods are based on the relationship 
between ICP/CPP and indices derived from cerebral blood flow velocity. 
Applications of TCD for nICP and nCPP monitoring are conceivable if one considers the 
insonated compliant MCA as a biological pressure transducer, whose walls can be deflected by 
transmural pressure (equivalent to CPP), modulating the FV pulsatile waveform accordingly 
39.  
Next chapter presents a comprehensive literature review of the existing methods for nICP and 
nCPP assessment based on transcranial Doppler ultrasonography.
Literature review 
 
32 
 
3 LITERATURE REVIEW 
 
 
This chapter is based on work published in Neurocritical Care 39: 
Cardim, D., Robba, C., Bohdanowicz, M., Donnelly, J., Cabella, B., Liu, X., Cabeleira, M., Smielewski, P., 
Schmidt, B., and Czosnyka, M. (2016). Non-invasive Monitoring of Intracranial Pressure Using Transcranial 
Doppler Ultrasonography: Is It Possible? Neurocrit. Care. 
 
 
 
3.1 Introduction 
 
TCD-based nICP continuous monitoring methods are mainly based on approximate semi-
quantitative relationships between ICP and cerebrovascular dynamics assessed with TCD. 
They can be divided into three categories: I) methods based on the TCD-derived pulsatility 
index (PI); II) methods based on the calculation of nCPP; and III) methods based on 
mathematical models. 
The existing non-invasive ICP methods based on TCD waveform analysis present a 
considerable variability in their reported accuracy inter and intra-categories. Considering the 
wide range of applications of TCD as a technique for nICP monitoring, this review presents 
TCD-based methods and their documented clinical or experimental applications with measures 
of accuracy in comparison to standard invasive methods for ICP monitoring. 
 
 
 
3.2 Methods 
 
Works from 1985 to 2017 were found on PUBMED database using the keywords ‘transcranial 
Doppler non-invasive intracranial pressure’, in a total of 97 studies. The inclusion criteria were 
the use of transcranial Doppler as a tool for non-invasive ICP with clinical or experimental 
applications of such methods. Excluded papers consisted of works on other TCD applications 
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than non-invasive ICP estimation, or absence of clinical or experimental applications in papers 
describing TCD-based methods for non-invasive ICP estimation. Selected articles were then 
subdivided into the categories above. Only available full-length articles in the English language 
were considered. The total number of articles considered was 36; some articles presented 
assessments in more than one category. Works derived from this thesis were not considered in 
this review but will be subsequently presented in the following results chapters. 
Main findings for each nICP category are presented in Table 3.1, Table 3.2 and Table 3.3. 
Sections in results present major attributes of the nICP categories. 
 
 
 
3.3 Results 
 
3.3.1 Methods based on the correlation between ICP and PI (nICPPI) 
 
Methods based on TCD-derived pulsatility index rely on the observation that ICP and PI are 
positively correlated. PI describes quantitatively and qualitatively morphological changes in 
the TCD waveform resulting from varying CPP. It is represented by the difference between 
systolic and diastolic flow velocities divided by the mean velocity, initially described by 
Gosling in 1974 51 (Equation 4.1). 
PI has been reported as inversely proportional to mean CPP, directly proportional to pulse 
amplitude of ABP and non-linearly proportional to the compliance of the cerebral arterial bed 
(Ca), cerebrovascular resistance (CVR) and heart rate (HR) 
52. In Gosling’s original work, 
normal PI values were reported between 0.5-1.19 51. Proximal stenosis or occlusion may lower 
PI below 0.5 due to downstream arteriolar vasodilation, whereas distal occlusion or constriction 
may increase PI above 1.19 53. A PI less than 0.5 may also indicate an arteriovenous 
malformation as the resistance in proximal vessels is reduced due to continuous distal venous 
ﬂow 54.  
More recently, a larger study including more than 350 healthy individuals has reported 
normative values for TCD assessment of arteries in the circle of Willis 55. Normal PI values 
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have been reported as 0.82±0.16 and 0.81±0.13 for distal and proximal MCA, respectively. 
Being a ratio, PI is not affected by the angle of insonation and therefore may be a sensitive 
parameter for early detection of intracranial hemodynamic changes 55. 
Table 3.1. summarises the studies which demonstrated a relationship between PI and ICP, 
either positive or inexistent.
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Method 
 
 
Author 
 
 
Study 
purpose 
 
 
Sample size 
and disease 
 
 
Invasive ICP  
monitoring 
 
 
nICP method accuracy and  
correlation measures with ICP 
 
 
Sensitivity 
 (%) 
 
 
Specificity   
(%) 
 
 
AUC 
nICPPI Steiger56 Investigate PI in 
TBI patients and 
compare them to 
healthy volunteers. 
9, TBI NA PI analysis revealed values from 1.5 to 2.0 in 
control subjects, showing a gradual increase in 
patients with post-traumatic brain oedema. PI 
values ≥3 were associated with severe 
intracranial hypertension. 
 
   
 Chan et al.57 Examine the 
relationships 
between FV, SJO2, 
and alterations in 
ABP, ICP, and 
CPP. 
41, TBI Subdural Rises in ICP or drops in ABP were associated 
with a reduction in FV, particularly with FVd 
falling more than FVs. PI was strongly 
correlated with ICP (R=0.9*). 
 
   
 Homburg et al.58 Investigate the PI-
ICP relation as to 
evaluate TCD as an 
alternative to 
invasive ICP. 
10, TBI Epidural Correlation between PI and ICP was R=0.82.    
 Martin et al.59 Assess PI in three 
distinct 
haemodynamic 
phases 
(hypoperfusion, 
hyperaemia and 
vasospasm). 
125, TBI Intraventricular/In
traparenchymal 
Higher PI values were found in all 
hemodynamic phases during the first 2 weeks 
after injury (on day 0, compared to days 1 
through 3 and days 4 through 14 post-trauma). 
   
 McQuire et al.60 Investigate the 
incidence of early 
abnormalities in the 
cerebral circulation 
after TBI by 
relating the results 
of CT scan with 
TCD-PI. 
22, TBI NM 10 patients presented increased PI in conditions 
indicative of ICH (space-occupying hematomas 
or brain swelling indications on CT). 
   
 Table 3.1. Modified from Cardim et al. 
39. nICP methods based on TCD-derived pulsatility index (nICPPI). 
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 Moreno et al.61 Investigate the 
correlation between 
TCD, ICP and CPP 
in TBI patients. 
125, TBI NA Correlation between PI and ICP was R2=0.69. 
Elevated PI (≥1.56) was predictive of poor 
outcome. 
 
   
 Rainov et al.62 Investigate a 
possible 
relationship 
between PI, RI, FV 
and ICP changes in 
adult patients with 
hydrocephalus. 
29, 
Hydrocephalus 
Epidural PI in patients with elevated ICP before shunting 
was significantly increased. Preshunting ICP 
and PI were not correlated (R=0.37). 
 
   
 Asil et al.32 TCD was compared 
with clinical 
examination and 
neuroradiologic 
findings. 
18, stroke and 
MCA infarction 
NM Increases in PI were correlated with midline 
shift as an indication of elevated ICP (R=0.66*). 
   
 Bellner et al.27 Investigate the 
relationship 
between ICP and PI 
in neurosurgical 
patients. 
81, (SAH, TBI 
and other 
intracranial 
disorders) 
Intraventricular Correlation between PI and ICP was R=0.94* 
 (ICP = 10.93 x PI – 1.28). 
 
In the ICP range of 5-40 mmHg, the correlation 
formula is: 
ICP = 11.5 x PI – 2.23 (R2=0.73*). 
In this interval, SD for nICPPI was ±2.5 mmHg 
in the ICP range of 5-40 mmHg. 
95% CI of ±4.2 mmHg. 
 
 
88 (threshold of 
10 mmHg) 
83 (threshold of 
20 mmHg) 
69 
(threshold of 
10 mmHg) 
99 
(threshold of 
20 mmHg) 
 
 Voulgaris et al.33 Investigate TCD as 
a tool for detection 
of cerebral 
haemodynamics 
changes. 
 
 
37, TBI Intraparenchymal The overall correlation between ICP and PI was 
R=0.64*. 
For ICP ≥20 mmHg, the correlation was 
R=0.82*. 
PI allows early identification of patients with 
low CPP and risk of cerebral ischemia. 
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 Behrens et al.63 Validate TCD as a 
method for ICP 
determination 
INPH 
10, INPH Intraparenchymal Correlation between PI and ICP was R2=0.22* 
(ICP=23 x PI + 14). 
95% CI for a mean ICP of 20 mmHg was −3.8 
to 43.8 mmHg. 
PI is not a reliable predictor of ICP. 
 
   
 Figaji et al.28 Examine the 
relationship 
between PI and ICP 
and CPP in children 
with severe TBI. 
34 children, TBI NM Marginal correlation between PI and ICP of 
R=0.36*. 
No significant relationships between PI and ICP 
when differences within individuals or binary 
examination of PI (PI <1 and ≥1) were 
considered. 
PI is not a reliable non-invasive indicator of ICP 
in children with severe TBI. 
 
25 (threshold of 
20 mmHg) 
88 
(threshold of 
20 mmHg) 
 
 Brandi et al.64 Assess an optimal 
nICP and nCPP 
following TBI 
using TCD. 
45, TBI Intraventricular Bellner’s equation resulted in nICP similar to 
measured ICP, with nICP of 10.6±4.8 and ICP 
of 10.3±2.8 mmHg. 
 
   
         
         
 Tude Melo et al.65 Evaluate the 
accuracy of TCD in 
emergency settings 
to predict 
intracranial 
hypertension and 
abnormal CPP in 
children with TBI. 
117 children, 
TBI 
Intraparenchymal PI ≥1.31 was observed in 94% of cases with 
initially elevated ICP, and 59% of those with 
normal initial ICP values. 
TCD is an excellent first-line examination to 
screen children who need urgent treatment and 
continuous invasive ICP monitoring. 
 
 
 
 
 
94 (for detecting 
initial ICH) 
95 (for 
detecting 
initial ICH) 
 
 
 
 
 
 
 
 
 Zweifel et al.66 Assess PI as a 
diagnostic tool for 
nICP and nCPP 
estimation. 
290, TBI Intraparenchymal Correlation between PI and ICP was R=0.31*. 
95% prediction interval > ±15 mmHg. 
The value of PI to assess nICP is insufficient. 
  0.62 (ICP ≥15 
mmHg) 
0.74 (ICP ≥35 
mmHg) 
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 De Riva et al.52 Assess the 
relationship 
between PI and 
CVR in situations 
where CVR 
increases (mild 
hypocapnia) and 
decreases (plateau 
waves of ICP) in 
TBI patients. 
345, TBI Intraparenchymal Correlation between PI and ICP in such 
situations was R=0.70*. 
95% CI of ±21 mmHg. 
   
 Wakerley et al.38  Assess the 
correlation between 
PI with CSF 
pressure. 
78,  
miscellaneous 
intracranial 
disorders 
 
LP Correlation between PI and ICP (CSF pressure) 
was R=0.65*. 
Binomial logistic regression indicated a strong 
significant relationship between raised ICP and 
PI (OR: 2.44; 95% CI: 1.57-3.78). 
81.1 96.3 0.84 (threshold 
≥20  cmH20) 
 Wakerley et al.37 Present a case 
where TCD serves 
as an effective tool 
for nICP 
monitoring. 
Case-report,  
Sagittal Sinus 
Thrombosis 
NM Increasing ICP was associated with rapid 
elevations of PI. On recording day 4, PI was 
reported to be 1.93 (considering a normal range 
of 0.6-1.2). ICP was deemed elevated according 
to clinical status (level of consciousness, 
headache) and papilledema. 
 
   
 O’Brien et al.67 Determine the 
relationship 
between PI, FVd 
and ICP in children 
with severe TBI. 
36 children, TBI Intraventricular/In
traparenchymal 
Initial 24 h post-injury 
Correlation between PI and ICP was R=0.6*. 
Beyond 24 h post-injury 
Correlation between PI and ICP was R=0.38*. 
 
 
Initial 24 h 
post-injury 
100 (threshold 
≥20  mmHg for 
PI of 1.3) 
Beyond 24 h 
post-injury 
47 (threshold 
≥20  mmHg for 
PI of 1.3) 
 
Initial 24 h 
post-injury 
82 
(threshold 
≥20  mmHg 
for PI of 1.3) 
 
 
Literature review 
 
39 
 
*Correlation coefficient is significant at the 0.05 level.  
ABP, arterial blood pressure; AUC, area under the curve; CI, confidence interval;  CT, computerized tomography; CSF; cerebrospinal fluid; FVd, diastolic flow velocity; ICH, 
intracranial hypertension; INPH, idiopathic normal pressure hydrocephalus; LP, lumbar puncture; MCA, middle cerebral artery; NA, not available; NM, not measured; NPV, 
negative predictive value; OR, odds ratio; PPV, positive predictive value; R correlation coefficient; R2, coefficient of determination; ; RI, resistance index; SAH, subarachnoid 
haemorrhage; SD, standard deviation; SJO2, jugular bulb venous blood oxygen saturation; TBI, traumatic brain injury. 
 
 
 Robba et al.68 Assess PI as a nICP 
estimator in rabbits 
submitted to the 
infusion of artificial 
CSF solution into 
the subarachnoid 
space. 
Experimental 
(28 New 
Zealand rabbits) 
Intraparenchymal Correlation between PI and ICP was R=0.54*. 
R considering changes of nICP and ICP in time 
domain was 0.36±0.47. 
95% CI of ±38.56 mmHg. 
  0.62 (≥20 
mmHg) 
0.66 (≥40 
mmHg) 
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3.3.2 Methods based on nCPP estimation  
 
The second approach for nICP monitoring was primarily intended for nCPP estimation. 
However, non-invasive ICP can be calculated based on the assumption that                                     
nICP = ABP - nCPP. There are four methods described in the literature (Table 3.2).  
 
Aaslid et al. 69 (nICPAaslid) 
Aaslid et al. (1986) 69 were the pioneers in developing a mathematical model for non-invasive 
estimation of CPP based on Transcranial Doppler waveform analysis. Supported by the 
knowledge that increased ICP was related to decreasing component of the flow waveform in 
the internal carotid artery 70, the authors deemed feasible that less evident changes in the flow 
pattern could be detected by more refined methods of waveform analysis. TCD, in such 
perspective, could be used to obtain an estimate of ICP. Considering CPP as the driving force 
for flow through the cerebral vascular bed and the main factor for determining pulsatile 
dynamics, the flow will be approximately proportional to CPP 69.  
During increases in ICP, the proportion of the systolic to the diastolic CPP increases as ICP 
approaches the diastolic ABP. Consequently, the pulsatile component of CPP increases 
proportionally to its mean value and this would also be reflected in the FV waveform. Thus, 
the ratio between mean FV (FVm) and pulsatile amplitude of FV (f1) would be expected to be 
related to CPP. The simplest approach, in this case, would be to use this ratio as an index for 
CPP. However, it does not consider changes in the ratio caused by variations in the amplitude 
of ABP waveform. Such limitation was solved by multiplying the ratio described above by the 
amplitude of the first harmonic of ABP (a1) 69: 
Equation 3.1 
𝑛𝐶𝑃𝑃𝐴𝑎𝑠𝑙𝑖𝑑 = (𝐹𝑉𝑚 𝑓1⁄ ) × 𝑎1  𝑚𝑚𝐻𝑔 (3.1) 
 
This method was validated in patients with supratentorial hydrocephalus undergoing 
ventricular infusion tests. ABP (radial artery), ICP (ventricular pressure) and FV were 
measured. The linear regression determined for nCPP estimation considering all cases was: 
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Equation 3.2 
𝐶𝑃𝑃 = 1.1 𝑛𝐶𝑃𝑃𝐴𝑎𝑠𝑙𝑖𝑑 − 5 𝑚𝑚𝐻𝑔 (3.2) 
 
In the individual case, there was a strong correlation between nCPP and CPP, R=0.93 to 0.99. 
The standard deviation (SD) between nCPP and CPP was 8.2 mmHg at 40 mmHg, while the 
mean deviation was only 1 mmHg. Overestimation occurred in two cases, 10 and 18 mmHg 
respectively. Underestimation was present in other two cases, 9 and 8 mmHg respectively. For 
the six remaining cases, the estimates were within ±5 mmHg of measured CPP. The method 
could differentiate correctly between low (<40 mmHg) and normal (>80 mmHg) CPP in all 
patients. At higher levels of CPP, the estimates presented with low accuracy, showing correct 
differentiation between CPPs of 70 and 100 mmHg in 80% of the cases. 
In another attempt of assessment, Czosnyka et al. 71 reported that although sufficiently sensitive 
to detect changes of CPP over time, this method presented limited accuracy, showing a 95% 
prediction error (PE) of ±27 mmHg. 
Considering studies on animal experimentation, Robba et al. 68 assessed this method in rabbits 
submitted to intracranial hypertension (ICH) through the infusion of artificial CSF solution into 
the subarachnoid space. ICP was increased to 70-80 mmHg, and the overall correlation between 
mean values of nICPAaslid and ICP was of 0.53 (p<0.05). The ability to detect increased ICP 
above 20 and 40 mmHg was calculated using receiver operating characteristic analysis (ROC), 
revealing areas under the curve (AUC) of 0.66 and 0.77, respectively. Considering only 
changes in time between nICP and ICP, averaged correlation was 0.61±0.35. The 95% 
confidence interval (CI) for ICP prediction was 59.60 mmHg. 
 
Czosnyka et al. 71 (nICPFVd) 
Some studies have demonstrated that certain patterns of the TCD waveform, like a decrease in 
FVd, reflect impaired cerebral perfusion caused by a CPP decrease 
71,72 (Figure 3.1). Czosnyka 
et al. 71 described this relationship as Equation 4.6. 
The correlation between nCPP and measured CPP in TBI patients was R=0.73; p<0.001. In 
71% of the examinations, the estimation error was below 10 mmHg, and in 84% of the 
examinations, the error was less than 15 mmHg. The method had a high positive predictive 
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value (94%) for detecting low CPP (<60 mmHg). Estimated CPP was highly specific for 
detecting changes in measured CPP over time, caused either by increases in ICP (plateau 
waves) or systemic hypotension. In six patients presenting plateau waves, nCPP compared with 
measured CPP had an average goodness-of-fit coefficient R2 of 0.82. Furthermore, nCPP was 
very sensitive to detecting decreases in ABP below 70 mmHg (in 10 patients) with an average 
goodness-of-fit coefficient R2 of 0.92. A good correlation was found between the average 
measured CPP and nCPP when day-by-day variability was assessed in a group of 41 patients 
(R=0.71). 
The accuracy of this method in TBI patients was prospectively assessed by Schmidt et al. 73. 
The absolute difference based on daily averages between direct CPP and nCPP was less than 
10 mmHg in 89% of measurements and less than 13 mmHg in 92% of measurements. The 95% 
CI for CPP prediction was ±12 mmHg for CPP varying from 70 to 95 mmHg.  
In another independent assessment of this method 74, mean values of nCPP and invasive CPP 
were 66.10±10.55 mmHg and 65.40±10.03 mmHg, respectively. The correlation between non-
invasive and invasive CPP measurements was strongly significant, R=0.92 (p<0.001).  
 
Figure 3.1. Extracted from Cardim et al., 2016 39. Systolic and diastolic flow velocities behaviour during a drop 
of cerebral perfusion pressure during a plateau wave increase of ICP observed in a TBI patient (source: Brain 
Physics Laboratory TBI Database, University of Cambridge). FVd component, in this case, indicates inadequate 
cerebral perfusion.  
 
CPP, cerebral perfusion pressure, FVs, systolic flow velocity; FVd, diastolic flow velocity, ICP, intracranial 
pressure; TBI, traumatic brain injury. 
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In another study 64, the comparison between measured ICP and CPP showed a bias±95% CI of 
5.6±17.4 mmHg for nICP and −5.5±20.6 mmHg for nCPP. 
In an experimental study68, during ICP increase to 70-80 mmHg the overall correlation between 
mean values of nICP and measure ICP was of 0.77 (p<0.05). The ability to detect increased 
ICP above 20 and 40 mmHg was given by AUCs of 0.86 and 0.94, respectively. Considering 
only changes of nICP and ICP in the time domain, the averaged correlation was 0.85±0.11. The 
95% CI was 26.26 mmHg. 
More recently, Rasulo et al. 75, compared nICPFVd with invasive ICP in three time frames: 
immediately before ICP placement, immediately after ICP placement, and 3 hours following 
ICP positioning. 12 patients (31.6%) presented episodes of ICP >20 mm Hg. The combined 
AUC for the three time points was 0.96 (95% CI 0.898-1) for ICH prediction. Sensitivity and 
specificity for the estimated best threshold (24.8 mm Hg) were 100% and 91.2%, respectively. 
The estimation bias was 6.2 mmHg (95% CI 5.08-7.30). 
 
Edouard et al. 76 (nICPEdouard) 
This method is based on a non-invasive assessment of CPP using a combination of phasic 
values of both MCA FV and ABP. It was primarily validated in pre-eclamptic and healthy 
pregnant women by comparing nCPP with CPP measured at the epidural space 77. 
In Edouard and colleagues’ prospective study 76, the objective was to assess the adequacy of 
such method for TBI patients with invasive ICP monitoring, in both a stable state and during a 
rapid change in cerebrovascular tone following an induced alteration in arterial blood carbon 
dioxide pressure (PaCO2). 
The non-invasive CPP (nICPEdouard) was calculated using the following formula: 
Equation 3.3 
𝑛𝐶𝑃𝑃𝐸𝑑𝑜𝑢𝑎𝑟𝑑 = (
𝐹𝑉𝑚
𝐹𝑉𝑚 −  𝐹𝑉𝑑
) × (𝐴𝐵𝑃𝑚 − 𝐴𝐵𝑃𝑑)  𝑚𝑚𝐻𝑔 (3.3) 
 
ABPm and ABPd represent the mean and diastolic ABP, respectively.  
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Twenty adults with bilateral and diffuse brain injuries were included in the study and 
subdivided into two groups. In group A (N=10), the comparison was repeatedly performed 
under stable conditions. In group B (N=10), the comparison was conducted during a CO2 
reactivity test. nICP was not estimated in this study. 
In group A, nCPP and measured CPP were correlated (slope, 0.76; intercept, +10.9; 95% CI, -
3.5 to +25.4). The relationship persisted during ICP increase caused by the reactivity test in 
group B (slope, 0.55; intercept, +32.6; 95% CI, +16.3 to +48.9). However, the discrepancy 
between nCPP and measured CPP increased as reflected by the increase in bias and variability. 
In another study 64, this method was tested for nICP and nCPP estimations, in a cohort of 45 
TBI patients. Bias±95% CI for prediction was 6.8±19.7 mmHg and −6.8±45.2 mmHg for nICP 
and nCPP, respectively. 
 
Varsos et al. 78 (nICPCrCP) 
The concept of critical Closing Pressure (CrCP) was first introduced by Burton’s model, 
described as the sum of ICP and vascular wall tension (WT) 79. WT represents the active 
cerebral vasomotor tone that combined with ICP determines the CrCP. Clinically, CrCP 
represents the lower threshold of ABP below which blood pressure in the brain 
microvasculature is inadequate to prevent the collapse and cessation of blood flow 79. CrCP 
can be assessed non-invasively using TCD, by comparing the pulsatile waveforms of FV and 
ABP. Given the association with the vasomotor tone of small blood vessels, CrCP can to 
provide information regarding the state of cerebral haemodynamics and reflect changes in CPP 
79–83 (Figure 3.2). 
The conception and assessment of the model for the non-invasive estimator of CPP (nCPPCrCP) 
were performed using a cohort of 280 TBI patients, divided into two subgroups: the formation 
group with 232 patients (including 455 recordings) and the validation group with 48 patients 
(including 325 recordings). Equations describing the model are presented in Section 4.2.3 
(Equation 4.2, Equation 4.3, Equation 4.4, Equation 4.7, Equation 4.8). 
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Figure 3.2. Extracted from Cardim et al., 2016 39. Representation of the CrCP interaction with ICP and WT in a 
situation of intracranial hypertension observed in a traumatic brain-injured patient (source: Brain Physics 
Laboratory TBI Database, University of Cambridge). During the increase of ICP, the CrCP also increases and WT 
decreases as an effect of preserved autoregulation.  
 
 
ABP, arterial blood pressure; CrCP, critical closing pressure; ICP, intracranial pressure; WT, wall tension; TBI, 
traumatic brain injury. 
 
nCPPCrCP was tested against invasive CPP using data from the validation group. nCPPCrCP was 
correlated with measured CPP (R=0.85, p<0.001), with a bias of 4.02±6.01 mmHg; in 83.3% 
of the cases with an estimation error below 10 mmHg. nCPPCrCP prediction analysis at low CPP 
limits (50, 60, and 70 mmHg) resulted in AUCs greater than 0.8 for all limits. nCPPCrCP was 
found to be strongly correlated with CPP changes in the time domain (mean R=0.733, range 
0.231–0.993). For each patient, nCPPCrCP presented a mean difference from CPP of 3.45 mmHg 
(range -4.69 to 19.03 mmHg), and a mean standard deviation of this difference of 5.52 mmHg 
(range 1.52–10.76 mmHg). nCPPCrCP could predict CPP between multiple recording sessions 
with a 95% CI of 1.89–5.01 mmHg.  
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Method 
 
Author 
 
Study 
purpose 
 
Sample size and 
disease 
 
Invasive ICP 
monitoring 
 
nICP/nCPP method accuracy and  
correlation measures with ICP/CPP 
 
AUC 
 
PPV  
(%) 
 
NPV 
(%) 
nICPAaslid Aaslid et al.69 Describe and assess a 
method for nCPP 
calculation based on 
FV and ABP. 
10, supratentorial 
hydrocephalus 
Intraventricular SD for nCPP estimation of 8.2 mmHg at 40 mmHg. 
Able to differentiate between low (≤40 mmHg) and normal 
(≥80 mmHg) CPP in all cases. 
Low accuracy (80%) at higher levels of CPP (70-100 mmHg). 
   
Czosnyka et al.71 Assessment of  
nICPAaslid. 
96, TBI Intraparenchymal 95% PE for nCPP estimation was >27 mmHg. 
Sensitive to detect changes of CPP over time. 
   
 Robba et al.68 Assessment of  
nICPAaslid. 
Experimental (28 
rabbits) 
Intraparenchymal Correlation between nICP and ICP was R=0.53*. 
R in the time domain of 0.61±0.35. 
95% CI of ±59.60 mmHg. 
0.66 (≥20 
mmHg) 
0.77 (≥ 40 
mmHg) 
  
nICPFVd 
 
Czosnyka et al.71 Describe and assess a 
method for nCPP 
calculation based on 
FV (using the 
concept of FVd) and 
ABP. 
96, TBI Intraparenchymal Correlation between nCPP and CPP was R=0.73*. 
Estimation error was less than 10 and 15 mmHg in 71 and 
84% of the cases, respectively. 
Highly specific for detecting changes over time:  R2=0.82. 
Averaged correlation considering day-by-day variability 
between CPP and nCPP was R=0.71. 
 
 94 (CPP 
≤60 
mmHg) 
 
Schmidt et al.73 Assessment of 
nICPFVd. 
25, TBI Intraparenchymal Error for nCPP estimation was less than 10 and 13 mmHg in 
89 and 92% of the cases respectively. 
95% CI of ±12 mmHg. 
   
Gura et al.74 Assessment of  
nICPFVd. 
47, TBI Intraparenchymal Correlation between nCPP and CPP was R=0.92*. 
Mean values of nCPP and CPP were 66.10±10.55 mmHg and 
65.40±10.03 mmHg, respectively. 
   
Table 3.2. Modified from Cardim et al. 39. nICP methods based on non-invasive cerebral perfusion pressure estimation. 
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Brandi et al.64 Assess an optimal 
nICP and nCPP 
following TBI using 
TCD. 
45, TBI Intraparenchymal nICP:  
Bias of 5.6  mmHg 
and 95% CI of ±17.4 mmHg. 
nCPP: 
Bias of −5.5  mmHg 
 and 95% CI of ±20.6 mmHg. 
   
 Robba et al.68 Assessment of  
nICPFVd. 
Experimental (28 
rabbits) 
Intraparenchymal Correlation between ICP and nICP was R=0.77*. 
R in the time domain of 0.85±0.11. 
95% CI of ±26.26 mmHg. 
0.86 (≥20 
mmHg) 
0.94 (≥40 
mmHg) 
  
 Rasulo et al.75 Assessment of  
nICPFVd. 
38, acute brain injury 28 
intraparenchymal, 
10 
intraventricular 
Bias of 6.2 mmHg  
and 95% CI of 11.8 mmHg 
0.96 (≥20 
mmHg) 
  
nICPEdouard Edouard et al.76 Describe and assess a 
method for nCPP 
calculation based on 
FV and ABP under 
stable conditions and 
during CO2 reactivity 
test. 
20, TBI Intraparenchymal During normocapnia: 
nCPP and CPP were correlated (slope, 0.76; intercept, 10.9; 
95% CI, -3.5 to 25.4 mmHg). 
During hypercapnia: 
nCPP and CPP were correlated, but with increased 
discrepancy, as reflected in confidence interval 
(slope, 0.55; intercept, 32.6; 95% CI, 16.3 to 48.9 mmHg). 
 
   
Brandi et al.64 Assessment of 
nICPEdouard. 
45, TBI Intraparenchymal nICP: 
Bias of 6.8 mmHg and 95% CI ±19.7 mmHg. 
nCPP: 
Bias of -6.8 mmHg and 95% CI ±45.2 mmHg. 
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*Correlation coefficient is significant at the 0.05 level.  
AUC, area under the curve; ABP, arterial blood pressure; CI, confidence interval; FV, cerebral blood flow velocity; NPV, negative predictive value; PPV, positive predictive 
value; PE, prediction error; R correlation coefficient; R2, coefficient of determination; SD, standard deviation; SAH, subarachnoid haemorrhage; TBI, traumatic brain injury. 
 
 
 
 
 
 
nICPCrCP 
 
 
 
 
 
 
Varsos et al.78 Describe and assess a 
method for nCPP 
calculation based on 
FV (using the 
concept of CrCP) and 
ABP. 
280, TBI Intraparenchymal Correlation between nCPP and CPP was R=0.85*. 
Bias±SD of 4.02±6.01 mmHg. 
nCPP estimation error was below 10 mmHg in 83.3% of the 
cases. 
 
Temporal analysis: 
Mean correlation in time domain was R=0.73 (0.23–0.99). 
Bias of 3.45 mmHg (range: 4.69-9.03 mmHg). 
Mean SD of 5.52 mmHg (range: 1.52–10.76 mmHg) and 95% 
CI of the SD of 1.89–5.01 mmHg. 
 
>0.8   
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3.3.3 Model-based nICP methods 
 
 
Black-Box model for ICP estimation (nICPBB) 
In this model, the intracranial compartment is considered a black-box (BB) system, with ICP  
being a system response to the incoming signal ABP 25. This mathematical model originates 
from systems analysis, which provides a method to describe the transmission characteristics, 
with input and output signals. The intracranial compartment is indirectly described by a transfer 
function 84,85 which connects the assumed input signal, ABP, with the output signal, ICP. Two 
linear models are first established to depict the relationship between ABP and ICP and that 
between ABP and FV, yielding two coefficients, f and w, respectively. By applying this linear 
mapping function, non-invasive ICP estimation can be performed by first estimating f from the 
coefficients w obtained from ABP and FV (TCD characteristics). An estimate of ICP can then 
be derived from ABP using the calculated f. The output data provides a continuous full 
waveform of nICP (in mmHg) and constant relationship between FV-ABP (Figure 3.3).  
nICPBB was first validated in a cohort of 11 TBI 
25. For each patient, measured and predicted 
ICP were compared during a time interval of 100 s. As a measure of the simulation’s accuracy, 
the mean of the absolute values of the differences (bias) between measured and predicted ICP 
values (MAD-ICP) was obtained. To verify the simulation’s capability of predicting the mean 
ICP averaged over one cardiac cycle (ICPCC), the mean of the absolute differences (bias) 
between measured and predicted ICPCC (MAD-ICPCC) was calculated. 
The MAD-ICP was smaller than 3 mmHg in 4 patients and smaller than 5 mmHg in 8 patients, 
and the maximum MAD-ICP was 7.5 mmHg. The MAD-ICPCC was slightly lower than the 
MAD-ICP; it was smaller than 3 mmHg in 4 patients and smaller than 5 mmHg in 9 patients, 
and again the maximum was 7.5 mmHg. On average, the patients’ MAD-ICP was 4.0±1.8 
mmHg, and the MAD-ICPCC was 3.8±1.9 mmHg. The 95% CI for ICP prediction was smaller 
than 5 mmHg in 3 patients and smaller than 10 mmHg in 8 patients, and the maximum was 
12.8 mmHg. The 95% CI for ICPCC was smaller than 5 mmHg in 4 patients and smaller than 
10 mmHg in 11 patients, and the maximum was 11.7 mmHg. 
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Figure 3.3. Extracted from Cardim et al., 2016 39. Schematic representation of the black-box model for nICP 
estimation. A known transfer function (represented by a linear model) between ABP and FV, alongside 
modification TCD characteristics, are used as means to continuously find a relationship between ABP and nICP 
transformations (unknown transfer function – a linear model between ABP and ICP).  
 
 
ABP, arterial blood pressure; FV, cerebral blood flow velocity; TCD, transcranial Doppler; nICP, non-invasive 
intracranial pressure. 
 
 
In another study, this method was applied in patients with different types of hydrocephalus as 
an aid to predict the time course of raised ICP during infusion tests, and its suitability for 
estimating the resistance to cerebrospinal fluid outflow (RCSF) 
30. The mean absolute error 
(bias) found between actual and simulated RCSF was 4.1±2.2 mmHg minute/ml, considering all 
types of hydrocephalus (N=21 patients). In this case, the correlation between actual and 
simulated RCSF was R=0.73 (p<0.001). By constructing simulations specific to different 
subtypes of hydrocephalus arising from several causes, the mean error decreased to 2.7±1.7 
mmHg minute/ml, whereas the correlation coefficient increased to R=0.89 (p<0.001).  
Another clinical application of this method considered nICP during plateau waves of 
intracranial pressure 26. The objective of this study was to clarify whether simultaneous changes 
of FV and ABP could assess such waves non-invasively in a cohort of 17 severely TBI patients. 
Plateau waves were observed in 7 of them. In both direct ICP and nICP recordings, similar 
typical plateau shapes of waveforms could be observed. On average, bias (ICP-nICP) was 
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8.3±5.4 mmHg at the baseline and 7.9±4.3 mmHg at the top of plateau waves. Increases of 
nICP and direct ICP during plateau waves showed a strong correlation, R=0.98 (p<0.001). 
This method was also applied to assess the impact of cerebral autoregulation to nICP 
assessment and investigate the ability of the model to adapt to the state of cerebral 
autoregulation (SCA), in order to improve the quality of nICP estimation and non-invasive 
assessment of pressure reactivity of the cerebrovascular system (PRx) 26,31. The study included 
145 patients with acute brain injury (135 TBI and 10 stroke). A FV-CPP relating index (Mx) 
was calculated as a correlation coefficient of 36 samples of CPP and FV mean values. The 
positive association between CPP and FV (Mx>0) indicates the passive dependence of blood 
flow on CPP, and therefore impaired autoregulation. Negative values of Mx implicate active 
cerebrovascular responses to changes in CPP or ABP, and therefore preserved autoregulation 
86. PRx (pressure reactivity index) works similarly to Mx but takes into account active 
regulation in cerebral blood volume 87,88.  
nICP was calculated from data collected in 197 different recordings of 145 patients. In 167 
recordings, the dynamics of FV or ABP met the inclusion criteria for the evaluation of SCA. 
In these recordings, Mx and PRx were calculated from FV, ABP, and measured ICP; nMx and 
nPRx were calculated with nICP instead of ICP. 
Correlations between Mx and nMx and between PRx and nPRx were significant, R=0.90 and 
R=0.62 (p<0.001), respectively. In 125 recordings of 106 patients, Mx was definite (>0.2 or  
<-0.2). In 2 of these recordings, the value of nMx was contradictory to Mx. Subsequently, nMx 
indicated definite SCA in 121 recordings of 104 patients. nMx was contradictory to Mx in 3 
cases. The specificity of nMx for Mx estimation was 92% and sensitivity 97%. 
The sensitivity of nPRx for predicting PRx values was 61%, and its specificity was 67%. The 
median ∆ICP (bias) (ICP-nICP) was 6.0 mmHg. In 75% of the evaluated recordings, ∆ICP was 
<9.1 mmHg. A paired comparison of nICP assessments with a fixed nICP procedure showed 
significantly lower ICP estimation errors if the nICP procedure was adapted to SCA (mean 
errors: 7.6 and 6.9 mmHg; p<0.005). Considering only TBI patients, the mean ∆ICP was 7.1 
mmHg; considering only stroke, it was 4.3 mmHg.  
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Cerebrovascular dynamics model for estimation of ICP 29,36 (nICPHeldt) 
This model-based nICP method focuses on the major intracranial compartments and their 
associated variables: brain tissue, cerebral vasculature and CSF. It continuously estimates and 
tracks ICP using measurements of peripheral ABP and FV in the MCA. This physiological 
model of cerebrovascular dynamics is represented by a circuit analogue and provides 
mathematical limits that relate the measured waveforms to ICP. Patient-specific ICP 
estimations are produced by an algorithm, with no calibration or training in specific populations 
needed. Ursino and Lodi 89 initially described the dynamical model of CSF and cerebral blood 
flow, then modified by many independently working neuroscientists.  
The nICPHeldt method was validated in a cohort of 37 TBI patients with severe closed head 
injury, in a total of 45 recordings. Thirty of these recordings presented bilateral FV monitoring. 
The correlation coefficient between nICPHeldt and measured ICP was R=0.90 for the total data 
obtained on the 2665 non-overlapping estimation windows. The bias of nICPHeldt versus 
measured ICP in this case across all patients was 1.6 mmHg and standard deviation of the error 
(SDE) of 7.6 mmHg. The overall correlation coefficient with measured ICP (ranging up to 100 
mmHg) was strong (R=0.9). However, considering only the bilateral recordings, the correlation 
dropped to 0.76, despite the smaller SDE of 5.9 mmHg due to the narrower range of ICP 
variation (few points above 40 mmHg). On a patient-record basis of the 45 estimates, the 
correlation coefficient was 0.92, reflecting the fact that the average ICP covers a range of about 
75 mmHg across these records, whereas the SDE was under 6 mmHg. 
The ability of the method to correctly identify elevated ICP was tested for the 2665 data pairs, 
considering a nICP threshold of 20 mmHg. The estimates presented a sensitivity of 83% and a 
specificity of 70%. A full receiver operating characteristic was obtained by varying the nICP 
threshold from 0 to 100 mmHg. This resulted in an AUC of 0.83. This procedure was repeated 
on a patient-record basis using the threshold of 20 mmHg, and the sensitivity and specificity 
were 90% and 80%, respectively. In this case, the ROC analysis, also obtained by varying the 
nICP threshold, had an AUC of 0.88. 
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Models based on non-linear regressions  
 
Modified nICPBB 
The previously described black-box model for ICP estimation 25 adopts a linear relationship 
among ABP, ICP and FV. Xu et al. 90, assuming that the relationships among these three signals 
are more complex than simple linear models, and consequently not adequate to depict the 
relationship between f and w coefficients, investigated the adoption of several nonlinear 
regression approaches. Considering that non-linear regressions, such as support vector 
machines (SVM)91, kernel spectral regression (KSR) 92, have been proved to be more powerful 
for the prediction problem than the linear ones 93,94, the authors proposed the use of these 
approaches to model the relationship between coefficients f and w. 
Modified nICPBB showed that the mean ICP error by the non-linear approaches could be 
reduced to below 6.0 mmHg compared to 6.7 mmHg of the original approach. Moreover, the 
ICP estimation error by the proposed non-linear kernel approaches was statistically smaller 
(p<0.05) than that obtained with the original linear model. 
 
Data mining 
Hu et al. 95 initially proposed an innovative data-mining framework for nICP assessment. The 
proposed framework explores the rules of deriving ICP from ABP and FV that are captured 
implicitly by a signal database without using an explicit mathematical model. The main 
strategy of this framework is to provide a mapping function to quantify the uncertainty of an 
ICP estimate associated with each database entry, and to use this information to determine the 
best entry to build an ICP simulation model for an optimal ICP estimation. It achieved 
significant improvements regarding ICP simulation accuracy. In comparison to nICPBB, for 
example, the proposed method presented a median normalised prediction error for ICP of 39% 
compared to 51% of nICPBB, and its median correlation coefficient between estimated and 
measured normalised ICP was 0.80 compared to 0.35 of nICPBB.    
In another work, Kim et al. 96 aimed at adopting a new (linear and non-linear) mapping 
functions into the previous data mining framework for nICP estimation to demonstrate that the 
performance of nICP assessment could be improved by utilising proper mapping functions. 
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The new framework used a database of simultaneously recorded signals (ABP, FV and ICP) 
and dynamic models of the signals (inputs: ABP and FV, output: ICP). Two types of relevant 
data are drawn from this database: hemodynamic features and dissimilarity measures. 
Hemodynamic features are extracted from ABP and FV to capture the characteristic aspects of 
the cerebral haemodynamic state. Dissimilarity measures are calculated as the distance between 
actual ICP and its estimates, obtained by simulating the dynamic models in the database. This 
approach quantifies how closely each dynamic model can estimate actual ICP only using the 
corresponding ABP/FV signals.  
The main strategy of the data mining framework is to formulate a mapping function between 
haemodynamic features and dissimilarity measures. The results demonstrated that a non-linear 
mapping function based on kernel spectral regression significantly improves the performance 
of the proposed data mining framework for nICP assessment in comparison to other linear 
mapping functions, showing a median ICP estimation error of 4.37 mmHg. 
 
Semisupervised machine learning 
As previously seen, FV waveform analysis has frequently been applied for non-invasive ICP 
assessment. Kim et al. 97 introduced a non-invasive ICH detection method based on the TCD 
measurement of FV alone to demonstrate its performance both in the supervised and 
semisupervised learning settings. 
ICH detection is a classification problem to differentiate patients with elevated ICP from those 
with normal (or low) ICP. The traditional approach uses only labelled samples to train a given 
classifier, referred to as supervised learning. The major drawback of this method is that it 
cannot utilise unlabelled samples even when useful information learned from them may result 
in the improvement of classification accuracy.  
To address the ambiguity in labelling samples, the authors adopted a new classification 
approach, a semisupervised learning. With this concept, labelling is not necessary since 
classifiers can be trained using both labelled and unlabelled samples.  
Simulation results demonstrated that the predictive accuracy (AUC) of the semisupervised 
method could be as high as 92%, while that of the supervised method was only around 82%. 
AUC of the PI-based method was as low as 59%. A decision curve analysis showed that the 
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semisupervised ICH detection method was not only more accurate but also clinically more 
useful than the supervised ICH detection method or the PI-based ICH detection method. 
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Method 
 
 
Author 
 
Study 
purpose 
 
Sample size 
 and disease 
 
Invasive ICP 
monitoring 
 
nICP method accuracy and  
correlation measures with ICP 
 
Sensitivity 
(%) 
 
Specificity 
(%) 
 
AUC 
nICPBB Schmidt et 
al.25  
Describe and 
assess a method 
for nICP 
calculation based 
on FV and ABP 
using a black box 
model. 
11, TBI Epidural Bias of 4.0 mmHg and SDE of 1.8 mmHg. 
In this cohort, a maximum 95% CI of 
±12.8 mmHg was found. 
   
Schmidt et 
al.30  
This study aimed 
at predicting the 
time course of 
raised ICP during 
CSF infusion tests 
and its suitability 
for estimating the 
RCSF using nICPBB. 
21, different types of 
hydrocephalus 
Epidural  Analysis of all records: 
Correlation between nRCSF and RCSF was 
R=0.73*. 
Bias of 4.1 mmHg and SDE for RCSF 
prediction of 2.2 mmHg . minute/ml. 
 
Analysis specific to different subtypes of 
hydrocephalus:   
Correlation between nRCSF and RCSF was 
R=0.89*. 
Bias of 2.7 mmHg and SDE for RCSF 
prediction of 1.7 mmHg . minute/ml.  
 
   
Schmidt et 
al. 26 
Assess nICPBB 
during plateau 
waves of ICP. 
17, TBI (Plateau (A) waves 
observed in 7 patients) 
Intraparenchymal Correlation between nICP and ICP during 
ICP increase was R=0.98*. 
 
Analysis considering the baseline of 
plateau waves: 
Bias of 8.3 mmHg and SDE of 5.4 mmHg.  
Analysis considering the top of plateau 
waves: 
Bias of 7.9 mmHg and SDE of 4.3 mmHg. 
Increases of nICP and direct ICP during 
plateau waves: 
R=0.98 (p<0.001) 
 
   
Table 3.3. Modified from Cardim et al. 39. nICP methods based on mathematical models. 
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Schmidt et 
al.31 
This study aimed 
at investigating the 
ability of nICPBB 
to adapt to the 
SCA, using Mx 
and PRx as 
parameters. 
 
145 (135 TBI, 10 Stroke)  Intraparenchymal/
Intraventricular 
Correlation between nMx and Mx was 
R=0.90*.  
Correlation between nPRx and PRx was 
R=0.62*. 
 
Median bias of 6.0 mmHg 
Only TBI: 
Bias of 7.1 mmHg. 
Only Stroke: 
Bias of 4.3 mmHg. 
 
For Mx: 97 
For PRx: 
61 
For Mx: 92 
For PRx: 
67 
 
nICPHeldt Kashif & 
Heldt et al.36 
Describe and 
assess a method 
for nICP 
calculation based 
on FV and ABP. 
37 (45 TCD recordings in total, 
30 bilateral), TBI 
Intraparenchymal Across all TCD records:    
Correlation between nICP and ICP was 
R=0.90.  
Bias of 1.6 and SDE of ±7.6 mmHg. 
Inferred 95% CI of ±14.9 mmHg. 
 
Across bilateral TCD records:  
Correlation between nICP and ICP was 
R=0.76. 
Bias 1.5 and SDE 5.9 mmHg. 
Inferred 95% CI of ±11.6 mmHg. 
 
On a patient-record basis: 
Correlation between nICP and ICP was 
R=0.90 (N=45 recordings). 
83 
 
 
 
 
 
 
 
 
 
 
 
90 
70 
 
 
 
 
 
 
 
 
 
 
 
80 
0.83 
(≥20 
mmHg) 
 
 
 
 
 
 
 
 
 
 
0.88 
(≥20 
mmHg) 
Modified nICPBB Xu et al.90 Describe and 
assess a method 
for nICP 
calculation based 
on FV and ABP, 
using an improved 
model for nICPBB. 
23 (14 TBI, 9 Hydrocephalus)  Intraparenchymal/
Intraventricular 
Biases for non-linear models were <6.0 
mmHg compared to 6.7 mmHg of the 
nICPBB (linear). 
Inferred 95% CIs for non-linear models 
were ≤ ±10.8 mmHg, compared to 10.6 
mmHg of the linear model. 
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*Correlation coefficient is significant at the 0.05 level.  
Inferred 95% CI was calculated as 1.96 x SDE. 
AUC, area under the curve; CI, confidence interval; R correlation coefficient; R2, coefficient of determination; SDE, standard deviation of the error; RCSF, resistance to 
cerebrospinal fluid (CSF) outflow; RCSF, nICP-derived RCSF; NPH, normal pressure hydrocephalus; TBI, traumatic brain injury; SAH, subarachnoid haemorrhage; SCA, state 
of cerebral autoregulation. 
Data mining Hu et al.95 Describe and 
assess a method 
for nICP 
calculation based 
on FV and ABP 
based on the 
concepts of data 
mining. 
9, TBI Intraventricular Median correlation between data-mining 
nICP and ICP was R=0.80. 
 
   
 Kim et al.96 Describe and 
assess a method 
for nICP 
calculation based 
on FV and ABP 
based on the 
concepts of data 
mining. 
57, TBI NM Kernal spectral regression-based method 
presented a median bias of 4.37 mmHg. 
   
Semisupervised 
learning 
Kim et al.97 Describe and 
assess a method 
for nICP 
calculation based 
on FV and ABP 
based on the 
concepts of 
semisupervised 
machine learning. 
90 (44 TBI, 36 SAH, 10 NPH) 
 
Intraparenchymal/
Intraventricular 
Decision curve analysis showed that the 
semisupervised method is more accurate 
and clinically useful than the supervised or 
PI-based method. 
  0.92 
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3.4 Discussion 
 
 
The review of the presented methods demonstrates that measures of accuracy for each method 
varied substantially within and among nICP categories. This variability illustrates the 
importance and necessity of studies applying the same number of samples, calculation methods 
and measures of accuracy to compare different nICP methods consistently.  
The several degrees of approximation for ICP monitoring (i.e., epidural, subdural, 
intraparenchymal and intraventricular) could contribute to a misleading interpretation in the 
validation of nICP methods against different invasive techniques. This is due to the presence 
of multiple intracranial compartments of variable deformability and ability to transmit pressure. 
Thus, ICP needs to be considered as an anisotropic parameter rather than a global isotropic 
pressure equally distributed in all intracranial compartments. Over this concept, each invasive 
method would then be specific to measuring compartmental pressures according to where they 
are located in the intracranial system. Under these circumstances, the characteristics of invasive 
ICP monitoring should also be considered in the standard nICP assessment. 
Nevertheless, qualitative-wise, TCD-based nICP methods generally presented a positive 
degree of agreement and acceptable correlations with measured ICP (or with CPP for nCPP-
based methods), with exceptions for PI-based methods. For this category, there is a divergence 
whether PI can predict ICP reliably, with some studies showing rather weak or even inexistent 
correlations between these two parameters 8,28,52,62,63,66,98. Such a controversy might originate 
from the different conditions in which PI can increase independently of ICP increases. For 
instance, during a decrease in CPP, PI presents an increasing trend, which can be related to 
increases in ICP or decreases in ABP (Figure 3.4). The same behaviour occurs during a 
decrease in PaCO2 or increases in pulsatility of ABP waveform. Instead of assuming its linear 
relationship with ICP, PI can rather be described as inversely proportional to mean CPP, 
directly proportional to ABP pulse amplitude and non-linearly proportional to Ca, CVR and 
heart rate 52. 
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The accuracy of the presented methods presented a wide variability for the different method 
categories (from 4.2 to 59.60 mmHg). Considering the clinically relevant range of ICP about 
10 to 20 mmHg, TCD-based methods at the current state of development cannot predict mean 
values of ICP reliably. Certain factors, like the transmission of cerebrovascular changes to TCD 
waveform, its linearity, stability in time and calibration coefficients are unknown and could 
contribute to limiting the accuracy of TCD-based methods. However, accuracy may not be the 
primary performance measure in every clinical situation, and such downsides may be 
compensated for by the ability of the method to track changes and trends of ICP over time, 
rather than its absolute value 39.  
 
 
 
Figure 3.4. Extracted from Cardim et al., 
2016 39. PI behaviour during drop in CPP 
observed in a traumatic brain-injured 
patient (source: Brain Physics Laboratory 
TBI Database, University of Cambridge). 
Dashed lines represent periods when PI 
increased due to increase in ICP, 
independently of changes in ABP. CPP 
(mmHg), cerebral perfusion pressure; PI 
(a.u.), pulsatility index; ICP (mmHg), 
intracranial pressure; ABP (mmHg), 
arterial blood pressure; TBI, traumatic 
brain injury. 
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3.5 Conclusion  
 
 
Transcranial Doppler ultrasonography is a versatile technique for nICP estimation. However, 
the variability in accuracy presented by different methods needs to be clarified in clinical 
conditions where the use of TCD for non-invasive ICP dynamics monitoring would be relevant. 
The following chapters of this thesis will present and discuss these applications.
Material & Methods 
62 
 
4 MATERIAL AND METHODS 
 
 
The methodology applied in this thesis can be divided into three categories, including 
retrospective and prospective studies. Different methodologies have been implemented to: I) 
the assessment of the accuracy of TCD-based nICP monitoring in comparison to standard ICP 
invasive methods; II) feasibility studies on the application of nICP monitoring in certain 
clinical conditions in which ICP monitoring is relevant but not often considered; III) the 
assessment of a novel method for nCPP estimation presented in this thesis.  
Studies in category I consisted of evaluations of the accuracy of TCD-based methods in 
comparison to a standard invasive method for ICP monitoring. nICP was compared to direct 
ICP in prospective and retrospective studies. In category II, the feasibility of nICP monitoring 
was evaluated in prospective and retrospective studies, in clinical conditions which ICP 
monitoring has not been considered due to risks and complications. Category III includes a 
retrospective study assessing nCPP estimation in TBI patients. 
 
4.1 Material 
 
Figure 4.1 depicts the organisation of retrospective and prospective studies and materials used 
in each of them. 
 
4.1.1 Prospective materials 
 
A material including prospectively collected data from TBI patients hospitalised in the 
Neurocritical Care Unit (NCCU) at Addenbrooke’s Hospital, Cambridge, UK, between 2013 
and 2015 was utilised in a study devoted to the accuracy of nICP. Patients were sedated, 
ventilated, and managed in the NCCU with a therapeutic protocol aiming for an ICP <25 
mmHg and CPP within 60–70 mmHg. The median pre-intubation Glasgow coma scale (GCS) 
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score of the patients was 6 (range 3–14). This database included daily recordings of ABP, ICP 
and FV in the MCA using TCD.  
 
Figure 4.1. Organogram describing the utilisation of retrospective and prospective materials within the study 
categories. 
 
 
 
ABP, arterial blood pressure; CSF, cerebrospinal fluid; ICP, intracranial pressure; TCD, transcranial Doppler 
ultrasonography. 
 
 
A feasibility study included in category II was based on material consisting of patients admitted 
to the Department of Trauma and Orthopaedics at Addenbrooke’s Hospital, Cambridge, UK, 
between March 2016 to March 2017. The patients had no history of neurological disease and 
undertook elective shoulder surgery in the beach chair position. The monitoring modalities 
included non-invasive ABP and FV in the MCA using TCD.  
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4.1.2 Retrospective materials 
 
A retrospective database has been prospectively collected since 1992 in the Brain Physics 
Laboratory, University of Cambridge. It includes patients admitted with traumatic brain injury 
in the NCCU at Addenbrooke’s Hospital, with over 400 patients archived. The monitoring 
modalities included direct ICP, ABP and FV in the MCA using TCD. This retrospective TBI 
database was utilised in studies of categories I, II and III. 
A second database was collected from 1994 to 1998 and 2006 at Addenbrooke’s Hospital, 
including patients who undertook an infusion test for the investigation of cerebrospinal fluid 
disturbances. The monitoring modalities included direct ICP (via lumbar puncture), non-
invasive ABP and FV in the MCA using TCD. This database was used in a study of category 
I. 
A retrospective material that includes patients undergoing orthotopic liver transplant surgery 
(OLT) admitted to the Transplant Unit at Addenbrooke’s Hospital, Cambridge, UK between 
December 2002 to March 2003 was used in a study of category II. Inclusion criteria for this 
study were the presence of chronic hepatic failure requiring OLT and acute liver failure 
requiring OLT. Exclusion criterion was the contraindication for OLT. The monitoring 
modalities included ABP and FV in the MCA using TCD.  
 
 
4.1.3 Ethics approval 
 
TBI data collection was approved by the Institutional Review Board (REC 97/290, 1997). For 
patients recruited before 1997, the NCCU Users’ Committee allowed TCD examinations for 
the assessment of TBI patients. Further use of the anonymised data was allowed as a part of 
clinical audits. 
The infusion test is a routine clinical investigation in the Hydrocephalus Clinic, Addenbrooke’s 
Hospital, with no ethical approval required.  Use of the anonymised data was allowed as a part 
of clinical audits. 
Material & Methods 
65 
 
The experimental protocol for OLT data collection and informed consent were approved by the 
Institutional Review Board (REC 02/308, 2002). Informed consent was obtained from all 
individual participants included in the study. 
The experimental protocol for data collection during shoulder surgery and informed consent 
were approved by the Institutional Review Board (REC 16/LO/0350, 2016). Informed consent 
was obtained from all individual participants included in the study. 
 
 
4.2 Methods 
 
4.2.1 Basic monitoring modalities 
 
Arterial blood pressure 
Mean ABP was invasively monitored from the radial artery and calibrated at heart level using 
a standard pressure monitoring set (Edwards Lifesciences, Irvine, California, USA) with 18-20 
G arterial catheters (Insyte-W, BD Medical Systems, Oxford, UK (Figure 4.2). When invasive 
monitoring was unavailable, ABP was monitored non-invasively using a finger-cuff 
plethysmograph device (Finapress 2300 (Ohmeda, Englewood, Colorado, USA) or Finometer 
Pro®, Finapres Medical Systems, Amsterdam, The Netherlands) calibrated either at heart or 
auditory meatus level. 
 
Intracranial pressure 
Invasive ICP monitoring was performed via an intraparenchymal probe inserted in the right 
cerebral hemisphere (Codman ICP MicroSensor, Codman & Shurtleff, Raynham, 
Massachusetts, USA, or Direct Pressure Monitor, Camino Laboratories, San Diego, California, 
USA) for patients requiring neurocritical care (Figure 4.2). In patients investigated for CSF 
disorders, ICP monitoring was performed via lumbar puncture using one spinal needle (18 G, 
3.50 in) inserted between the lumbar L3/L4 or L4/L5 vertebrae, considering the foramen of 
Monro as the zero-calibration reference. 
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 Transcranial Doppler ultrasonography 
Cerebral blood flow velocity measurements were obtained from the middle cerebral artery 
(either unilateral or bilaterally) by using a TCD ultrasonography system (Neuroguard, 
Medasonics, Fremont, California, USA; NeuroQ, Deltex; Rimed IntraView or Digi-LiteTM, 
Israel; or DWL Compumedics, Germany). FV was monitored exclusively from the MCA M1 
segment o through the temporal window with a 2-MHz probe. The probe was held in place 
during the recording using a head band or frame provided by the TCD device manufacturer 
(Figure 4.2). 
 
Figure 4.2. A representation of simultaneous recordings of ABP, ICP and FV. (A) Full range of recording; (B) 
representation of the signals waveforms. Source: Brain Physics Laboratory database, University of Cambridge. 
 
 
ABP (mmHg), arterial blood pressure; ICP (mmHg), intracranial pressure; FV (cm/s) cerebral blood flow velocity. 
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4.2.2 Data acquisition  
 
Data were recorded, post-processed and analysed using ICM+ software (Cambridge Enterprise, 
UK, http://www.neurosurg.cam.ac.uk/icmplus). ABP, ICP and FV waveforms were sampled 
from an analogue output at 30 or 50 Hz and subsequently digitalised to 100 Hz using an 
analogue-to-digital converter (DT 2814, Data translation, Marlboro, California, USA).  
 
4.2.3 Derived physiological parameters 
 
Mean values 
All data were treated with a moving average filter with a 10-seconds window to obtain the 
mean values. 
 
Systolic and diastolic components 
The maximum and minimum values from a 2-seconds calculation window were treated as the 
systolic and diastolic values, respectively. 
 
Cerebral perfusion pressure 
CPP was calculated as the difference between mean ABP and ICP.  
 
Pulsatility index 
TCD-based pulsatility index was calculated according to:  
Equation 4.1 
𝑷𝑰 =
𝑭𝑽𝒔 − 𝑭𝑽𝒅  
𝑭𝑽𝒎
(𝟒. 𝟏) 
 
s, systolic; d, diastolic; m, mean cerebral blood flow velocities (FV, in cm/s). 
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Critical Closing Pressure 
The critical closing pressure of the cerebral circulation was calculated according to Varsos et 
al. 83. 
Equation 4.2 
𝑪𝒓𝑪𝑷 = 𝑨𝑩𝑷 −
𝑨𝑩𝑷
√(𝑪𝑽𝑹 ∙  𝑪𝒂  ∙  𝑯𝑹 ∙  𝟐𝝅)𝟐 +  𝟏 
  (𝒎𝒎𝑯𝒈) (𝟒. 𝟐)  
 
Where: 
Equation 4.3 
    𝐶𝑉𝑅 =  
𝐴𝐵𝑃
𝐹𝑉
(4.3) 
 
Equation 4.4 
𝐶𝑎 =  
𝐶𝑎𝐵𝑉1
𝑎1
(4.4) 
 
CVR (mmHg/(cm/s)) represents cerebral vascular resistance, Ca (cm/mmHg) denotes 
compliance of the cerebral arterial bed (arteries and arterioles) and HR, heart rate given in 
beat/s. a1 represents the pulse amplitude of the first harmonic of the ABP waveform; f1, the 
pulse amplitude of the first harmonic of the FV waveform; CaBV1, the pulse amplitude of the 
first harmonic of the cerebral arterial blood volume waveform (CaBV). The pulse amplitude of 
first harmonics is determined with fast Fourier transformation (FFT). 
 
 
Cerebral compliance (C) represents the ability of the brain to adapt to changes in volume (∆V) 
inside the cranium in response to changes in pressure (∆P) to avoid intracranial hypertension. 
This parameter includes the cerebrovascular arterial compliance (Ca), which describes the 
change of cerebral arterial blood volume in response to change in ABP 99.  
Derived from CrCP and ABP, other indices, such as the diastolic closing margin (DCM) of the 
brain microvasculature, can be obtained. Previous works have demonstrated that diastolic ABP 
(ABPd) below CrCP is associated with the loss of measurable FV during diastole 
100, causing 
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an acceleration of brain ischemia when CPP decreases further. The difference in pressures 
between ABPd and CrCP (DCM) represents the force that allows cerebral blood flow 
circulation during diastole. When DCM is exhausted (≤0 mmHg), vessels will collapse 
resulting in cessation of cerebral blood flow 100,101. 
Equation 4.5 
𝐷𝐶𝑀 =  𝐴𝐵𝑃𝑑 − 𝐶𝑟𝐶𝑃  (𝑚𝑚𝐻𝑔) (4.5) 
 
Non-invasive intracranial pressure 
nICP was calculated using different TCD-based methods. As previously described in Chapter 
3, these methods are:  
 
• Black box model (nICPBB) (Section 3.3.3): 
ABP-nICP transformations for this method were derived from analysis of a retrospective 
database of patients with traumatic brain injury (N=140). 
 
 
• nICPFVd: 
nICPFVd was calculated as the difference between ABP and nCPPFVd, according to the 
relationship described by Czosnyka et al. 71 
Equation 4.6 
𝑛𝐶𝑃𝑃𝐹𝑉𝑑 = 𝐴𝐵𝑃 × 
𝐹𝑉𝑑
𝐹𝑉𝑚
 + 14  (𝑚𝑚𝐻𝑔) (4.6) 
14 mmHg is the zero compensation factor established in a cohort of TBI patients 71. 
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• nICPCrCP: 
nICPCrCP was calculated as the difference between ABP and nCPPCrCP as described in by Varsos 
et al. 78: 
Equation 4.7 
𝑛𝐶𝑃𝑃𝐶𝑟𝐶𝑃 = 𝐴𝐵𝑃 × [0.734 −  
0.266
√(𝐶𝑉𝑅 ∙  𝐶𝑎  ∙  𝐻𝑅 ∙  2𝜋)2 + 1
] − 7.026  (𝑚𝑚𝐻𝑔) (4.7) 
 
Equation 4.8 
𝑛𝐼𝐶𝑃𝐶𝑟𝐶𝑃 = 𝐴𝐵𝑃 − 𝑛𝐶𝑃𝑃𝐶𝑟𝐶𝑃  (𝑚𝑚𝐻𝑔) (4.8) 
 
• nICPPI: 
nICP estimation based on TCD-derived PI was calculated from the linear regression of known 
values of ICP and PI obtained from a retrospective cohort of TBI patients (N=292). The 
regression equation was based on data analysed by Budohoski et al.102 and given by: 
Equation 4.9 
𝑛𝐼𝐶𝑃𝑃𝐼 = 4.47 × 𝑃𝐼 + 12.68 (𝑚𝑚𝐻𝑔) (4.9) 
 
Non-invasive cerebral perfusion pressure 
nCPP was calculated as the difference between ABP and nICP and according to a novel TCD-
based method proposed in this thesis (Chapter 7). 
 
 Continuous indices of cerebral autoregulation 
Cerebral autoregulation is the ability of the brain to maintain relatively constant blood flow 
during changes in perfusion pressure or arterial blood pressure. Continuous indices of cerebral 
autoregulation were calculated from spontaneous fluctuations of ABP and FV. The correlation 
coefficient methodology as described by Czosnyka et al. 86 was used, in which ABP signal was 
used for identification of spontaneous fluctuations and treated as the stimulus. Mean FV was 
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used as a surrogate marker of cerebral blood flow, i.e., the comparator signal. The correlation 
coefficient between ABP and FV, termed Mxa (mean flow index), was calculated 103. Mxa 
close to +1 denotes that slow fluctuations in ABP produce synchronised slow changes in FV, 
indicating defective cerebral autoregulation. Based on previous studies considering TBI 
patients, negative values or values less than 0.3 indicate intact cerebral autoregulation, while 
positive values above 0.3 indicate failure of cerebral autoregulation 104–106. For Mxa 
calculation, all signals were time-averaged using a window of 10 s. Subsequently, a moving, 
linear correlation coefficient between ABP and FV signals were calculated using a 300-seconds 
window with an update every 10 s 86. 
Cerebral autoregulation was also assessed using the autoregulation index (ARI), a 
dimensionless index ranging from 0 to 9, for which a response of FV to a hypothetical impulse 
change in ABP is estimated using transfer function analysis of spontaneous fluctuations in ABP 
and FV 107,108. An ARI of 9 describes a system in which CBF returns quickly to baseline levels 
after step changes in ABP; an ARI value of 0 describes a system in which there is no 
compensatory change in CBF, indicating completely impaired cerebral autoregulation. On this 
scale, normal autoregulatory capacity is defined as an ARI of 4 to 7, abnormal 3 and below 
107,109,110.  ARI was calculated using a plugin developed for ICM+®, performed over a 120 s 
long-sliding window updated every 10 s. FV changes recorded during the step change in ABP 
are normalised and compared to 10 grades (0-9) to determine which model response constitutes 
the best fit, and the grade of that response is returned as ARI 107. 
 
Optimal ABP 
A method for individualisation of CPP-oriented management based on the determination of 
cerebrovascular reactivity (using the pressure reactivity index (PRx)) has been proposed 
previously 111,112. PRx is the correlation coefficient between ABP and ICP 113, and studies in 
TBI populations have indicated that PRx >0.25 is associated with impaired cerebral 
autoregulation in patients with poor outcome 106. This methodology was applied to obtain 
optimal values for ABP, instead of CPP. In this case, only nICP was available, thus the non-
invasive PRx (nPRx) was calculated. For nPRx calculation, all signals were time-averaged 
using a window of 10 s. Subsequently, a moving, linear correlation coefficient between ABP 
and nICP signals were calculated using a 300-seconds window with an update every 10 s. 
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4.2.4 Statistical analysis 
 
Statistical analysis was performed using R Studio software (R version 3.4.1) and OriginPro 
software (version 8, OriginLab Corporation, Wellesley, Massachusetts, USA). The distribution 
of all data samples was checked for normality using the Shapiro-Wilk test. Depending on the 
distribution, either parametric or non-parametric statistical tests were used in the analysis. 
The analysis included correlations between non-invasive ICP estimators and direct ICP 
regarding mean values and changes in the time domain. The Bland-Altman method was used 
to determine the agreement between invasive ICP and the different nICP methods, with their 
respective bias and 95% confidence interval for prediction. The bias represents the difference 
between mean values of nICP and ICP; 95% CI is calculated as 1.96 times the standard 
deviation of the bias. Also, the area under the curve (AUC) of the receiver operating 
characteristic curve (ROC) was performed to determine the accuracy of the nICP and nCPP 
methods to predict certain ICP and CPP thresholds. Similarly, where applicable, the ROC 
analysis was used to calculate the sensitivity and specificity of various thresholds. The 
predicting ability is considered reasonable when the AUC is higher than 0.7, and strong when 
the AUC exceeds 0.8 114. Statistical differences between ROC curves were verified using the 
DeLong's test for two correlated ROC curves (R package pROC 115).  
The specific statistical methods applied in individual studies are described in the respective 
chapters.
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5 RESULTS AND DISCUSSIONS I: ASSESSMENT OF THE 
ACCURACY OF TCD-BASED nICP MONITORING 
METHODS 
 
 
5.1 A prospective study on non-invasive assessment of ICP in patients with 
traumatic brain injury 
 
The results presented in this section have been published in Journal of Neurotrauma 8: 
Cardim, D., Robba, C., Donnelly, J., Bohdanowicz, M., Schmidt, B., Damian, M., Varsos, G. V, Liu, X., 
Cabeleira, M., Frigieri, G., Cabella, B., Smieleweski, P., Mascarenhas, S., and Czosnyka, M. (2015). Prospective 
study on non-invasive assessment of ICP in head injured patients: comparison of four methods. J. Neurotrauma. 
 
 
Introduction 
 
Chapter 3 highlighted that the existing non-invasive ICP methods based on TCD waveform 
analysis present with different degrees of agreement for ICP prediction in patients with 
traumatic brain injury and other clinical conditions.  
Considering this issue, this prospective observational study compared a set of TCD-based nICP 
methods with direct invasive ICP measurements in a single cohort of TBI patients to determine 
the accuracy of nICP. 
 
 
Materials and methods 
 
Patient population 
This study included prospectively collected data described in Section 4.1.1. This material 
consisted of 40 patients with traumatic brain injury (32 males (80%), 8 females (20%), 
population median age 32 years (IQR: 50-21)). 
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Clinical monitoring and data collection 
The implemented clinical monitoring included ABP, ICP and FV as described in Section 4.2.1, 
in a total of 66 recordings. For FV, the right MCA was chosen because the intraparenchymal 
ICP probe was inserted on the right side, but for recordings in which right FV was of poor 
quality and left side was better, this side was chosen. 
Four TCD-based nICP methods were assessed in this study, namely: nICPBB, nICPFVd, 
nICPCrCP and nICPPI. These methods were chosen to contemplate all TCD-based nICP 
categories described in Chapter 3.  
nICP methods and derived physiological parameters were calculated as described in Section 
4.2.3. 
 
Statistical analysis 
Multiple measurements were considered as independent values. The data were tested for 
normal distribution using the Shapiro-Wilk test and found to be non-parametric. Statistical 
comparisons between the mean values of direct ICP and nICP were performed using Student’s 
t-test. The analysis included correlations between non-invasive ICP estimators and measured 
ICP regarding mean values, with R representing the Pearson correlation coefficient, with the 
level of significance set at 0.05. Results are presented as mean ± SD. The 95% CI for prediction 
and bias of the nICP methods were estimated using the Bland-Altman analysis. ROC analysis 
was performed to determine the ability of the non-invasive methods to predict raised ICP (using 
a threshold of 17 mmHg). This threshold was chosen due to its proximity to values which 
would commonly prompt treatment in the clinical setting (normally above 20-25 mmHg 7). For 
recordings in which mean ICP changes were greater than 7 mmHg, the averaged correlation in 
the time domain between ICP and nICP methods was calculated, as well as the correlation 
between ∆ICP and ∆nICP. In this case, “∆” represents the difference between the maximum 
and minimum mean value in each recording during ICP changes. Correlations in the time 
domain are independent of mean values of ICP or nICP and represent the ability of a nICP 
method to replicate relative changes observed in direct ICP across time.  
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Results 
 
Table 5.1 presents mean values of the physiological variables assessed in the prospective 
cohort.   
Among the 66 recordings analysed, 8 presented considerable spontaneous changes in ICP 
(∆ICP) ≥7 mmHg in the time domain. Table 5.2 summarises the averaged correlation 
coefficients in the time domain between direct ICP and nICP methods. In the same table, 
correlations between ∆ICP and ∆nICP are compared. An example of nICP recording with the 
four investigated methods is presented in Figure 5.1. 
 
 
Table 5.1. Physiological variables and nICP estimations assessed, presented and mean ± SD.  
 
ABP 93.74±12.72 
ICP 13.57±4.96 
CPP 80.17±12.30 
nICPBB 13.07±4.18 
nICPFVd 20.91±7.82* 
nICPCrCP 18.01±2.35* 
nICPPI 17.68±1.02* 
 
ABP (mmHg), arterial blood pressure; ICP (mmHg), intracranial pressure; CPP (mmHg), cerebral perfusion 
pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; nICPFVd (mmHg), estimator 
based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator based on the concept of critical 
closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; SD, standard deviation. 
*At the 0.05 level, ICP and nICP are significantly different (p<0.05). 
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Table 5.2. Correlations between non-invasive ICP methods with invasive ICP in the time domain (mean±SD) and 
between ∆ICP and ∆nICP in cases when ∆ICP ≥7 mmHg (N=8). Correlation between ∆ICP and ∆nICP was not 
significant in any of the methods. 
 
 
R (time domain) R (∆ICP vs ∆nICP) 
nICPBB nICPFVd nICPCrCP nICPPI ∆nICPBB ∆nICPFVd ∆nICPCrCP ∆nICPPI 
0.48±0.40 -0.28±0.69 0.18±0.56 0.61±0.35 0.68 -0.32 0.28 0.19 
 
nICPBB (mmHg), estimator based on a black-box mathematical model; nICPFVd (mmHg), estimator based on the 
diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator based on the concept of critical closing 
pressure; nICPPI (mmHg), estimator based on the pulsatility index; SD, standard deviation of the mean. 
 
 
Table 5.3 presents statistical comparisons among nICP methods evaluated. nICPBB, nICPFVd 
and nICPCrCP demonstrated moderate but significant correlations (p<0.05) with direct ICP; 
while nICPPI had poor correlation (p>0.05) (Figure 5.2). In regards to Bland-Altman analysis, 
nICPBB and nICPPI showed biases close to zero, and along with nICPCrCP, presented similar 
95% CI, close to 10 mmHg. nICPFVd showed greater bias and 95% CI (Figure 5.3). In Figure 
5.3 each plot was complemented by the corresponding error histograms.  
As observed in Table 5.1, the patient cohort presented a low range of mean ICP values. 
Consequently, to obtain a consistent ROC analysis, it was necessary to use a threshold 
reasonably close to, but below critical values for intracranial hypertension treatment. nICPFVd 
presented the best AUC value (AUC=0.70). Also, Table 5.3 presents results from the arithmetic 
average of only the best non-invasive ICP estimators (nICPAv), i.e., nICPBB, nICPFVd and 
nICPCrCP. This method showed slightly improved AUC=0.73 (95% CI: 0.59-0.87) (Figure 5.4), 
but not statistically significant when compared to nICPFVd (p=0.48). 
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Table 5.3. Correlations between non-invasive methods with invasive ICP (R) (N=66 recordings), bias (±SD), 
95% CI for ICP prediction and AUC. The combination of the best performing estimators (nICPAv) resulted in 
better correlation with direct ICP and improved 95% CI and AUC. 
 
Method        R Bias 95% CI    AUC  
nICPBB     0.39* -0.50±5.07 9.94 0.66 
nICPFVd 0.39* 7.34±7.45⁺ 14.62 0.70 
nICPCrCP 0.35* 4.44±4.69⁺ 9.19 
 
0.64 
 
nICPPI 
 
0.15 4.11±4.90 9.62 0.43 
nICPAv 0.47* 3.76±4.69⁺ 9.17 0.73 
 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; nICPFVd 
(mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator based on the 
concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; nICPAv (mmHg), 
averaged estimator based on nICPBB, nICPFVd and nICPCrCP; R, Pearson correlation coefficient; CI: confidence 
interval; AUC: area under ROC curve; SD, standard deviation. 
  
*Correlation is significant at the 0.05 level. ⁺At the level of 0.05 the population mean is significantly different 
from the test mean (0).  
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ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; 
nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator 
based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; R, 
correlation coefficient in the time domain. 
Figure 5.1. Example of recording of nICP 
with four investigated methods in a case 
when ICP changed considerably. (A) ICP; 
(B) nICPBB; (C) nICPFVd; (D) nICPCrCP; 
(E) nICPPI. In this case, all nICP 
estimators could replicate changes in ICP 
in time reliably (R>0.60). 
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Figure 5.2. Linear regressions and Pearson correlation plots between ICP and nICP estimators for (A) nICPBB, 
(B) nICPFVd, (C) nICPCrCP and (D) nICPPI. nICPBB, nICPFVd, nICPCrCP presented moderate correlations with ICP. 
 
 
 
 
Grey shaded areas on the plots represent the 95% confidence intervals for the linear regressions between ICP and 
nICP. 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; 
nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator 
based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; R, 
Pearson correlation coefficient. 
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Figure 5.3. Bland-Altman and error histograms plots showing bias and 95% CI for prediction of ICP for (A) 
nICPBB, (B) nICPFVd (B), (C) nICPCrCP and (D) nICPPI. The overall 95% CI ranged around 10 mmHg. 
 
 
 
 
Red lines represent the bias between nICP and ICP; blue dashed lines represent the upper and lower 95% 
confidence intervals for ICP prediction. 
 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; 
nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator 
based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index. 
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Figure 5.4. Receiver operating characteristic analysis showing the area under the curve (AUC) for the averaged 
nICP estimator (nICPAv, AUC = 0.73). 
 
 
Discussion 
 
Many pathological events occurring during intracranial hypertension, such as critically reduced 
CPP and episodic rises in ICP caused by hyperaemia, can be identified by remarkable changes 
in cerebral blood flow velocity assessed using TCD 116. For instance, as ICP increases and CPP 
correspondingly decreases, a characteristic highly pulsatile FV pattern can be observed. 
Ongoing increases in ICP may result in reduction followed by loss of diastolic flow, 
progressing to isolated systolic spikes in the FV waveform. This culminates in an oscillating 
flow pattern which has been associated with the onset of intracranial circulatory arrest 103,117.  
In this study, although mean nICP did not demonstrate a strong correlation with direct ICP, the 
cerebral circulation dynamics could be observed with TCD-based methods as nICP changes in 
the time domain. 
The best performance for monitoring of ICP dynamics was presented by nICPPI, which showed 
the strongest averaged correlation coefficient in the time domain across 8 patients (R=0.61), 
followed by nICPBB (R=0.48). Although none of the methods presented a satisfactory 
correlation between ∆nICP and ∆ICP, nICPBB was the best considering variations of ICP ≥7 
mmHg (R=0.68, p=0.06), demonstrating the ability of this method to detect differences in the 
magnitude of ICP changes recorded in time. 
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Considering the mean absolute changes in ICP, nICPBB had the best performance, as it 
presented the most consistent indicators for ICP prediction. For nICPBB, the bias was not 
significantly different from zero, indicating that both methods were not different in rendering 
mean ICP values. Its 95% CI for prediction was even smaller as previously reported by Schmidt 
et al. (12.8 mmHg) 25 or for nICPHeldt (15 mmHg (SDE of 7.6 mm Hg) 
36. Furthermore, AUC 
for nICPBB was close to reasonable values (0.7) denoting the method’s ability to distinguish 
elevated ICP. 
In contrast, nICPFVd and nICPCrCP biases were significantly different from zero (Table 5.3). 
However, for nICPFVd, moderate correlation coefficients and reasonable AUC were observed. 
nICPCrCP, on the other hand, did not present a reasonable AUC. nICPFVd had the greatest 95% 
CI for ICP prediction and nICPCrCP the smallest. The low range of ICP encountered (Table 5.1) 
can be a potential limitation, as it prevented a thorough prediction analysis in conditions of 
elevated intracranial pressure. This characteristic can be attributed to the therapeutic protocol 
applied in TBI patients. 
Despite the best ability to detect changes in ICP across time domain, nICPPI did not show any 
consistent statistical parameters for ICP estimation; hence, it can be considered the weakest 
estimator. These findings contradict the results published by Bellner et al., in which PI strongly 
correlated with ICP 27 (Section 3.3.1). However, such results agree with findings from Figaji 
et al., whose work shows that PI is not a reliable non-invasive estimator of ICP in children with 
severe TBI 28. These results related to the non-specificity of PI to changes in ICP as discussed 
in Section 3.4 and demonstrated in Figure 3.4. 
To find a more reliable method using an approach capable of approximating the different 
features of each estimator considered in this assessment, those methods presenting the best 
estimation for ICP ‘as a number’ (absolute ICP changes), i.e., nICPBB, nICPFVd and nICPCrCP, 
were averaged to form a new method, named nICPAv. The inclusion of nICPPI in this calculation 
did not yield any improvement in estimation. In comparison to the best estimator nICPBB, 
nICPAv only presented inferior values for bias, which was significantly different from zero. 
Thus, in this context, nICPAv represents a more reliable way to predict ICP non-invasively, 
possibly because it includes a broader set of inputs (ABP, mean FV, FVd and CrCP).   
Under these circumstances, the variability in accuracy observed for nICP may be explained by 
specific characteristics of the methods. nICPBB, for instance, reflects ABP waveform being 
constantly modified by TCD characteristics; hence, it is susceptible to changes in vascular 
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components (such as CVR, Ca) and consequently CBF. nICPFVd responds to the ratio FVd/FVm, 
which is subject to decreases during hypoventilation due to vasodilation 71. It also replicates 
changes in ICP provoked by varying ABP, as mean ABP is a multiplier in the formula.  
nICPCrCP, as previously described, is also modulated by changes in CVR and Ca. For nICPPI, it 
is known that decreasing CPP produces specific changes in FV with stable systolic and falling 
diastolic values 117,118. These changes may be observed in PI, since this index is inversely 
proportional to CPP, among other factors 52. These interactions illustrate that nICP methods 
essentially reflect changes in cerebrovascular parameters, particularly modulating cerebral 
blood flow velocity acquired using TCD. However, different methods might respond to specific 
factors.  
An essential aspect of every monitoring method is the degree of accuracy required for clinical 
application. According to the Association for Advancement of Medical Instrumentation and 
the Brain Trauma Foundation guidelines 9,10,119, ICP monitoring devices should have 
continuous output in the 0-100 mmHg range, with an accuracy of ±2 mmHg in the 0-20 mmHg 
range, and maximum prediction error of 10% for ICP >20 mmHg. In this study, the estimation 
performance represented by the 95% CI ranged around 10 mmHg, with all methods above the 
specified limits.   
Another aspect worthy of consideration in the assessment of non-invasive methods is the 
accuracy of the current invasive ICP methods and their agreement. In the clinical practice, 
intraventricular and intraparenchymal pressure methods represent the gold standard for ICP 
monitoring. However, epidural probes are also often used. Simultaneous measurement of ICP 
using intraparenchymal and intraventricular probes showed a bias of −1.2 and a 95% CI of 6.8 
mmHg (SDE of 3.4 mmHg) 120. In another study, simultaneous measurements of ICP using an 
intraparenchymal and epidural probes presented a bias of 4.3 mmHg, with 95% CI of 17 mmHg 
(SDE of 8.5 mmHg) 121. 
Ideally, invasive and TCD-based nICP methods should present similar measures of accuracy. 
However, it is important to highlight that non-invasive techniques are subjected to certain 
interferences (signal attenuation and movement artefacts, for TCD), which certainly influence 
their degrees of accuracy.  
Nevertheless, the nICP methods evaluated in this study, showing biases ranging from -0.5 to 
7.34 mmHg and 95% CI from 9.19 to 14.68 mmHg (Table 5.3), in general, performed better 
than the invasive epidural method available for the clinical management of patients. 
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5.2 Non-invasive assessment of intracranial pressure during infusion test  
 
The results presented in this section have been published in Acta Neurochirurgica 122: 
Cardim, D., Czosnyka, M., Donnelly, J., Robba, C., Cabella, B.C.T., Liu, X., Cabeleira, M.T., Smielewski, P., 
Haubrich, C., Garnett, M.R., Pickard, J.D., and Czosnyka, Z. (2016). Assessment of non-invasive ICP during CSF 
infusion test: an approach with transcranial Doppler. Acta Neurochir. (Wien). 158, 279–87. 
 
 
Introduction 
 
Infusion test is a diagnostic modality that enables the assessment of the CSF dynamics and the 
compensatory ability of the cranial-spinal fluid system in patients diagnosed with 
hydrocephalus 123. The principle of this test is based on a constant infusion rate of artificial 
CSF into any accessible compartment, which produces a gradual and uncompensated increase 
in ICP 124.  
Proceeding with the assessment of the nICP accuracy, this study compared the estimation 
performances of the four previously presented nICP methods in a prospective cohort of patients 
with hydrocephalus whose CSF dynamics were investigated using infusion tests with 
controllable rise of ICP.  
 
 
Material and Methods 
 
Patient population 
This study included data from a retrospective database of patients with CSF disturbances 
described in Section 4.1.2. This material consisted of 53 patients who undertook infusion tests. 
The median age of the patients was 55 years (IQR: 66-38 years; 31 males (58.5%), 22 females 
(41.5%)). Most of the data collection took place in the first period of 1994-1996 (N=39, 
73.6%). Nevertheless, the experimental protocol and materials used did not differ for data 
collected in 2006. 
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Infusion test 
An infusion test is a computerised method involving the cerebrospinal infusion of artificial 
CSF (normal saline or Hartman’s solution) into the subarachnoid space, based on the traditional 
constant rate infusion test described by Katzman and Hussey 124. For this purpose, one spinal 
needle (18 G, 3.50 in) is inserted between the lumbar L3/L4 or L4/L5 vertebrae, and it is used 
for both pressure measurements and fluid infusion. This needle is connected to a pressure 
transducer via a stiff saline-filled tube and to an infusion device (Alaris® GH Plus Syringe 
Pump, Carefusion) with a 50 ml syringe (BD PlasticTM), mounted on a trolley containing a 
pressure monitor (Simonsen & Will, Sidcup, England) connected to a computer 125. The 
threshold of the opening pressure is 13 mmHg, and the infusion rate is 1 ml/min when the 
pressure is higher than the threshold. If the pressure is lower than the threshold, the infusion 
rate is 1.5 ml/min when. The start of the infusion is initiated after baseline recording (10 
minutes), whereas the end of the infusion is signalled by the achievement of a steady-state ICP 
plateau phase. After termination of the infusion, ICP is continuously recorded until it reaches 
a steady baseline level 125 as depicted in Figure 5.5.  
 
Clinical monitoring and data collection 
The implemented clinical monitoring included ABP, ICP and FV (Figure 5.5) as described in 
Section 4.2.1, in a total of 53 recordings. In this case, ABP was monitored non-invasively using 
a Finapres® finger cuff device (Ohmeda Finapres® 2300, Englewood, Colorado, USA), 
calibrated at the level of the heart. This device supports applications in which waveform-
dependent indices are extracted 126; however, its absolute ABP measurements presented inter-
individual variability 127.  
nICPBB, nICPFVd, nICPCrCP and nICPPI were evaluated. nICP methods and derived 
physiological parameters were calculated as described in Section 4.2.3. 
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Figure 5.5. Example of recording demonstrating the baseline and plateau phases of the infusion test and the 
parameters assessed (ABP, ICP, FV).  
 
 
ABP (mmHg), arterial blood pressure; ICP (mmHg), intracranial pressure; FV (cm/s), cerebral blood flow 
velocity. 
 
Statistical analysis 
The data were tested for normal distribution using the Shapiro-Wilk test and distributions were 
non-parametric. The analysis included Spearman correlations (R) between mean ∆ICP and 
∆nICP and averaged correlations for variations of nICP in the time during ICP increase. The 
magnitude of ICP changes (∆) was calculated as the difference between mean values of plateau 
and baseline phases in each recording during the test. Median values of ICP and nICP are 
presented with their respective interquartile range (IQR) in mmHg. The Bland-Altman method 
was used to determine the agreement between measured ICP and the various nICP methods, 
with their respective 95% CI for prediction of ICP and bias for baseline and plateau phases. 
Also, the Mann-Whitney test was used to assess whether nICP samples differed significantly 
from ICP for both baseline and plateau phases. Wilcoxon test was applied to determine whether 
the population medians differed between baseline and plateau phases for each nICP estimator 
and other physiological parameters.  
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Results 
 
Table 5.4 presents comparisons among non-invasive methods adopted in this study. Table 5.5 
presents the assessed physiological parameters applied for nICP estimations, at baseline and 
plateau phases, and their ∆ correlations with ∆ICP and ∆ABP.  
Regarding confidence intervals (bias±95% CI), nICPBB showed 4.46±15.33 mmHg; nICPFVd 
showed 11.90±25.19 mmHg; nICPCrCP showed 11.12±15.09 mmHg and nICPPI showed 
8.91±10.58 mmHg. During plateau phase, every method presented increased 95% CI:                            
-7.35±19.21 mmHg for nICPBB; 1.66±29.97 mmHg for nICPFVd; -2.53±17.80 mmHg for 
nICPCrCP and -6.18±19.07 mmHg for nICPPI (Table 5.4).  
Correlations between ∆ICP and ∆nICP were better represented by nICPPI and nICPBB, R= 0.45 
(p=0.0007) and R=0.30 (p=0.03), respectively. nICPFVd and nICPCrCP presented lower and non-
significant correlations: R=0.20 (p=0.15), R=0.21 (p=0.13), respectively (Figure 5.6, Table 
5.5).  
For nICP changes in time domain during ICP increase, nICPPI, nICPBB and nICPFVd presented 
similar averaged correlations, 0.39±0.40, 0.39±0.43 and 0.35±0.41, respectively. nICPCrCP 
presented a smaller correlation (R=0.29±0.24). Figure 5.7 demonstrates the variability in the 
correlations in the time domain between nICP and ICP, with examples of a good and a poor 
recording of nICP with the four investigated methods when ICP changed considerably during 
the infusion test. 
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Figure 5.6. Linear regressions and correlation plots considering the differences (∆) between plateau and baseline 
phases during infusion tests. (A) ∆nICPBB, (B) ∆nICPFVd, (C) ∆nICPCrCP and (D) ∆nICPPI. Only nICPBB and nICPPI 
presented moderate significant correlations with direct ICP. 
 
 
 
Grey shaded areas on the plots represent the 95% confidence intervals for the linear regressions between ∆nICP 
and ∆ICP. 
∆, magnitude of changes between baseline and plateau phases during infusion test; ICP (mmHg), intracranial 
pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; nICPFVd (mmHg), estimator 
based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator based on the concept of critical 
closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; R, Spearman correlation coefficient. 
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Figure 5.7. Examples of good (A) and poor (B) recordings of nICP with the four investigated methods when ICP 
changed considerably during the infusion test. Correlation coefficients in the time domain (R) are depicted for 
each nICP method in each situation. 
 
 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; 
nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator 
based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; R, 
correlation coefficient in the time domain. 
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Table 5.4. Median values (IQR), bias (±SD) and 95% CI for ICP prediction are described for baseline and plateau phases. Spearman correlation between ∆ICP and ∆nICP and 
averaged correlation across time during ICP increase are described (N=53). At the 0.05 level, baseline and plateau distributions of nICP and ICP were significantly different. 
 
 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; nICPFVd (mmHg), estimator based on the diastolic cerebral blood 
flow velocity; nICPCrCP (mmHg), estimator based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; CI, confidence interval; 
∆, magnitude of changes between baseline and plateau phases during infusion test; R, Spearman correlation coefficient; SD, standard deviation. 
*At the 0.05 level, distributions between nICP and ICP are significantly different. 
†The population mean is significantly different with the test mean (zero). 
⁺Spearman correlation coefficient is significant at the 0.05 level. 
 
 
Method Baseline Phase Plateau Phase R  R  
 Median (IQR) Bias 95% CI Median (IQR)   Bias 95% CI (∆ICP vs ∆nICP) (time domain) 
nICPBB 10.76 (15.08-7.30)* 4.46±7.82† 15.33 14.86 (20.1-11.26)* -7.35±9.80† 19.21 0.30⁺ 0.39±0.43 
nICPFVd 16.97 (22.56-11.64)* 11.90±12.85†    25.19 21.74 (32.85-14.15) 1.66±15.29 29.97 0.20 0.35±0.41 
nICPCrCP 18.34 (20.38-14.89)* 11.12±7.07† 15.09 19.65 (23.80-16.92) -2.53±9.08†   17.80 0.21 0.29±0.24 
nICPPI 16.57 (17.46-16.06)* 8.91±5.40† 10.58 17.12 (17.73-16.40)* -6.18±9.73† 19.07 0.45⁺ 0.39±0.40 
ICP 7.74 (11.06-2.95) - - 22.13 (29.77-16.41) - - - - 
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Table 5.5. Median (IQR) values for all physiological variables estimated during baseline and plateau phases, with their corresponding ∆ correlations with ∆ICP and ∆ABP. 
 
Variable Baseline Plateau p value R (∆ICP)  R (∆ABP) 
ICP 7.77 (11.06-2.95) 22.13 (29.77-16.41)* <0.001 - 0.1 
ABP 89.68 (101.5-78.23) 96.08 (121-87.07)* <0.001 0.11 - 
HR 67.86 (77.96-61.98) 70.12 (79-60.83) 0.39 0.15 0.28⁺ 
CPP 82 (98.67-73.27) 79.40 (96.53-67.14)* <0.001 -0.38⁺ 0.82⁺ 
FVm 54.2 (66.27-42.47) 49.76 (61.92-39.07)* <0.001 0.14 -0.20 
FVs 81.61 (101.6-66.76) 79.97 (98.65-63.35) 0.07 -0.03 -0.21 
FVd 33.17 (43.86-27.32) 31.93 (40.61-23.57)* <0.001 -0.22 0.21 
PI 0.84 (1.05-0.76) 0.99 (1.13-0.83)* <0.001 0.45⁺ -0.04 
CVR 1.64 (1.95-1.22) 1.55 (2.05-1.13) 0.56 -0.21 0.62⁺ 
 
ICP (mmHg), intracranial pressure; ABP (mmHg), arterial blood pressure; HR (beats/min), heart rate; CPP (mmHg), cerebral perfusion pressure; FV (cm/s), cerebral blood 
flow velocity (m, mean; s, systolic; d, diastolic); PI, pulsatility index; CVR (mmHg . s/cm); R, Spearman correlation coefficient; ∆, magnitude of changes between baseline and 
plateau phases during infusion test. 
*At the 0.05 level, distributions between baseline and plateau are significantly different. 
⁺ Spearman correlation coefficient is significant at the 0.05 level. 
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Discussion 
 
The assessment of TCD-based nICP estimators during infusion tests revealed a limited 
accuracy of non-invasive ICP and a discrepancy in the ICP estimation. Among the estimators 
evaluated, relative changes in mean ICP were better associated with nICPPI and nICPBB. 
Considering trends of measured ICP in the time domain, all nICP methods presented better 
performance and the overall correlations were comparatively more balanced.  
The mean absolute values estimated by all nICP methods were significantly different from ICP 
during baseline phase, whereas during plateau phase nICPFVd and nICPCrCP had the same 
distributions as ICP. This indicates the inaccuracy of the nICP methods to predict the absolute 
measure of ICP in the context of infusion tests. Nevertheless, all paired comparisons between 
estimators for baseline and plateau showed significant differences, demonstrating that infusion 
test produced a significant increase in nICP for every estimator. Although significant within 
the same method, these differences were disproportional in the comparison between direct ICP 
and nICP estimations. Such disproportionality was reflected in the 95% CI for ICP prediction 
found for baseline and plateau phases.  
nICPPI and nICPBB were the only estimators presenting significant correlations between ∆ICP 
and ∆nICP and demonstrated a moderate ability to detect the magnitude of changes in direct 
ICP (Table 5.4). nICPPI, nICPBB and nICPFVd displayed moderate averaged correlations for 
detection of ICP trends in the time domain. Generally, nICP estimation differed mostly 
regarding prediction of ICP absolute values during infusion tests, and in a lesser extent, for 
detection of dynamic changes.  
The relative accuracy of TCD-based nICP methods may vary between different types of 
intracranial hypertension: vasogenic, CSF circulatory or secondary to brain volumetric 
changes. The nature of ICP elevation during infusion test is attributed to increasing CSF 
circulation due to the addition of an increasing volume into the CSF space. TCD 
ultrasonography, however, is a technique mainly capable of detecting arterial cerebrovascular 
changes 128. Hence, it would be expected that TCD-based nICP methods would present better 
accuracy to detect ICP changes of vasogenic origin, rather than changes related CSF 
circulation. This can be exemplified by the fact that for cases in which ICP changes related to 
vasogenic fluctuations (plateau waves, B waves) overlapped the rise related to increasing CSF 
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circulation, the correlation in the time domain between ICP and nICP appeared remarkably 
better (Figure 5.8). In these cases, the vasogenic waves patterns were reliably replicated. 
ICP changes originating from increased CSF circulation have direct and indirect influences on 
cerebral haemodynamics. The direct impact is represented by changes in CPP, altered directly 
by ICP. On the other hand, ICP has a secondary effect on cerebral haemodynamics, via changes 
in systemic haemodynamics. The changes in ABP observed during infusion tests are associated 
with an early Cushing response 129, in which rising ICP produces an increase in ABP. 
Therefore, the transmission of fluctuations in CSF circulation to the cerebral arterial bed is 
primarily a result of CPP decrease and secondarily an ABP increase.                         
In respect to hemodynamic and TCD-derived cerebrovascular parameters used for the methods’ 
estimations (Table 5.5), only HR, FVs and CVR did not differ between baseline and plateau 
phases. Within the variables presenting significant difference, only changes in CPP and PI 
(∆CPP and ∆PI) were significantly correlated with changes in ICP. Contrary to more optimistic 
studies on the relationship between ICP and PI 27, in this case, PI presented a moderate 
correlation with ICP. This was mainly associated with changes in FVd since FVs did not differ 
significantly between baseline and plateau phases.  
The changes in ABP were found to be significantly correlated to changes in CVR. Although 
CVR was not significantly different between baseline and plateau phases, the subsequent 
increase in ABP produced by an early Cushing response caused minor vasogenic changes in 
cerebral haemodynamics 129. This could have contributed to the better accuracy in cases 
presenting changes in ICP of vasogenic origin.  
In this scenario, the low accuracy of ICP prediction observed for TCD based-methods can be 
attributed to the nature of ICP elevation during infusion tests. Although increased CSF 
circulation can produce secondary changes on cerebral haemodynamics, the specificity of TCD 
for cerebrovascular changes, like ICP changes of vasogenic origin, may preclude the reliable 
application of TCD-based nICP methods in conditions which ICP changes are related to CSF 
circulation. However, it is also important to consider that the nICP methods evaluated were 
derived from cohorts of TBI patients. Therefore, different physiological mechanisms leading 
to ICP fluctuations in TBI and hydrocephalus might have interfered in the way ICP was 
estimated. 
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Figure 5.8. Modified from Cardim et al. 122. Examples of vasogenic waves during infusion test. (A) Shadowed 
area represents a plateau wave of ICP. (B) Shadowed area represents B waves of ICP. A noticeable positive 
correspondence between ICP and nICP methods are observed during the occurrence of vasogenic waves. 
 
 
 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; 
nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator 
based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index. 
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5.3 Non-invasive assessment of intracranial pressure during plateau waves 
 
The results presented in this section have been published in Neurocritical Care 130: 
Cardim, D., Schmidt, B., Robba, C., Donnelly, J., Puppo, C., Czosnyka, M., and Smielewski, P. (2016). 
Transcranial Doppler Monitoring of Intracranial Pressure Plateau Waves. Neurocrit. Care, 1–9. 
 
 
Introduction 
 
Plateau waves of ICP (or Lundberg A waves) 131,132 are frequent phenomena leading to acute 
intracranial hypertension in patients requiring neurocritical care. They are characterised by 
acute and relevant increases in ICP (generally up to 40 mmHg 87), related to increased volume 
of arterial blood in response to an arterial vasodilation stimulus. Such phenomena may develop 
in patients with intact cerebral autoregulation 87 and low cerebrospinal compensatory reserve 
133, suffering from many cerebral pathological conditions including TBI 87, idiopathic 
intracranial hypertension 134, SAH 135, brain tumours, hydrocephalus 136, and craniosynostosis 
137. 
During the occurrence of plateau waves, ICP rises from normal or slightly elevated to 
uncompensated levels, with relatively stable ABP 138. The mechanism driving plateau waves 
can be described as a ‘vasodilatory cascade’, initiated by vasodilatory stimuli like ABP 
decrease 87. Following this, a rapid increase in cerebral arterial blood volume (CaBV) leads to 
a cyclic rise in ICP, decrease in CPP, further vasodilation and a further rise in ICP. This cycle 
is maintained until the cerebral vasculature reaches a state of maximum vasodilation, 
biologically fixed by the rigid collagen fibres in the tunica adventitia 138. The reverse of this 
positive feedback loop occurs when a vasoconstrictive stimulus initiates a vasoconstrictive 
cascade, decreasing CaBV with a consequent drop in ICP towards normal levels 
138,139.  
The previous sections of this chapter have shown that TCD-based nICP estimators present with 
different measures of accuracy 39, with potential indications that their accuracy is better when 
changes of ICP are related to vasogenic phenomena 122,140. Considering these assumptions, this 
study aimed to assess the four previously described TCD-based nICP methods in a cohort of 
patients presenting changes in ICP purely of vasogenic origin (specifically plateau wave 
increases of ICP), to verify whether they predict ICP under such conditions reliably.   
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Materials and methods 
 
Patient population 
From the previously described database of 446 adult TBI patients (Section 4.1.2) (median age 
of patients: 30 years (IQR: 18–78, with 75% being male), 27 patients were identified, in whom 
at least one plateau wave occurred during the monitoring period. One of these patients (with 
one recording of plateau wave) was recruited at the Universidad de la República School of 
Medicine Hospital, Montevideo, Uruguay (with the approval of the local ethical committee). 
Plateau waves were identified as sudden and spontaneous increases in ICP and pulse amplitude 
of ICP during which CPP and FVm dropped while ABP remained relatively stable (Figure 5.9).  
 
 
 Clinical monitoring and data collection 
The implemented clinical monitoring included ABP, ICP and FV as described in Section 4.2.1. 
nICPBB, nICPFVd, nICPCrCP and nICPPI were evaluated. nICP methods and derived 
physiological parameters were calculated as described in Section 4.2.3. 
 
Figure 5.9. Example of the algorithm used for identification of plateau waves: sudden and spontaneous increases 
in ICP and pulse amplitude of ICP during which CPP and FV dropped while ABP remained relatively stable. 
 
 
ABP (mmHg), arterial blood pressure; ICP (mmHg), intracranial pressure; FV (cm/s), cerebral blood flow 
velocity; CPP (mmHg), cerebral perfusion pressure; ICPAmp (mmHg), pulse amplitude of ICP. 
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Statistical analysis 
All plateau waves were treated as independent phenomena. The data were tested for normal 
distribution using the Shapiro-Wilk test and found to be non-parametric. The analysis included 
Spearman correlations between ∆ICP and ∆nICP, and averaged correlations for variations of 
nICP in the time domain during plateau waves. “∆” (magnitude) represents the difference 
between plateau phase (at the top of plateau waves), and baseline phase (before the onset of 
plateau waves) mean values in each recording. R symbolises the Spearman correlation 
coefficient, with the level of significance set at 0.05. Median values of ICP and nICP are 
presented with their respective IQR in mmHg. 
A ROC analysis was performed to determine the ability of the non-invasive methods to detect 
raised ICP during plateau waves, using a threshold of 35 mmHg. This threshold was chosen 
considering the high values of ICP observed during both phases of plateau waves. In this case, 
35 mmHg represents mathematically half way between baseline and plateau phases ICP values. 
Also, considering the spontaneous nature of plateau waves, a ROC analysis was also performed 
to determine the ability of the methods to distinguish relative changes in ICP between baseline 
and plateau phases. 
 
 
Results  
 
In 27 patients, 36 plateau waves were identified during the TCD monitoring sessions. 7 patients 
presented two plateau waves, and one patient presented 3 consecutive plateau waves. The mean 
length of plateau waves was 13 min, ranging from 2–30 min. Table 5.6 presents correlations 
(∆R) between ∆ICP and ∆nICP, averaged correlations in the time domain and prediction values 
for each nICP method.  
The correlations in the time domain were reasonably good, with R>0.60 for all methods. 
nICPPI, nICPBB and nICPCrCP presented similar averaged correlations (R≥0.78). Examples of 
good and poor correlations between ICP and nICP during plateau waves are shown in Figure 
5.10. 
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Correlations between ∆ICP and ∆nICP were better represented by nICPCrCP and nICPBB, 
whereas the other methods presented inferior and non-significant correlations (Figure 5.11). 
All ∆nICP mean values were significantly underestimated in comparison to ∆ICP.  
 
Table 5.6. Median values (IQR) of the differences between plateau and baseline phase (∆, in mmHg), ∆ 
correlations with ICP and correlations in the time domain for all nICP methods evaluated. ∆ICP and ∆nICP 
distributions were significantly different in all cases. AUC for each nICP method is presented considering the 
threshold of 35 mmHg. 
 
Method ∆ R (∆ICP vs ∆nICP) R (time domain) AUC (95% CI) 
nICPBB 9.00 (13.18-5.05) 0.44* 0.78±0.15 0.82 (0.71-0.93) 
nICPFVd 10.10 (17.74-4.56) 0.19 0.62±0.46 0.77 (0.65-0.88) 
nICPCrCP 2.89 (4.12-2.11) 0.48* 0.78±0.30 0.79 (0.67-0.91) 
nICPPI 2.82 (5.20-1.92) 0.30 0.80±0.24 0.81 (0.70-0.91) 
ICP 24.49 (26.72-21.19) - - - 
 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; 
nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator 
based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; ∆ 
magnitude of changes between baseline and plateau phases during plateau waves. 
*Spearman correlation coefficient is significant at the 0.05 level.  
 
nICPPI presented the best AUC value for predicting intracranial hypertension (at the threshold 
of ICP ≥35 mmHg). Nevertheless, all methods presented AUC above 0.7, an indication of 
reasonable prediction abilities for detecting ICH. The DeLong’s test for two correlated ROC 
curves did not reveal any statistically significant difference between nICP methods. The ICP 
thresholds yielding the best sensitivity and specificity were 27.41 mmHg (AUC = 0.86), 28.42 
mmHg (AUC = 0.79), 23.08 mmHg (AUC = 0.75), 20.28 mmHg (AUC = 0.84), respectively 
for nICPBB, nICPFVd, nICPCrCP and nICPPI, respectively. 
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Figure 5.10. Modified from Cardim et al. 130. Example of recordings showing reliable and unreliable replications 
of ICP plateau waves by different TCD-based nICP methods (panels A and B, respectively). On Y axis, mean 
absolute values of ICP and nICPs are presented; and on X axis, relative changes of ICP and nICP in the time 
domain. 
 
 
ICP (mmHg), intracranial pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; 
nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator 
based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index. 
 
 
nICPCrCP and nICPPI presented null values for specificity and negative predictive value, 
indicating that values of these two estimators during plateau waves were always below 35 
mmHg (although they reacted to rise in ICP, a notable underestimation of direct ICP was 
observed). Nevertheless, all methods presented good positive predictive values (65%, 69%, 
58%, 58% for nICPBB, nICPFVd, nICPCrCP and nICPPI, respectively), which otherwise would 
indicate that many of the positive results were false positives. 
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Figure 5.11. Linear regressions and Spearman correlation plots between ∆ICP and ∆nICP for (A) nICPBB, (B) 
nICPFVd, (C) nICPCrCP and (D) nICPPI. Only nICPBB and nICPCrCP presented statistically significant correlations 
with ICP. 
 
 
 
Grey shaded areas on the plots represent the 95% confidence intervals for the linear regressions between ∆nICP 
and ∆ICP. 
∆, magnitude of changes between baseline and plateau phases during plateau waves; ICP (mmHg), intracranial 
pressure; nICPBB (mmHg), estimator based on a black-box mathematical model; nICPFVd (mmHg), estimator 
based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), estimator based on the concept of critical 
closing pressure; nICPPI (mmHg), estimator based on the pulsatility index; R, Spearman correlation coefficient. 
 
To distinguish relative changes in ICP between baseline and plateau phases, nICPPI and nICPBB 
presented the best prediction abilities (AUC = 0.84 (95% CI: 0.74-0.93) and AUC = 0.80 (95% 
CI: 0.70-0.91), respectively). The DeLong’s test did not reveal a significant difference in AUC 
between these methods (p=0.51). nICPFVd and nICPPI presented lower prediction abilities, with 
AUC = 0.75 (95% CI: 0.63-0.86) and AUC = 0.74 (95% CI: 0.62-0.85), respectively. 
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Table 5.7 presents the median values (IQR) for the physiological parameters evaluated during 
baseline and plateau phases. During plateau waves, ICP and pulse amplitude of ICP (ICPAmp) 
increased and CPP decreased significantly, whereas ABP remained unchanged. FVm and FVd 
presented significant decreases, whereas FVs increased significantly. This resulted in 
significant increase in PI and decrease in CVR.  
 
Table 5.7. Median (IQR) values for all physiological parameters estimated during baseline and plateau phases. 
 
Variable Baseline Plateau 
ICP 22.81 (28.49-19.91) 46.45 (55.22-40.64)* 
ABP 93.34 (98.30-86.14) 93.55 (97.44-85.28) 
HR 75.72 (84.91-65.42) 74.73 (80.45-66.14)* 
CPP 70.89 (78.22-60.38) 45.91 (52.87-37.17)* 
FVm 57.31 (71.87-43.16) 45.52 (63.96-33.15)* 
FVs 109.35 (132.35-92.78) 113.55 (141.72-99.44)* 
FVd 31.04 (40.24-23.26) 22.99 (36.60-10.97)* 
PI 1.39 (1.68-1.21) 2.00 (2.83-1.68)* 
CVR 1.23 (1.47-1.00) 0.99 (1.25-0.68)* 
CaBVAmp 2.38 (3.73-1.82) 3.36 (4.77-2.42)* 
CrCP 51.37 (56.88-41.89) 65.33 (70.67-52.07)* 
ICPAmp 2.21 (2.58-1.70) 6.16 (7.88-4.90)* 
nICPBB Amp 1.97 (2.70-1.61) 3.44 (4.07-2.67)* 
 
ABP (mmHg), arterial blood pressure; CaBVAmp (mmHg), cerebral arterial blood volume amplitude; CPP 
(mmHg), cerebral perfusion pressure; CrCP (mmHg), critical closing pressure; CVR (mmHg . s/cm), cerebral 
vascular resistance; FV (cm/s), cerebral blood flow velocity (m, mean; s, systolic; d, diastolic); HR (beats/min), 
heart rate; ICP (mmHg), intracranial pressure; ICPAmp (mmHg), pulse amplitude of ICP; nICPBB Amp (mmHg), 
pulse amplitude of non-invasive ICP based on the black-box model; PI, pulsatility index; 
 *At the 0.05 level, distributions between baseline and plateau are significantly different. 
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As the only nICP method providing waveform, nICPBB also presented increased pulse 
amplitude (nICPBB Amp), even with replication of the characteristic triangular waveform shape 
observed during plateau waves 141 (Figure 5.12). The correlation between ∆ICPAmp and 
∆nICPBB Amp was significant (R=0.50, p<0.05), however, nICPBB Amp was significantly 
underestimated in comparison to ICPAmp during plateau phase (bias=-2.88 mmHg, p<0.05). 
 
Figure 5.12. Modified from Cardim et al.130. Example of plateau wave recording with direct ICP and nICPBB. In 
comparison to baseline phase, at the top of plateau waves, ICP and nICPBB presented an increased pulse amplitude. 
The characteristic triangular shape of ICP waveform observed during plateau waves was replicated by nICPBB. 
 
 
ICP (mmHg), intracranial pressure; nICPBB Amp (mmHg), pulse amplitude of non-invasive ICP based on the black-
box model. 
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Discussion 
 
Among the methods evaluated, only nICPBB and nICPCrCP presented significant correlations 
with ∆ICP in patients with changes in ICP purely of vasogenic origin. On the other hand, 
relative changes in ICP across time were confidently replicated by all methods. Moreover, they 
presented reasonable prediction ability to detect intracranial hypertension and relative changes 
in ICP associated with plateau waves. 
Given the findings presented in Section 5.2, it appears that ICP changes in the time domain are 
better estimated by TCD-based nICP methods when changes in ICP are related to vasogenic 
phenomena. For instance, during CSF infusion tests, a controlled and artificial increase in CSF 
circulation causes an elevation in ICP similar to the pattern observed during plateau waves. 
Nevertheless, the correlations in the time domain obtained were considerably weaker in 
comparison to those observed for plateau waves, in which ICP changes were specifically 
related to increases in cerebral arterial blood volume. Furthermore, such findings were not 
better replicated in the analysis considering the prospective TBI cohort presented in Section 
5.1, in which changes in ICP across time were not always related to vasogenic waves.  
In retrospect, the accuracy measures of the nICP methods evaluated in different clinical 
conditions can be summarised as presented in Table 5.8. The average 95% confidence interval 
for nICP estimation has been around 20-25 mmHg during plateau waves and 17 mmHg for 
infusion test, whereas generally in TBI it has shown a smaller value, around 10 mmHg. nICPBB 
has been the best method in the clinical conditions evaluated. The correlation in the time 
domain between direct and estimated ICP has been strongest during plateau waves (around 0.8, 
except for nICPFVd, R=0.63). For infusion test, this correlation has been much lower (between 
0.3 and 0.4 for nICPBB, nICPFVd and nICPCrCP). In TBI, it has been between 0.5 to 0.6, but only 
for nICPBB and nICPPI.  
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Table 5.8. Summary of the accuracy measures for TCD-based nICP methods in different clinical conditions. 
 
Accuracy measure Plateau Waves CSF infusion test39 TBI8  
 nICPBB nICPFVd nICPCrCP nICPPI nICPBB nICPFVd nICPCrCP nICPPI nICPBB nICPFVd nICPCrCP nICPPI 
Bias baseline -2.74 3.60 -2.93 -3.99 4.46 11.90 11.12 8.91 - - - - 
Bias plateau 17.12 -7.22 -23.86 -24.46 -7.35 1.66 -2.53 -6.18 - - - - 
95% CI baseline 18.02 23.85 18.85 17.58 15.33 25.19 15.09 10.58 - - - - 
95% CI plateau 21.54 35.54 19.83 20.53 19.21 29.97 17.80 19.07 - - - - 
Bias whole recording -9.93 -1.81 -13.39 -14.22 - - - - -0.50 7.34 4.44 4.11 
95% whole recording 24.46 31.97 28.51 28.02 - - - - 9.94 14.62 9.19 9.62 
R in time 0.77±0.15 0.63±0.45 0.77±0.30 0.80±0.24 0.39±0.40 0.39±0.43 0.35±0.41 0.29±0.24  0.48±0.40 -0.28±0.69 0.18±0.56 0.61±0.35 
∆R 0.41* 0.19 0.45* 0.32 0.30* -0.17 0.21 0.45* -  - - - 
 
nICPBB (mmHg), estimator based on a black-box mathematical model; nICPFVd (mmHg), estimator based on the diastolic cerebral blood flow velocity; nICPCrCP (mmHg), 
estimator based on the concept of critical closing pressure; nICPPI (mmHg), estimator based on the pulsatility index. CI (mmHg), confidence interval for ICP prediction; R, 
correlation coefficient; ∆, magnitude of changes in ICP. 
*Spearman correlation coefficient is significant at the 0.05 level. 
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All nICP methods assessed in this chapter are not patient-specific, therefore requiring 
formation datasets for their generation. Their calibration factors were derived from extensive 
TBI datasets, in which, for most cases, ICP variations were smaller than during plateau wave 
genesis. The cerebrovascular model for estimation of ICP (nICPHeldt, Section 3.3.3) 
36, for 
example, is a nICP method that produces patient-specific ICP estimates not relying on 
formation datasets or training procedures. nICPHeldt has been tested in two cases presenting 
plateau waves and showed a 95% CI of 6.4 mmHg (in a situation of a single plateau wave) and 
18.8 mmHg (in a situation of two consecutive plateau waves).  
The results of a previous assessment of nICPBB during plateau waves have been described in 
Section 3.3.3. In that study, clinical material from 17 TBI patients was used to construct the 
nICP simulation model, which resulted in better accuracy and the stronger correlation between 
∆ICP and ∆nICPBB in comparison to this current assessment (see Table 3.3) 140. The formation 
dataset, in that case, was more specific for plateau waves, in which 7 patients (41% of the 
dataset) presented such phenomena. In contrast, the model of nICPBB used in this thesis 
considered a large general TBI cohort (N=140 patients) (described in Sections 3.3.3 and 4.2.3). 
Consequently, the way nICPBB was generated in both studies might have contributed to such 
discrepancy in results.  
Under these circumstances, it is possible to infer that nICP methods derived from formation 
datasets specific for certain conditions may present better accuracy than those based on general 
datasets. Some findings supporting this inference were discussed in Section 5.1, which 
demonstrated that the nICP methods presented smaller 95% CI in the analysis of a TBI cohort 
convergent to the methods’ formation datasets, i.e., general regarding different sources of ICP 
changes. However, one obvious disadvantage of specific formation datasets is the restriction 
of applicability of the nICP method in differing clinical conditions. 
This effect can also be exemplified with the results from Section 5.2, in which the assessment 
of nICP methods derived from TBI datasets in patients with hydrocephalus resulted in a bad 
accuracy.  
Despite the lack of individual calibration, the nICP methods presented reliable accuracy to 
track changes in ICP across time during plateau waves and identify these events associated 
with ICH thresholds. Since plateau waves are recurrent phenomena in TBI patients, affecting 
approximately 25% of cases 138 and a predictor of poor outcome 138, the identification of these 
ICP surges non-invasively could represent a major application of TCD-based nICP methods. 
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In the clinical practice, it could provide a better understanding of the clinical state of the patient 
and guide oriented treatments in situations of sustained plateau waves.
Results & Discussions I 
107 
 
5.4 General limitation factors 
 
 
The quality of TCD and ABP recordings are essential requirements for ICP estimation using 
TCD-based methods. Aspects such as depleted signal resolution and noise, for instance, may 
prevent a meaningful nICP estimation.  
The use of radial artery ABP calibrated at the level of the heart instead of actual blood pressure 
at head level could also limit nICP estimation. This condition approximate peripheral ABP to 
intracranial ABP non-accurately, and might affect the accuracy of methods that rely on ABP 
waveform analysis.
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6  RESULTS & DISCUSSIONS II: FEASIBILITY OF TCD-
BASED nICP MONITORING 
 
 
This chapter presents the results of studies on the feasibility of nICP monitoring in three clinical 
conditions. There are various situations inside and outside the neurocritical care settings in 
which the impracticality or invasiveness of the current methods for ICP monitoring impedes 
the assessment of this parameter, therefore precluding more oriented treatment protocols in 
cases of disturbed cerebral haemodynamics.  
The presented studies aim to assess the feasibility of TCD-based nICP monitoring in clinical 
conditions in which invasive monitoring was impractical or unachievable. The nICP estimator 
used in these studies was the black box model (nICPBB), based on its comparative best 
performance to other TCD-based methods as presented in Chapter 5. 
 
 
6.1 Feasibility of nICP to detect interhemispheric pressure gradients in closed 
traumatic brain injury 
 
 
Introduction 
 
The central nervous system presents a compartmentalised structure with rigid subdivisions. In 
the cranium, such components consist of the left and right hemisphere divided by the falx, the 
ventricles, the posterior fossa separated by the tentorium, and the extracranial space below the 
foramen magnum 142. In pathological conditions such as TBI, sustained and significant 
intercompartmental pressure gradients between these structures can cause brain midline shift 
143 and herniations 142 (Figure 6.1).  
 
 
Results & Discussions II 
109 
 
Figure 6.1. Head CT scan illustrating a brain midline shift. In this example, the shift occurs from the right to the 
left brain hemisphere. 
 
 
CT, computed tomography; A, anterior; L, left; P, posterior; R, right. 
 
If CSF circulates freely, it cancels possible pressure gradients in the brain, as per Pascal law, 
the pressure is uniformly distributed in the fluid. Following TBI, local or global brain swelling 
may acutely disturb the CSF circulation. Therefore, the concept that the intracranial 
compartment is a space in which ICP is uniformly distributed has been challenged 144–146. 
Although there is a consensus on the existence of craniospinal and suprainfratentorial pressure 
gradients, the existence of interhemispheric gradients is still debatable 144. Intracranial pressure 
gradients have been reported in adult and paediatric TBI populations 147,148 in the presence 
144,149,150 and absence 143,144,151,152 of unilateral mass lesions, and also in patients with non-
traumatic unilateral mass lesions 143.  
Assuming the existence of interhemispheric pressure gradients, there is a concern in cases of 
unilateral mass lesions related to ICP at the ipsilateral and contralateral sides of contusion. 
Most studies comparing ICP in such conditions suggested a greater pressure ipsilateral to the 
contusion 144,153; however, this is still a matter of debate since other findings suggested a greater 
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pressure at the contralateral side 145,146. Potential explanations for this controversy lay on the 
issue that different types of lesions may produce different patterns of pressure gradients 144. 
Nevertheless, one should consider that pressure asymmetry could also be associated with 
derangements in the cerebral vasculature as a secondary injury following TBI.   
Considering that bilateral ICP monitoring can be impractical and unavailable in many centres, 
these questions have remained unanswered. In this scenario, techniques that can provide a non-
invasive global assessment of the cerebral haemodynamics and nICP monitoring could help 
elucidate this controversy.  
This study aims to evaluate the presence of interhemispheric pressure gradients in patients 
managed for closed head injury with brain midline shift, using bilateral TCD ultrasonography 
as means for nICP monitoring.  
 
 
Material and methods 
 
Patient population 
A group of 97 patients from the retrospective TBI cohort described in Section 4.1.2 was 
analysed in this study. The patient’s median age was 34 years (range 13-76 years; 78% males). 
The median initial GCS score was 6 (range 3–15).  
All patients were sedated, paralysed, ventilated, and treated with a CPP-oriented strategy, 
targeted at least 70 mmHg 154. The patients were kept normothermic (body temperature at 35-
37˚C), an ICP higher than 25 mmHg was treated with mannitol (2 mg/kg), and ABP was 
maintained by volume expansion and administration of dopamine and/or epinephrine.  
All significant intracranial mass lesions that were observed on initial CT scans were promptly 
removed by the consultant neurosurgeon. For methodological purposes, all patients in whom a 
craniectomy was performed before the assessments were excluded from the study, as this could 
artificially disturb the symmetry of cerebral blood flow. The inclusion criteria were the 
presence of a unilateral lesion, the presence of midline shift and absence of craniectomy at the 
moment of monitoring.  
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In the current clinical practice, patients with midline shift not treated actively (including the 
early evacuation of compression, decompressive craniectomy) are rarely seen. This is the 
reason the study was based on a retrospective cohort with midline shift without evacuation of 
any mass lesion.  
 
Analysis of CT Scans 
Brain CT scans were analysed and graded using a simplified system based on the classification 
of Marshall et al. 155, focussing on brain swelling, dominant side of lesion and midline shift. 
Only CT scans that had been obtained close to the time of the TCD recording were selected 
and analysed. For those patients who underwent early neurosurgical interventions, the 
postoperative CT scan rather than the scan that was obtained initially was chosen.  
Brain swelling was scored according to the following radiographic features: the disappearance 
of sulci, effacement of ventricles, basal cistern compression, and reduction in the difference 
between white and grey matter (i.e., the disappearance of the white-grey matter difference in 
more than 50% of the slices). The sum of these factors produced a score from 0 to 4, with 0 
indicating no swelling and 4 indicating severe swelling. 
The side of the brain containing the primary lesion was noted, but the type and specific location 
of intraparenchymal lesions were not considered. Three groups were identified: patients with 
parenchymal lesions on the right or left side and patients without any noticeable parenchymal 
lesion but presenting midline shift. 
The midline shift was measured in millimetres according to the scale on the CT scan. A positive 
value was assigned to displacement of the midline from the right to the left side, and a negative 
value to the displacement of the midline from the left to the right side. No midline shift was 
graded as a zero value. 
 
Clinical monitoring and data collection 
The implemented clinical monitoring included ABP, ICP and FV as described in Section 4.2.1. 
The ICP probe was inserted intraparenchymally into the right frontal region. FV was obtained 
from the left and right middle cerebral arteries for a period of 20 minutes to 2 hours. 
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The nICP assessment was performed using the black-box model (nICPBB). Derived 
physiological parameters and nICPBB were calculated as described in Section 4.2.3. nCPP was 
derived from nICPBB. 
All recordings were performed on separate days, and the measured parameters from each 
recording were averaged over the whole monitoring period so that every recording was 
represented by one set of averaged data including left and right FV, nICP, nCPP and CT 
findings. The nCPP was calculated as the difference between mean ABP and nICPBB. 
Analysis considered the calculations of the left–right mean value of the nICP                         
(nICPm = [nICPL + nICPR]/2), the left–right difference in nICP (nICPDiff = nICPL - nICPR), and 
its absolute left–right difference (nICPAbs Diff = |nICPL - nICPR|). The same calculations were 
performed for nCPP and FV. 
 
Statistical analysis 
Multiple measurements were treated as independent events. The data were tested for normal 
distribution using the Shapiro-Wilk test and are presented as median (IQR). Data distributions 
were non-parametric. Correlations between the different variables were performed using the 
Spearman correlation coefficient (R), with statistical significance set at 0.05. Statistical 
measurements were performed with the Wilcoxon rank sum test with continuity correction, and 
the Wilcoxon signed rank test. 
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Results 
 
 
Interhemispheric difference in non-invasive ICP and CPP  
From 97 patients, 73 did not meet the inclusion criteria: 64 patients did not present midline 
shift at any moment; 9 patients had either unilateral or bilateral craniectomy - two of these 
patients presented midline shift before having a craniectomy, and their recordings were 
considered for analysis. 
From the 24 patients presenting midline shift, the total number of recordings was 63; 34 
presenting midline shifts from left to right (-), and 29 from right to left (+). For these patients, 
only CT scans obtained before craniectomy were used for midline shift assessment. Midline 
shift varied from 1.0 to 14 mm (median 3 (5-2)). The location of the head injury lesions in these 
patients was predominant on the left side (N=14 (58%)). The degree of swelling was moderate 
(median score of 2 (3-2), range 0-4; swelling score 0: N=1; score 1: N=9; score 2: N=29; score 
3: N=23; score 4: N=1). The values of midline shift and brain swelling were correlated (R=0.30, 
p<0.01). 
Table 6.1 lists the median (IQR) of pressure and flow for patients. Figure 6.2 shows an example 
of a patient recording presenting a noticeable nICP asymmetry.  
nICPL and nICPR were correlated with each other (R=0.79, p<0.001), and with invasive ICP 
(Figure 6.3, R=0.50 and 0.51 (p<0.001), respectively for left and right sides). nICPm was also 
correlated with ICP (R=0.53, p<0.001). nICPDiff, nICPAbs Diff and invasive ICP were not 
significantly correlated with brain swelling (R=-0.16, R=0.24 and R=0.07, respectively). 
There was a significant correlation between nICPDiff and the extent of midline shift (R=0.34, 
p<0.01). This relationship indicates that nICP on the side of brain expansion was smaller than 
in the compressed side when there was a midline shift (Figure 6.4). nICP at the side of 
expansion was significantly different in comparison to the compressed side (18.86±5.71 mmHg 
(mean ± SD) versus 20.30±6.78 mmHg for expansion and compressed sides, respectively; with 
a mean difference of -1.44±3.61 mmHg, p<0.01).   
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Table 6.1. Median (IQR) of the assessed variables. 
 
Variable Median (IQR)  
ABP 103.40 (109.20-94.00)  
ICP 21.27 (26.48-16.60) 
CPP 80.58 (86.17-72.64) 
FVm 55.21 (65.76-43.89)  
FVL 56.18 (64.53-40.45)  
FVR 56.68 (70.37-41.07)  
FVAbs Diff 10.88 (18.06-6.09)  
nICPm 19.95 (24.16-16.88)*  
nICPL 19.42 (23.65-15.70)*  
nICPR 20.93 (25.82-17.21)* 
nICPAbs Diff 2.37 (5.00-1.11) 
nCPPm 82.42 (87.06-75.69)** 
nCPPL 82.95 (88.13-76.43)** 
nCPPR 81.24 (86.71-74.31)** 
nCPPAbs Diff 2.37 (5.00-1.11) 
 
*nICP (left, right and mean) is not significantly different from ICP (p>0.05). 
**nCPP (left, right and mean) is not significantly different from CPP (p>0.05). 
Abs = absolute; diff = difference; m, mean; L, left; R, right. 
ABP (mmHg), arterial blood pressure; CPP (mmHg), cerebral perfusion pressure; FV (cm/s), cerebral blood flow 
velocity; ICP (mmHg), intracranial pressure; nICP (mmHg), non-invasive intracranial pressure; nCPP (mmHg), 
non-invasive cerebral perfusion pressure. 
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Similarly to nICP, nCPPL and nCPPR were correlated with each other (R=0.89, p<0.001), as 
well as with invasive CPP (R=0.71 and 0.67 (p<0.001), respectively for left and right sides). 
nCPPm was also correlated with CPP (R=0.71 (p<0.001)). CPP and nCPPm presented an inverse 
relationship with brain swelling (R=-0.29 (p=0.02), R=-0.27 (p=0.04), respectively). There was 
a trend between nCPPAbs Diff and brain swelling (R=0.24 (p=0.06)). 
nCPPDiff was inversely correlated with midline shift (R=-0.34 (p<0.01)), indicating that nCPP 
was greater on the side of brain expansion (Figure 6.5). nCPP at the side of expansion was 
significantly different in comparison to the compressed side (79.48±7.84 mmHg versus 
78.03±8.93 mmHg for expansion and compressed sides, respectively; with a mean difference 
of 1.45±3.61 mmHg (p<0.01)).  
 
 
Cerebral haemodynamics in patients with midline shift  
FVL and FVR presented a strong correlation with each other (R=0.79 (p<0.001)), but not with 
nICPm or ICP. FVDiff did not significantly correlate with midline shift (R=-0.19). There was no 
significant difference between FV at the sides of expansion and compression (difference of 
3.27±13.73 cm/s). FVAbs Diff did not correlate with brain swelling (R=-0.02). 
 
Figure 6.2. An example of continuous recording of mean ABP, FV and nICP of a patient presenting a midline 
shift of -3.0 mm. It is possible to observe the asymmetry of nICP in this patient, in whom the mean left-right 
difference throughout the monitoring period was 11.67 mmHg. 
 
 
ABP (mmHg), arterial blood pressure; FV (cm/s), cerebral blood flow velocity; nICP (mmHg), non-invasive 
intracranial pressure.  
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Figure 6.3. Correlation scatterplots between ICP and nICP. (A) Left nICP vs ICP (R=0.50, p<0.001); (B) Right 
nICP vs ICP (R=0.51, p<0.001). 
 
 
 
Grey shaded areas on the plots represent the 95% confidence intervals for the linear regressions between ICP and 
nICP. 
ICP (mmHg), intracranial pressure; nICP (mmHg), non-invasive intracranial pressure.  
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Figure 6.4. Correlation scatterplot of the relationship between brain midline shift and the interhemispheric 
difference in nICP (R=0.34, p<0.01). Negative values for midline shift represent a brain expansion from the left 
to the right side; for positive values, an expansion from the right to the left side. When there is a midline shift, it 
is suggested that nICP was smaller on the side of brain expansion; therefore, nICP cannot be considered the driving 
force of the brain asymmetry demonstrated by a noticeable midline shift.  
 
 
Grey shaded area on the upper panel represents 95% confidence intervals for the linear regressions between nICP 
and midline shift.  
MS, midline shift (mm); nICP, non-invasive intracranial pressure (mmHg).  
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Figure 6.5. Scatterplot of the relationship between brain midline shift and the left-right difference in nCPP                  
(R=-0.34, p<0.01). Similarly to Figure 6.4 negative values for midline shift represent a brain expansion from the 
left to the right side; for positive values, an expansion from the right to the left side. When there is a midline shift, 
it is suggested that nCPP is greater on the side of brain expansion.  
 
 
nCPP (mmHg), non-invasive cerebral perfusion pressure. 
 
 
Discussion 
 
Pressure gradients have been observed between a variety of intracranial compartments 
previously 142, and the specific vulnerability of the brain to it seems to have been neglected so 
far. Clinically, ICP transducers are usually only placed unilaterally in the brain parenchyma or 
intraventricularly. Nevertheless, in conditions which an interhemispheric pressure gradient is 
present, elevated ICP in the contralateral hemisphere may be treated insufficiently or even 
disregarded. Particularly, the absence of bilateral monitoring gains importance if one takes into 
consideration that intracranial hypertension 7 and brain midline shift 156 are related to poor 
outcome after TBI. In such cases, an early identification of interhemispheric pressure gradients 
without the risks associated with invasive monitoring would be useful. 
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There has been a controversy in the literature concerning interhemispheric pressure gradients 
in cases with focal lesions. Sahuquillo et al. 144 affirmed that patients after TBI presented ICP 
higher in the hemisphere with the mass lesion. Such results are in agreement with the majority 
of findings in experimental models, in which ICP was always higher ipsilateral to the mass 
lesion 157. Nevertheless, Wolfla et al. 145,146, verified in a swine model of extradural temporal 
lesions that ICP was always highest on the contralateral side to the mass. These contradicting 
results may be because intradural and extradural lesions produce different patterns of pressure 
gradients, or due to anatomical differences between the intracranial compartment of humans 
and swine 145. Another potential explanation lays on the fact that different mechanisms could 
generate interhemispheric pressure gradients. For example, a complete or partial blockage of 
the subarachnoid space between brain hemispheres impairing the free circulation of CSF, or 
even derived from differences in CPP 145.  
 
Asymmetry of ICP and CPP assessed non-invasively   
The common conceptual thinking about interhemispheric pressure gradients dictates that ICP 
will be higher on the side of brain expansion in response to trauma and consequent local tissue 
pressure gradients leading to mass shifts 158. Contrarily to what is mostly reported in the 
literature, in our study, intracranial pressure estimation was smaller on the side of brain 
expansion, and therefore not the plausible driving force of the observed brain asymmetry as 
evidenced by a measurable midline shift. However, uneven CPP distributions across 
hemispheres were the plausible cause of the midline shift.  
A greater CPP on the side of brain expansion could originate from derangements in the cerebral 
vasculature as a secondary consequence of head trauma.  It has been reported that TBI patients 
may present with a heterogeneous pattern of cerebrovascular dysfunction 159,160. For example, 
a dysfunction of the cerebrovascular endothelial wall may initiate an uncontrolled ion and 
protein transfer from the intravascular to the extracellular brain compartments. Anatomically, 
this process increases the volume of the extracellular space by water accumulation, causing 
brain swelling 161. However, other scenarios, like unilateral vasoparalysis, leading to purely 
cerebral blood volume increase, are also possible. 
A previous study on the same group of TBI patients with midline shift 162, showed that cerebral 
autoregulation assessed using TCD was impaired on the side of brain expansion. Another study 
163 exploring the effects of brain asymmetry on cerebral haemodynamics, found that the critical 
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closing pressure of the vessels 164 was lower on the side of brain expansion. This could be 
related to damaged and dilated vessels, resulting in a lower vascular resistance in comparison 
to vessels in the uninjured contralateral hemisphere.  
In the present assessment, it appears that an impaired cerebrovascular bed was associated with 
a greater blood perfusion to the side of brain expansion. In addition, the absolute 
interhemispheric difference in nCPP presented a positive trend with brain swelling, suggesting 
that the more asymmetrical nCPP is, the greater the brain swelling. This is in agreement with 
the hypothesis of an impaired cerebrovascular bed in this patient cohort, as brain swelling might 
originate following endothelial dysfunction in TBI 161.  
These findings jointly with our results suggest that interhemispheric pressure gradients might 
not be a direct pressure gradient-controlled phenomenon, in which mass lesions are the only 
source of pressure gradients and brain asymmetry. Instead, considering the observed patterns 
of cerebral haemodynamics displayed by nCPP, it appears to be a phenomenon that presents 
components of vascular and vasogenic origins.  
 
Clinical relevance of interhemispheric gradients and the significance of nICP 
monitoring 
For patients with mass lesions and vulnerable to interhemispheric pressure gradients, a bilateral 
ICP monitoring would be essential as it could guide a more oriented management. Moreover, 
unilateral ICP monitoring can be imprecise, and sometimes the presence of interhemispheric 
pressure gradient can lead to delayed cerebral ischaemia. Nevertheless, the invasiveness of the 
ICP monitoring techniques has prevented their widespread use.  
TCD-based nICP monitoring would potentially eliminate these complications, but despite its 
ability to detect dynamic changes in ICP, the accuracy of ICP estimation in comparison with 
invasive methods is not ideal. In the present study, the 95% CI for ICP prediction considering 
nICP estimated at the right hemisphere (where invasive ICP was measured) was ±14.7 mmHg. 
However, if only applied to measure the relative left-right difference in nICP, the accuracy of 
this method does not play a crucial role in the interpretation of the findings. 
The use of TCD-based nICP monitoring would be useful in anticipating the identification of 
pressure gradients that would only be detected by a head CT. In practical terms, for instance, 
had an increasing pressure gradient been detected, it would be useful to repeat imaging, as it 
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could confirm potential haemorrhage or increasing midline shift. Although there are no 
standard protocols on how to treat pressure gradients in the brain, a possible management 
would be targeting CPP to standard thresholds 9 and treating ICP based on the highest value. 
This management should also consider that ICP is not solely a number, but a trend containing 
relevant information about cerebral haemodynamics 165. 
  
Limitations 
This retrospective cohort analysis reaches for old material, as according to changes in practice, 
patients with midline shift rarely are managed without surgery, such as evacuation of lesion or 
decompression. Although such cases are currently less common, this study could demonstrate 
the applicability of TCD as an alternative for bilateral ICP monitoring. 
The data are not homogeneous, particularly concerning age, GCS and number of recordings 
per patient. However, stratification of the data was not applied as each measurement was 
considered an independent event in the analysis if patients presented persistent midline shift 
and managed for traumatic brain injury. 
It is presumed that there was an interhemispheric cerebral arterial pressure gradient. Therefore, 
differences in bilateral nICP may be directly translated to differences in nCPP. In regards to 
the CPP-oriented management protocol applied (CPP ≥70 mmHg), this is no longer used in 
clinical practice 9. However, driving CPP to 70 mmHg could have contributed to further shifts 
in the absence of adequate cerebral autoregulation.
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6.2  Feasibility of nICP associated with a TCD multiparameter assessment of 
cerebral haemodynamics during orthotopic liver transplant 
 
 
Introduction 
 
The pathophysiology of hepatic encephalopathy is not completely understood, but the 
development of cerebral oedema resulting in ICH and neurologic deterioration is a well-known 
phenomenon of acute liver failure (ALF) 166,167.  
ICH development may be linked to both the systemic inflammatory state and effects of 
neurotoxins in ALF.  Cerebral hyperammonaemia due to compromised detoxification in the 
failing liver results in its enzymatic conversion to osmotically active glutamine, with 
subsequent astrocyte swelling and brain oedema 168. Although the prevalence and mortality 
caused by these complications have decreased in the past years due to advancements in 
treatment, the onset of oedema and ICH in ALF patients represent a leading cause of death 
(mortality >50%) 169 and permanent neurological damage 170,171.  
Patients with ALF are vulnerable to sudden relevant changes of ABP, causing changes in CBF 
in conditions of functional loss of cerebral blood flow autoregulation. For the same reason, 
they may be considered less suitable for major surgery with significant blood losses and fluid 
shifts, such as orthotopic liver transplantation (OLT). Arterial hypertensive or hypotensive 
episodes during OLT may provoke cerebral hypoperfusion or hyperperfusion leading to either 
ischemia or aggravation of cerebral oedema and even cerebral haemorrhage. Failure to regain 
consciousness despite satisfactory graft function has also been reported after OLT 172–175, which 
may originate from episodes of ICH during transplantation. 
In patients with ALF, the benefits of ICP monitoring include the precise and early detection of 
ICH; a correct evaluation of response to therapies; the knowledge of cerebral perfusion 
pressure, which guides vasopressors administration in the setting of loss of cerebral 
autoregulation characteristic of ALF176; the procurement of prognostic information, especially 
for deciding candidacy for transplant; the lengthening of survival time, increasing the chances 
for organ allocation177; and the improvement of anaesthetic management during OLT, in which 
ICH is common178.  
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On the other hand, in patients with hepatic failure, due to the risk of coagulopathy, the standard 
invasive ICP monitoring may cause some complications, like haemorrhage (approximately 
49% 179). Taking these implications into account, this study aims to test the feasibility of nICP 
monitoring in association with a TCD multiparameter approach for cerebral haemodynamics 
assessment in patients with ALF undergoing OLT. 
 
 
Materials and methods 
 
Patient population 
Six patients from the retrospective OLT material described in Section 4.1.2 were analysed in 
this study. The median age was 56 years (range 51-65 years; 67% males). On arrival to the 
surgical suite, a standard monitoring was applied, including pulse-oximetry, 
electrocardiography and invasive arterial blood pressure monitoring. Patients were not pre-
medicated. After preoxygenation, general anaesthesia was induced with intravenous with 
propofol alfentanil (0.25 – 1.0 mg) and paralysis achieved with atracurium (0.6 mg/kg). A 
continuous infusion of remifentanil was started after induction (20 mg at a rate of 4-6 ml/h). 
Muscle relaxation was maintained with a continuous infusion of atracurium (40 – 60 mg/h, 10 
mg/ml). A mixture of air/oxygen/isoflurane at sub-minimal alveolar concentrations (0.5 – 
1.5%) was the volatile agent of choice. Ventilation was controlled to an end-tidal carbon 
dioxide (ETCO2) of 4-4.5 kPa during surgery. 
 
Clinical monitoring and data collection 
The implemented clinical monitoring included ABP and FV as described in Section 4.2.1. FV 
was obtained from the left and right middle cerebral arteries throughout the surgery. During 
every surgery, three time periods were defined: the dissection phase (T0), from surgical start 
till portal vein has been clamped; the anhepatic phase (T1), when the portal vein is clamped; 
and at last the reperfusion phase (T2), when the portal vein is released until the completion of 
the surgery. The mean recording time was 6 hours. 
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The analysis considered the calculations of the left and right sides mean values of each TCD-
derived parameter, which included nICPBB, nCPP (derived from nICPBB), cerebral 
autoregulation (Mxa), pulsatility index, critical closing pressure, diastolic closing margin and 
optimal ABP as described in Section 4.2.3. 
 
 
 
Statistical analysis 
Data were tested for normal distribution using the Shapiro-Wilk test and are presented as 
median (IQR). Data distributions were non-parametric. Statistical measurements were 
performed with the Kruskal-Wallis rank sum test followed by pairwise comparisons using 
Wilcoxon rank sum test across the different phases of OLT. The statistical significance level 
was set at p<0.05. 
 
 
Results 
 
Table 6.2 summarises patient demographics and clinical information. Table 6.3 shows the 
different parameters assessed at each phase during OLT averaged by patient. Table 6.4 shows 
the same parameters for individual patients evaluated at each phase during OLT. 
The variable presenting statistically significant changes between surgery phases was nCPP (T0-
T2, mean decrease of 8.17 mmHg (p=0.03)). ABP and DCM presented a reduction trend 
throughout OLT, as well as FV and CrCP from T0 to T1. PI presented an increasing trend, 
whereas nICP remained constant (Table 6.3). 
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Table 6.2. Patients demographics and acute liver failure aetiology. 
 
Patient Age Sex ALF aetiology 
1 51 M ArLD/HCV  
2 60 M ArLD 
3 51 M Cryptogenic cirrhosis (likely NASH)  
4 65 F HCV/HCC  
5 53 F PSC 
6 57 M PSC 
 
ALF, acute liver failure; ArLD, alcohol-related liver disease; HCV, hepatitis C virus; NASH, non-alcoholic 
steatohepatitis; HCC, hepatocellular carcinoma; PSC, primary sclerosing cholangitis; M, male; F, female. 
 
Considering reference values for TCD parameters in a healthy population 55, patients presented 
low FV in all phases during OLT (FV <60 cm/s). In an individualised analysis, patients 2, 3, 5 
and 6 presented low flow velocity patterns in all phases; patient 4 presented low flow only 
during T2. PI values deviated from normal ranges in all patients throughout OLT (PI >0.8 55) 
(Table 6.4).  
 
Table 6.3. Variables assessed at each phase during OLT averaged by patient. Only nCPP presented statistically 
significant changes between surgery phases (T0-T2, mean decrease of 8.17 mmHg (p=0.03)). 
 
  T0 T1 T2 
ABP 72.22 (77.92-69.93) 69.86 (74.19-66.34) 63.36 (66.58-59.17) 
ABPs 111.2 (117.00-109.60) 108.08 (112.94-105.35) 101.65 (108.46-97.45) 
ABPd 52.82 (56.18-50.04) 52.32 (56.25-46.09) 44.48 (47.64-41.22) 
FV 53.90 (58.65-33.65) 44.04 (51.29-38.57) 52.87 (65.72-40.03) 
PI 1.15 (1.42-1.06) 1.17 (1.24-1.14) 1.28 (1.41-1.18) 
nICP 12.50 (14.22-10.89) 12.09 (12.79-11.45) 12.12 (13.25-8.70) 
nCPP 58.25 (63.35-58.00) 57.73 (60.92-55.71) 51.14 (51.62-50.47) 
Mxa 0.50 (0.60-0.48) 0.64 (0.69-0.54) 0.61 (0.76-0.51) 
CrCP 23.00 (21.91-19.77) 26.02 (28.60-24.10) 23.12 (23.22-21.28) 
DCM 30.00 (33.73-26.52) 23.63 (28.25-21.50) 21.82 (26.07-19.89) 
 
ABP (mmHg) (s, systolic; d, diastolic), arterial blood pressure; FV (cm/s), cerebral blood flow velocity; PI, 
pulsatility index; nICP (mmHg), non-invasive intracranial pressure; nCPP (mmHg), non-invasive cerebral 
perfusion pressure; Mxa, autoregulation index; CrCP (mmHg), critical closing pressure; DCM (mmHg), diastolic 
closing margin. 
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Overall, nCPP presented low values in all phases (<60 mmHg 180). Individually, patients 2, 3 
and 6 presented low nCPP in all phases; patient 4 only during T0 and T1; patient 1 during T1 
and T2 and patient 5 only during T0. nICP was below the clinical threshold of 20 mmHg for 
intracranial hypertension throughout OLT for all patients (Table 6.4). 
Mxa index showed impaired cerebral autoregulation throughout OLT. Furthermore, Mxa 
showed a gradual worsening in autoregulation from T0-T1. CrCP was never close to ABP in 
any phases. Consequently, DCM did not reach critical values (≤0 mmHg) throughout OLT, 
remaining above a median of 23 mmHg (Table 6.3).Figure 6.6 shows an example of monitored 
ABP, FV, nICP, nCPP, CrCP and Mxa throughout OLT phases for a single patient. Figure 6.7 
depicts individual and mean changes for ABP, nICP and nCPP; Figure 6.8 for FV and PI; 
Figure 6.9 for the autoregulation index; and Figure 6.10 for CrCP and DCM.  
Figure 6.11 and Figure 6.12 show examples of optimal curves for ABP obtained from 
individual patients, in which nPRx below levels associated with impairment of cerebral 
autoregulation (<0.25) revealed optimal values for ABP in certain cases (U-shaped curves). 
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Figure 6.6. Representation of multiparameter monitoring performed with transcranial Doppler during orthotopic 
liver transplant. This figure depicts “patient 5”, in which is possible to observe the overall changes in cerebral 
haemodynamics among different surgical phases.  
 
 
ABP (mmHg), arterial blood pressure; FV (cm/s), cerebral blood flow velocity; nICP (mmHg), non-invasive 
intracranial pressure; nCPP (mmHg), non-invasive cerebral perfusion pressure; CrCP (mmHg), critical closing 
pressure; Mxa (a.u.), autoregulation index; T0, dissection phase; T1, anhepatic phase; T2, reperfusion phase. 
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Table 6.4. Variables assessed at each phase during OLT considering individual cases.  
 
  T0 
 
T1 
 
T2 
 
1 2 3 4 5 6   1 2 3 4 5 6   1 2 3 4 5 6 
ABP 81.96 69.07 62.63 79.50 73.15 71.29 
 
64.77 66.08 67.12 74.72 81.24 72.60 
 
58.06 54.13 64.20 62.52 74.39 67.38 
ABPs 118.91 110.92 111.46 120.73 106.35 109.18  104.57 99.53 117.84 107.68 114.42 108.47  96.86 99.23 109.92 92.75 116.25 104.07 
ABPd 59.23 49.30 40.70 57.11 52.25 53.39  44.78 50.00 40.66 56.78 63.30 54.64  40.81 36.02 42.44 46.53 54.29 48.01 
FV 63.47 49.61 23.44 58.80 58.18 28.32 
 
73.53 40.58 37.89 47.50 52.55 32.29 
 
69.20 50.44 33.45 74.49 55.29 36.55 
PI 0.91 1.21 1.88 1.08 1.06 1.49 
 
1.18 1.17 1.55 1.13 0.94 1.26 
 
1.36 1.43 1.54 1.19 1.17 1.18 
nICP 9.65 10.63 11.68 14.52 15.09 13.31 
 
9.12 12.16 11.26 13.36 12.02 13.00 
 
7.70 5.65 12.54 11.71 13.48 15.90 
nCPP 72.31 58.44 50.95 64.98 58.06 57.97 
 
55.66 53.92 55.86 61.66 69.22 59.60 
 
50.35 48.47 51.66 50.81 60.91 51.48 
Mxa 0.48 0.49 0.45 0.67 0.63 0.5 
 
0.44 0.7 0.68 0.69 0.52 0.60 
 
0.49 0.56 0.66 0.82 0.42 0.8 
CrCP 23.97 18.94 15.82 22.26 26.78 23.75 
 
23.79 26.99 20.10 32.55 29.14 25.04 
 
23.22 13.72 23.04 25.19 23.20 20.69 
DCM 35.26 30.36 24.88 34.85 25.47 29.64 
 
20.99 23.02 20.56 24.23 34.17 29.59 
 
17.59 22.30 19.40 21.33 31.09 27.33 
 
ABP (mmHg) (s, systolic; d, diastolic), arterial blood pressure; FV (cm/s), cerebral blood flow velocity; PI (a.u.), pulsatility index; nICP (mmHg), non-invasive intracranial 
pressure; nCPP (mmHg), non-invasive cerebral perfusion pressure; Mxa (a.u.), autoregulation index; CrCP (mmHg), critical closing pressure; DCM (mmHg), diastolic closing 
margin. 
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Figure 6.7. Longitudinal plots for (A) arterial blood pressure, (B) non-invasive intracranial pressure and (C) non-
invasive cerebral perfusion pressure throughout OLT. Although all three parameters had a decreasing trend, only 
nCPP presented significant changes between phases (T0-T2 (p<0.03)). 
 
 
 
Triangles on the plots represent the mean values for each variable at a specific surgery phase. Thick black lines 
represent the linear fit of the data; grey shadowed areas represent the 95% confidence interval of the linear model 
representative of the data. 
ABP (mmHg), arterial blood pressure; nICP (mmHg), non-invasive intracranial pressure; nCPP (mmHg), non-
invasive cerebral perfusion pressure; OLT, orthotopic liver transplant. 
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Figure 6.8. Longitudinal plots for (A) cerebral blood flow velocity and (B) pulsatility index throughout OLT. The 
patients presented low FV (<60 cm/s) and augmented PI (>0.8) in all phases during OLT.  
 
 
 
Triangles on the plots represent the mean values for each variable at a specific surgery phase. Thick black lines 
represent the linear fit of the data; grey shadowed areas represent the 95% confidence interval of the linear model 
representative of the data. 
FV (cm/s), cerebral blood flow velocity; PI (a.u.), pulsatility index; OLT, orthotopic liver transplant. 
 
Figure 6.9. Longitudinal plot for autoregulation index throughout OLT. Mean Mxa demonstrates impaired 
cerebral autoregulation throughout OLT, with gradual worsening from T0-T1. 
 
 
Triangles on the plots represent the mean values for each variable at a specific surgery phase. The thick black line 
represents the linear fit of the data; grey shadowed areas represent the 95% confidence interval of the linear model 
representative of the data. 
Mxa, autoregulation index; OLT, orthotopic liver transplant. 
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Figure 6.10. Longitudinal plots for (A) CrCP and (B) DCM throughout OLT. CrCP was never close to ABP in 
any phases. Therefore, DCM did not reach critical values (≤0 mmHg). 
 
 
 
Triangles on the plots represent the mean values for each variable at a specific surgery phase. The thick black 
lines represent the linear fit of the data; grey shadowed areas represent the 95% confidence interval of the linear 
model representative of the data. 
CrCP (mmHg), critical closing pressure; DCM (mmHg), diastolic closing margin; OLT, orthotopic liver 
transplant. 
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Figure 6.11. An example of an optimal curve for arterial blood pressure with corresponding recordings of ABP, 
ICP and nCPP throughout OLT.  
 
 
The lowest point on the “U-shaped” curve represents the optimal values for ABP, which, in this case, was close 
to 70 mmHg. 
ABP (mmHg), arterial blood pressure; nICP (mmHg), non-invasive intracranial pressure; nCPP (mmHg), non-
invasive cerebral perfusion pressure; nPRx (a.u.), autoregulation index; OLT, orthotopic liver transplant. 
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Figure 6.12. Optimal curves for arterial blood pressure obtained in different patients. 
 
 
 
The lowest points on the “U-shaped” curves represent the optimal values for ABP. 
ABP (mmHg), arterial blood pressure; nPRx (a.u.), autoregulation index. 
 
 
 
 
Discussion 
 
In a variety of clinical settings, multimodal applications of TCD may provide an early detection 
of the onset of cerebrovascular derangements and facilitate their clinical management. In 
previous studies on ALF, TCD provided a repeatable and reliable non-invasive, bedside 
assessment of CBF changes, allowing the evaluation of the OLT feasibility 181 and the 
identification of predominant haemodynamic patterns 182. In the present study, different 
patterns of cerebral haemodynamics could be identified non-invasively during OLT using a 
Results & Discussions II 
134 
 
TCD-derived multimodal approach englobing nICP, nCPP, cerebral autoregulation, CrCP and 
DCM. 
The assessment of cerebral autoregulation with TCD during OLT has been investigated 
previously. In a study of Ardizzone et al. 183, this parameter was evaluated by investigating 
parallel changes in ABP and FV during a slow phenylephrine infusion at the beginning and end 
of OLT for 1 hour at each period compared with a baseline. Before OLT, autoregulation was 
impaired in all patients (N=6). However, it markedly improved at the end of surgery. In another 
study from the same author using a larger patient cohort (N=23) 184, autoregulation and 
cerebrovascular resistance significantly increased from anhepatic to postreperfusion phases 
(within the first hour), decreasing from postreperfusion to recovery in the neohepatic phase 
(end of surgery). Such results agree with findings of this study, as cerebral autoregulation 
assessed through changes of either ABP and FV (Mxa, Figure 6.9) demonstrated values 
indicative of a non-reactive cerebrovascular bed throughout OLT. 
The scenario of impaired cerebral autoregulation may explain the low cerebral blood flow 
velocity pattern presented by patients. In addition, the estimated cerebral perfusion pressure 
below 60 mmHg may indicate that patients were on the verge of the lower limit of 
autoregulation. In this condition, FV decreases passively with decreasing CPP 105.  
PI, as an index describing changes in TCD waveform resulting from changes in CPP, deviated 
from normal range under these conditions. However, it did not show increased values as 
demonstrated by Abdo et al. 182 in previous works assessing cerebral haemodynamics in 
patients with ALF (PI=2.4 or PI=1.71 185).  
Although ICP monitoring is not an uncommon practice in patients with ALF developing severe 
hepatic encephalopathy 186,187, ICP behaviour during OLT has been reported only in few 
studies. In a study of six cases from Keays et al. 188, the mean ICP level was higher during the 
“preclamp phase” and the “graft reperfusion” phase than the “anhepatic phase”. Lidofsky et al. 
178 have shown that ICP tended to vary significantly intraoperatively. It initially increased 
during the dissection phase, then declined over the anhepatic phase, and again increased during 
the reperfusion phase. Lastly, Detry et al.’s study 189 suggested that in ALF patients, 
particularly in those who developed intracranial hypertension before OLT, the dissection and 
reperfusion phases were associated with a risk of brain injury secondary to elevated ICP and 
low CPP. The anhepatic phase, as similarly to the previous studies, seemed to be linked to a 
decrease in ICP. ICP increase occurring during liver dissection and reperfusion phases suggest 
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a possible role of toxic substances released from necrotic hepatocytes during liver handling and 
products of ischemia/reperfusion injury released during reperfusion phase 189.  
The overall nICP behaviour was kept relatively constant throughout OLT. An exception was 
patient 5 (Figure 6.6), who presented a similar pattern of ICP decrease during anhepatic phase 
and increase during reperfusion as previously described 178,188,189. However, changes in nICP 
between phases were not significantly different, and nICP mean values were not associated 
with intracranial hypertension.   
nCPP presented a stronger decrease tendency, particularly from anhepatic to reperfusion 
phases, in which all patients presented nCPP decrease. As nICP remained relatively constant 
during this period, the observed changes can be attributed to decreases in ABP (Figure 6.7). 
Considering that cerebral autoregulation in pathological conditions is subject to haemodynamic 
changes such as in ABP, ICP and CPP, the determination of optimal thresholds for these 
parameters could provide a reasonable, individualised management of cerebral 
haemodynamics in critical situations, such as ICP surges. Based on these assumptions, a 
previous study could identify a narrow CPP target (optimal CPP  (CPPopt)) by defining the level 
of best cerebrovascular reactivity, using PRx 112. The authors showed that the deviation from 
CPPopt was associated with worse outcome in TBI patients 
112. In the present study, optimal 
ABP could be obtained in certain patients, demonstrating the feasibility of identifying these 
targets during OLT using TCD-based non-invasive monitoring. (Figure 6.11, Figure 6.12).  
Critical closing pressure is another useful TCD-derived parameter related to critical thresholds 
for ABP. By monitoring CrCP, the DCM can also be trended and may represent a significant 
clinical threshold in patients with arterial hypotension, ICH, or with pathologically increased 
vascular wall tension 100. In the six cases evaluated, although DCM decreased significantly 
throughout OLT (Figure 6.10), it was not exhausted (≤0 mmHg), indicating that cerebral blood 
flow circulation was not completely compromised. 
Although this is a retrospective observational study with a limited sample size, TCD appears 
to be a feasible tool for assessment of cerebral haemodynamics in the OLT setting and could 
provide clinically relevant information for patient management in such conditions with high 
risk of neurological impairment.
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6.3 Feasibility of nICP associated with a TCD multiparameter assessment of 
cerebral haemodynamics during shoulder surgery in the beach chair position 
 
 
Introduction 
 
The beach chair position (BCP) offers several advantages for shoulder surgery, such as a better 
intra-articular visualisation and less risk of neurovascular trauma in comparison to surgery 
performed in the lateral decubitus position 190. However, BCP may provoke hypotension in the 
presence of general anaesthesia, which alters cardiovascular reflex responses 191,192.  
There are published reports of rare but devastating neurologic injuries occurring in healthy 
patients in the beach chair position. These included stroke, spinal cord ischemia, and transient 
visual loss 193–200. The incidence of neurologic complications after shoulder surgery in the 
beach chair position remains unknown, but a survey of the American Shoulder and Elbow 
Surgeons indicated that the incidence of major stroke in this clinical setting is 0.0004% 196.  
Because of the gravitational effects of positioning the head above the level of the heart and 
ABP hypotension, such neurologic complications reported after shoulder surgery in BCP may 
be the result of impaired cerebral autoregulation, inadequate cerebral perfusion and cerebral 
ischaemia. By assessing cerebral haemodynamics in patients undergoing surgery in the beach 
chair position, this study aims to provide possible answers to the questions listed above. 
There are few published reports on the use of TCD for the assessment of cerebral 
haemodynamics of patients in BCP, however, most simply used mean FV as the main 
parameter 201,202. Therefore, the objective of this study is to assess cerebral haemodynamics 
using a multiparameter TCD-derived approach in patients undergoing shoulder surgery who 
were positioned from supine to beach chair position. 
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Material and methods 
 
Patient population 
This study included prospectively collected data described in Section 4.1.1. This material 
consisted of 33 patients undergoing shoulder surgery in the beach chair position. The study 
considered a group of 23 patients: 4 patients could not be included due to the absence of an 
insonation window for TCD; 6 patients due to poor recordings of either ABP or FV. The 
median age was 55 (N=23; IQR: 66.50-37; 18 males (78%)). 
On arrival to the surgical suite, a standard monitoring was applied, including pulse-oximetry, 
electrocardiography, and non-invasive arterial blood pressure in the arm. Patients were not pre-
medicated. After preoxygenation, general anaesthesia was induced with intravenous propofol 
(2 mg/kg). To facilitate endotracheal intubation, cisatracurium besilate (0.15 mg/kg) was 
administered intravenously, and then lungs were ventilated with a mixture of oxygen/air and 
sevoflurane (mean alveolar concentration of 0.8 to 1.0) to maintain an ETCO2 of 4.5 to 5.5 kPa 
during surgery.  
Ultrasound guided interscalene block using an in-plane approach was performed to provide 
intra and post-operative analgesia. Initially, the probe was placed at the level of the cricoid 
cartilage and scanned laterally to identify the carotid artery and internal jugular vein. The 
sternocleidomastoid muscle overlies these structures. The anterior scalene muscle is seen 
below the lateral edge of the sternocleidomastoid by moving the probe laterally. The brachial 
plexus was identified as a groove containing the hypo-echoic nerve structures between the 
anterior and the middle scalene muscle. Then, the needle was brought in the same plane as the 
probe so that the whole length of the needle could be visualised. A small amount of local 
anaesthetic was injected to hydro-dissect and open the fascial plane. This allowed clearer 
visualisation of the nerve structures; then, 15 to 20 ml of bupivacaine 0.25-0.5% were injected 
around superior and middle trunks of brachial plexus, between anterior and middle scalene 
muscles. 
 
Clinical monitoring and data collection 
The implemented clinical monitoring included ABP and FV as described in Section 4.2.1. 
Arterial blood pressure was non-invasively measured for clinical purposes with a cuff via an 
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oscillometric method from the arm (ABPARM). For the study, ABP was monitored non-
invasively using a finger-cuff (Finometer Pro®, Finapres Medical Systems, Amsterdam, The 
Netherlands) calibrated at the auditory meatus level (ABPFINGER)). Cerebral haemodynamics 
parameters were calculated using ABPFINGER. FV was assessed ipsilateral to the surgery side. 
Only ABPFINGER and FV signals were recorded simultaneously.  
ABPFINGER and FV monitoring were performed in two different periods: in the supine position, 
immediately after induction of anaesthesia (phase A); and before the commencement of surgery 
with the patient in beach chair position (phase B). Beach chair position was achieved by tilting 
the table to an angle range of 45-90 degrees adjusted for surgical exposure on an individual 
basis. The mean monitoring time was 5.40±1.60 minutes for phase A and 5.30±1.50 minutes 
for phase B. ABPARM was collected retrospectively from the hospital’s electronic records 
system during the study’s analysis phase. Preoperative (in the anaesthetic room, before 
anaesthesia induction) and operative values (in the operation room, with the patient in beach 
chair position) for ABPARM were collected. All parameters were calculated and averaged for 
both phases.  
The analysis considered the calculations of the mean values of each TCD-derived parameter 
evaluated, which included nICPBB, nCPP (derived from nICPBB), cerebral autoregulation 
(ARI), pulsatility index, critical closing pressure and diastolic closing margin as described in 
Section 4.2.3. In this case, given the short monitoring periods, ARI provides a better measure 
of cerebral autoregulation owing to its shorter calculation window. 
 
Statistical analysis 
The data were tested for normal distribution using the Shapiro-Wilk test and are presented as 
median (IQR). All parameters assessed were non-parametric. Statistical measurements were 
performed with the Wilcoxon rank sum test with continuity correction, and the Wilcoxon 
signed rank test for paired comparisons. Also, a Spearman correlation coefficient matrix 
analysis was employed to assess correlations between the various parameters considering 
differences from supine to beach chair position (delta correlations (∆)). Delta differences 
between parameters are presented as mean and percentage of change. The statistical 
significance level for all tests was set at p<0.05. 
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Results 
 
Table 6.5 presents demographics, medical and surgical characteristics of patients undergoing 
shoulder surgery. Table 6.6 presents results for all physiological and cerebral haemodynamics 
parameters assessed on phase A (supine), phase B (beach chair position) and their respective 
mean delta changes expressed in percentage. Table 6.7 presents the correlation coefficients of 
changes in FV and ABP with changes in other parameters evaluated. 
 
Table 6.5. Patient’s demographic characteristics, medical history and type of surgical procedures performed 
(N=23). 
 
Characteristics  
Age (years) 55 (66.50-37.00) 
Sex, male/female, n (%) 18 (78%) / 5 (22%) 
BMI (kg/m2) 27.70 (34.35-25.70) 
Medical history  
Hypertension 30% 
Diabetes mellitus 13% 
Hypercholesterolemia 9% 
Myocardial infarction 4% 
Obesity 4% 
Depression 22% 
Asthma 13% 
Sleep apnoea 4% 
Thyroid lump 4% 
Adrenal mass 4% 
Factor XI haemophilia 4% 
Gastroesophageal reflux disease 4% 
Procedure  
Arthroscopic subacromial decompression  26% 
Arthroscopic cuff repair  22% 
Shoulder replacement  17% 
Arthroscopic acromioclavicular joint  17% 
Shoulder stabilization  13% 
Arthroscopic shoulder capsular release 4% 
BMI, body-mass index. 
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Table 6.6. Physiological and cerebral haemodynamics parameters assessed on phases A and B. Significant 
differences occurred in DCM (mean decrease of 6.43 mmHg (-34%) (p=0.009)) and PI (mean increase of 0.11 
(+11%) (p=0.05)). 
 
  A B p-value 
ABPFINGER 61.71 (69.30-52.41) 48.53 (66.35-37.64) 0.21 
ABPs FINGER 83.52 (95.40-67.72) 76.22 (90.71-58.29) 0.39 
ABPd FINGER 48.83 (56.38-41.67) 34.58 (55.47-25.34) 0.17 
FV 40.86 (50.77-33.72) 43.01 (51.66-32.06) 0.27 
nICP 4.52 (9.57-2.07) 2.14 (9.14-(-0.18)) 0.66 
nCPP 57.66 (63.92-49.54) 43.79 (57.66-37.46) 0.14 
ARI 1.53 (2.59-0.68) 1.41 (2.21-0.91) 0.96 
PI 1.00 (0.85-1.14) 1.03 (0.90-1.34) 0.048 
CrCP 31.65 (37.94-22.18) 25.33 (41.95-13.15) 0.60 
DCM 18.08 (23.88-11.23) 10.44 (15.71-7.78) 0.01 
ETCO2 5.30 (5.40-4.90) 5.20 (5.35-4.80)  0.17 
 
 
ABPFINGER (mmHg) (s, systolic; d, diastolic), arterial blood pressure monitored at the auditory meatus level; FV 
(cm/s), cerebral blood flow velocity; nICP (mmHg), non-invasive intracranial pressure; nCPP (mmHg), non-
invasive cerebral perfusion pressure; ARI, cerebral autoregulation index; PI, pulsatility index; CrCP (mmHg), 
critical closing pressure; DCM (mmHg), diastolic closing margin; ETCO2 (kPa), end-tidal carbon dioxide 
concentration. 
 
 
 
 
Table 6.7. Mean delta (magnitude) changes and correlation coefficients between FV and ABP. 
 
  ∆ (%)   R with ∆ABP p-value   R with ∆FV p-value 
ABPFINGER -14  - -   0.48 0.02 
ABPs FINGER -7.8  - -  0.57 0.005 
ABPd FINGER -18.4  - -  0.46 0.03 
FV -6%  0.48 0.02  - -  
nICP -29%  0.61 0.002  0.33 0.12 
nCPP -12%  0.95 0  0.42 0.05 
ARI +7%  -0.14 0.52  0.12 0.58 
PI +11%  -0.1 0.64  -0.23 0.29 
CrCP -9%  0.8 0  0.17 0.43 
DCM -34%  0.61 0.01  0.36 0.09 
ETCO2 -3%   0.04 0.84   -0.01 0.95 
 
ABPFINGER (mmHg) (s, systolic; d, diastolic), arterial blood pressure monitored at the auditory meatus level; FV 
(cm/s), cerebral blood flow velocity; nICP (mmHg), non-invasive intracranial pressure; nCPP (mmHg), non-
invasive cerebral perfusion pressure; ARI, cerebral autoregulation index; PI, pulsatility index; CrCP (mmHg), 
critical closing pressure; DCM (mmHg), diastolic closing margin; ETCO2 (kPa), end-tidal carbon dioxide 
concentration; ∆ (delta), variation between phases A and B in percentage; R, Spearman correlation coefficient. 
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There was a significant difference between preoperative and operative ABPARM (86.67 (80.83-
95.67) and 76.00 (69.83-80.83), respectively; mean decrease of 9.68 mmHg (-12%) (p<0.001)). 
Between supine and BCP (Table 6.6), significant differences occurred in DCM (mean decrease 
of 6.43 mmHg (-34%) (p=0.009)) and PI (mean increase of 0.11 (+11%) (p=0.05)). Mean 
ABPFINGER exhibited a decreasing trend from phase A to B, as well as nICP, nCPP and CrCP. 
ETCO2 did not change significantly between the two phases. 
When compared to TCD parameters in a healthy population 55, patients in this study had low 
FV (<60 cm/s). PI values also deviated from normal ranges in both measurement points (PI 
>0.8 55). nCPP values were lower than previously reported in healthy volunteers (<60 mmHg 
180) and decreased further from supine to BCP. nICP presented a decreasing trend between 
phases; however, the observed changes in nCPP were better correlated with changes in 
ABPFINGER than nICP (Table 2, ∆R=0.95 (p<0.001) and ∆R=0.44 (p=0.04), respectively). 
ARI showed lower levels indicating impaired cerebral autoregulation (ARI <3 107,109,110) in 
phases A and B. CrCP did not approach diastolic ABPFINGER from phase A to B. Consequently, 
DCM did not reach critical values (≤0 mmHg), remaining above a mean of 12 mmHg during 
BCP. Changes in CrCP were strongly correlated with changes in estimated diastolic ABP 
(∆R=0.82, p<0.001). Nevertheless, considering individual cases, two patients during phase B 
(one with a history of arterial hypertension) and one patient during phase A presented alarming 
values for DCM below 5 mmHg. Changes in DCM and diastolic FV were correlated (∆R=0.40 
(p=0.05)). 
No patient presented any symptoms or signs suggestive of neurological damage after shoulder 
surgery in our cohort. Individual and mean changes across phases from supine (A) to beach 
chair position (B) are shown in Figure 6.13 for ABPFINGER, FV, nICP and nCPP; Figure 6.14 
for autoregulation index; and Figure 6.15 for CrCP and DCM. 
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Figure 6.13. Longitudinal plots showing changes between supine (phase A) and beach chair position (phase B) 
for (A) ABPFINGER, (B) FV, (C) nICP and (D) nCPP. Mean ABP exhibited a decreasing trend, which was reflected 
in the other parameters. 
 
 
 
Triangles on the plots represent the mean values for each variable at a specific surgery phase. Thick black lines 
represent the linear fit of the data; grey shadowed areas represent the 95% confidence interval of the linear model 
representative of the data.  
ABP (mmHg), non-invasive arterial blood pressure calibrated at the auditory meatus; FV (cm/s), cerebral blood 
flow velocity; nICP (mmHg), non-invasive intracranial pressure; nCPP (mmHg), non-invasive cerebral perfusion 
pressure. 
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Figure 6.14. Longitudinal plot showing changes between supine (phase A) and beach chair position (phase B) for 
cerebral autoregulation index (ARI). Mean ARI showed lower levels indicating impaired cerebral autoregulation 
(ARI <3). 
 
 
Triangles on the plots represent the mean values for each variable at a specific surgery phase. The thick black line 
represents the linear fit of the data; grey shadowed areas represent the 95% confidence interval of the linear model 
representative of the data. 
ARI (a.u.), autoregulation index. 
 
Figure 6.15. Longitudinal plots showing changes between supine (phase A) and beach chair position (phase B) 
for critical closing pressure (A) and diastolic closing margin (B). CrCP did not approach diastolic ABP. 
Consequently, DCM did not reach critical values (≤0 mmHg). 
 
 
 
Triangles on the plots represent the mean values for each variable at a specific surgery phase. The thick black 
lines represent the linear fit of the data; grey shadowed areas represent the 95% confidence interval of the linear 
model representative of the data.  
CrCP (mmHg), critical closing pressure; DCM (mmHg), diastolic closing margin. 
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Discussion 
 
This study demonstrates that changing from the supine to beach chair position adversely affects 
cerebral haemodynamics with a significant decrease in DCM and increase in pulsatility index; 
and impairment in all cerebral haemodynamics parameters. Overall, all patients studied had 
impaired cerebral autoregulation in both positions. 
In previous studies reporting catastrophic perioperative central nervous system infarction 
associated with shoulder surgery in the sitting position, the patients did not present any risk 
factors for perioperative stroke 195. Despite its low incidence, intraoperative stroke associated 
with shoulder surgery remains a significant problem. Shoulder surgery in the beach chair 
position presents a unique risk for intraoperative stroke among orthopaedic procedures, which 
can be attributed to postural hypotension as well as head and neck manipulation leading to 
cerebral hypoperfusion. Another key factor that may compromise CBF is mechanical 
obstruction due to embolic events, such as atherosclerotic plaques, thromboemboli (platelet 
aggregation), air, or fat 195. Nevertheless, the contribution of thromboembolic mechanisms for 
neurologic events during shoulder surgery remains unclear.  For instance, in Pohl and Cullen’s 
report 195, out of 4 cases presenting complications, one was diagnosed with a left hemisphere 
watershed stroke. 
A pattern of cerebral hypoperfusion observed in the study can be represented by the low 
cerebral blood flow velocity pattern, and it may be explained by the absence of optimal cerebral 
autoregulation (Figure 6.14). Moreover, estimated cerebral perfusion pressure below 60 mmHg 
in both phases may indicate that patients were on the verge of the lower limit of autoregulation, 
pointing out that FV decreases passively with CPP 105. Pulsatility index, as a parameter 
describing changes in TCD waveform resulting from changes in CPP, deviated from normal 
range under these conditions. However, PI did not show high values as indicated in previous 
studies assessing cerebral haemodynamics in patients with traumatic brain injury, for instance 
(PI>2) 52. 
Cerebral autoregulation has been reported as diminished in patients undergoing shoulder 
surgery in the beach chair position previously. A study from Laflam et al. 203, applying near-
infrared spectroscopy (NIRS) for autoregulation assessment using COx (a correlation index 
between ABP and regional cerebral oxygen saturation (rSCO2)), indicated that these patients 
were more likely to have impaired autoregulation and lower rSCO2 in comparison to patients 
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undergoing surgery in the lateral decubitus position. Although other authors have applied TCD 
as a tool for cerebral haemodynamics assessment during BCP 203, this is the first study reporting 
the impairment of TCD-based cerebral autoregulation in this surgery setting.  
The cerebral autoregulation was impaired in both positions. Considering that the patients 
studied did not present any previous indications of neurological impairment, disturbed 
autoregulation during supine position could be attributed to the effects of anaesthetic agents on 
cerebral circulation. Propofol has been reported to preserve autoregulation either at high or low 
doses in healthy individuals 204. However, high doses of this drug have been shown to impair 
autoregulation in TBI patients 205. Sevoflurane in standard doses has not been reported to alter 
global CBF and autoregulation 206,207; however, alterations on regional CBF have been reported 
with inhalational anaesthetic agents 208. Although the anaesthetic agents used in the study have 
not been reported to alter cerebral autoregulation, an early hypotensive effect and decrease in 
systemic vascular resistance 209 after administration of propofol could have been the cause for 
the disturbed autoregulation during the supine phase, as monitoring was performed 
immediately after anaesthesia induction. An example of how ABP and CBF velocity generally 
behaved in both surgery phases is depicted in Figure 6.16. 
 
Figure 6.16. Example demonstrating the behaviour of ABP and FV during phases A (supine position) and B 
(beach chair position). Changes in ABP with correspondent changes in FV indicate disturbed cerebral 
autoregulation.  
 
 
ABP (mmHg), non-invasive arterial blood pressure calibrated at the auditory meatus; FV (cm/s), cerebral blood 
flow velocity. 
 
Results & Discussions II 
146 
 
The changes in estimated cerebral perfusion pressure were strongly correlated with changes in 
ABP monitored at the auditory meatus level (Table 6.7, ∆R = 0.82 (p<0.001)). It is believed 
that the gravitational effects of BCP contribute to the observed arterial hypotension and 
consequent CPP decrease, as in anaesthetised patients an altered baroreflex compromises 
haemodynamic control in the sitting position 210. Arterial hypotension is commonly reported in 
procedures performed in this surgery setting, which has been reported to produce ABP 
decreases of 20% in an extensive study including 5177 patients undergoing neurosurgery and 
orthopaedic surgeries. 50% of these patients experienced a severe hypotension defined as an 
ABP decrease ≥40% relative to preoperative values 211. In another study including 4169 
shoulder surgery procedures, 47% of patients presented hypotension defined as an ABP <66 
mmHg or a decrease >30% from pre-anaesthesia values. 37% of these patients experienced 
severe hypotension 198. Other studies from McCulloch et al. 201, Hanouz et al. 202 and Buget et 
al. 212 also reported decreases in ABP after supine to BCP positioning. 
Although the decrease in ABPFINGER reached an average of 14% (also observed for ABPARM – 
12% decrease), besides cerebral hypoperfusion, the changes from supine to BCP were also 
reflected in DCM (Table 6.7, ∆ of -34%, delta correlation with ABP, R=0.8 (p<0.001)).  
Cases with DCM ≤0 mmHg could not be identified in the cohort, although DCM decreased 
significantly between phases (Figure 6.10). Nevertheless, in 3 isolated cases, DCM approached 
alarming values (~5 mmHg), which could have been the ideal scenario for fluid and 
vasopressor administration to increase ABP towards safe levels concerning cerebral perfusion. 
In addition, overall changes in DCM and diastolic FV were correlated, indicating a decrease in 
FV during diastole and consequent increase in pressure passivity to cerebral circulation 100.  
For instance, in a study of Hanouz et al. 202, the authors reported that beach chair position 
induced ABP decrease requiring vasopressors and fluid challenge in 44 patients (83% of the 
study’s cohort). In this study, the authors only relied on ABP decrease of 20% from pre-
induction values to guide the vasopressors intervention, only considering mean FV for the 
assessment of cerebral haemodynamics. 
Given these findings, continuous multiparameter TCD monitoring could provide a more 
comprehensive interpretation of the haemodynamic changes and guide individualised 
management of ABP and cerebral haemodynamics in the BCP operative setting. A special 
scenario would be combining ABP and multiparameter TCD monitoring for cases at imminent 
risk of cerebrovascular derangements such as patients with idiopathic intracranial 
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hypertension, hydrocephalus, diabetes, arterial hypertension and patients with a history of 
stroke. In these cases, special attention should be given to managing ABP within normal ranges 
with vasopressors or fluids before and throughout beach chair position to maintain an adequate 
cerebral perfusion pressure. 
 
 
Limitations 
This study has several potential limitations. First, simultaneous measurements of baseline FV 
and ABP were not monitored before anaesthesia induction. It was hypothesized that supine 
position after induction should be the baseline phase, as the effects of anaesthesia on cerebral 
haemodynamics should be considered. Moreover, due to surgical configurations, an extended 
monitoring of the parameters throughout surgery could not be performed. However, according 
to Hanouz et al. 202, significant changes in cerebral haemodynamics occurred only from 
baseline (after anaesthesia induction in supine position) to BCP. Because of technical reasons, 
FV was assessed only ipsilateral to the side of surgery, therefore not accounting for differences 
in flow that may exist between left and right MCAs. ABPARM and ABPFINGER could not be 
compared effectively in any stages of the experimental protocol since simultaneous recordings 
of these parameters were technically unfeasible.
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7 RESULTS & DISCUSSIONS III: ASSESSMENT OF nCPP 
USING A SPECTRAL VOLUME ACCOUNTING METHOD 
 
 
Introduction 
 
Cerebral perfusion pressure is one of the primary modalities in neurocritical care 7. It is defined 
as the difference between arterial blood pressure and intracranial pressure. CPP is interpreted 
as the main force maintaining CBF. Its accuracy in direct monitoring depends on the precision 
of two independent pressure transducers for each ABP and ICP. 
 ABP is usually measured with an external transducer, with input blood pressure transmitted 
via an indwelling arterial catheter. It is typically zeroed at the heart level, but for neurocritical 
care patients requiring monitoring of CPP, it should be zeroed at the level of the auditory 
meatus and re-zeroed following every change of body position. As most patients receiving 
neurocritical care are managed with head elevation (to ease brain venous return), zeroing the 
ABP transducer at the heart level may produce overestimation of CPP from 10 to 20 mmHg 
213. Since blood flows vertically from the heart, with head elevation, there is a reduction in ABP 
directly related to the water column between heart and brain (generally 1 mmHg for each 1.35 
cm) 214. 
Furthermore, contemporary ICP microtransducers are zeroed against atmospheric pressure 
only once during implantation. Their drift over time (usually not above 1 mmHg per day 215) 
may accumulate over long monitoring period (usually 2-3 weeks), adding significant additional 
errors in CPP monitoring.  
Therefore, direct invasive monitoring of mean CPP is more complex than it appears. As 
described Chapter 3, Section 3.3.2, various studies have been conducted to measure CPP non-
invasively (nCPP) based on TCD monitoring of blood flow profiles in the MCA 71,73,76,78,216. 
The relative accuracy of such estimation was reported to vary from 12-20 mmHg 71,73,76,78,216. 
However, due to inappropriate zeroing of pressure transducers, these assessments could be 
inaccurate since direct CPP is uncertain.  
In this study, a new TCD-based method for nCPP estimation (spectral nCPP or nCPPs) is 
proposed. This method is based on accounting for changes in pulsatile cerebral arterial blood 
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volume (CaBV) applied to the analysis of a simplified hydrodynamic model of CBF and CSF 
dynamics 89,139,217. This study aims to test the performance of this method by comparing 
changes in nCPPs versus changes in direct CPP. Since their absolute comparison is limited due 
to problems secondary to ABP zeroing, this assessment is focused on cases in which CPP is 
changing in the time domain: I) rise during vasopressor-induced augmentation of ABP, and II) 
decrease during spontaneous changes in ICP (plateau waves).  
 
 
Material and methods 
 
Spectral non-invasive cerebral perfusion pressure estimation method 
 
A common approach to model the cerebral vasculature is to compartmentalise the different 
regions of the brain and mechanistically capture their interactions through a mathematical 
model. A model of CBF and CSF dynamics has been proposed previously by Ursino and Lodi 
89,139, which captures the dynamics in the arterial, capillary, venous and CSF circulation. This 
model has been modified later by Czosnyka et al. 217, by incorporating realistic values for 
known components including cerebrovascular resistance, intracranial and arterial compliance, 
and CSF outflow resistance. The electrical equivalence of this model is presented in Figure 7.1. 
The input circuit of the model may be presented in a simplified way as a resistance-conductance 
circuit. A parallel switch of ohmic resistance (CVR) and conductive resistance (1/jω ∙ Ca) adds 
to a total impedance: 
Equation 7.1 
𝑍(𝑗𝜔) =
𝐶𝑉𝑅
𝑗𝜔 ∙ 𝐶𝑎
𝐶𝑉𝑅 +
1
𝑗𝜔 ∙ 𝐶𝑎
=
𝐶𝑉𝑅
𝑗𝜔 ∙ 𝐶𝑉𝑅 ∙ 𝐶𝑎 + 1
  (7.1) 
 
Where ω symbolizes circular frequency (𝜔 =  2𝜋 ∙ 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦); CVR represents 
cerebrovascular resistance; Ca, compliance of cerebral arteries and arterioles. Units are given 
in mmHg/(cm3/s). 
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Figure 7.1. The electrical model of cerebral blood flow (CBF) and cerebrospinal fluid (CSF) dynamics, extracted 
from Czosnyka et al. 217.  
 
 
The CBF pathway starts with the arterial blood inflow to the brain through the resistance of large intracranial 
arteries (Ra), with arterial blood pressure (ABP) as the input pressure from the carotid and basilar arteries. From 
there, arterial blood passes at high pressure (Pa), through the small cerebral arteries. These vessels act as a storage 
system for pulsatile blood volume, which is modelled by the compliance Ca. Forward flow through the 
cerebrovascular resistance (CVR) vessels is modulated by the cerebral autoregulation. The capillary and venous 
blood flow and storage are lumped together and modelled by the compliance of Cv at pressure Pv. Finally, venous 
blood flows out through the bridging veins represented by the Starling resistor Rb to the sagittal sinus at pressure 
Pss. The CSF pathway encompasses formation of CSF (with a rate of If), storage in the distensible fluid structures 
formed by the ventricles, basal cisterns and spinal sac (with compliance of Ci), and finally reabsorption through 
the arachnoid granulations to the sagittal sinus with the resistance to outflow being denoted as RCSF. Both CBF 
and CSF pathways take place inside the rigid skull with an intracranial pressure being depicted here as P i. The 
model was calibrated using realistic values for known components including cerebrovascular resistance, 
intracranial and arterial compliance, and CSF outflow resistance 217. 
 
The modulus of impedance can be expressed as: 
Equation 7.2 
|𝑍(𝜔)|  =  
𝐶𝑉𝑅
√𝐶𝑉𝑅2 ∙  𝐶𝑎 ∙  𝜔2  + 1 
(7.2) 
 
which depends on the frequency f of the flow (ω = 2π ∙ f). Units are given in mmHg/(cm3/s). 
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For a constant flow (ω=0), the modulus of impedance becomes: 
 
|Z(0)| = 𝐶𝑉𝑅 =
𝐶𝑃𝑃
𝐹𝑉
(7.2𝑎) 
  
CPP denotes mean cerebral perfusion pressure; FV, mean blood flow velocity in the MCA. 
 
Considering pulse waves (ωHR=heart rate (HR)), the modulus equals the ratio a1/f1: 
 
|Z(𝜔𝐻𝑅)| =
𝑎1
𝑓1
(7.2𝑏) 
 
Where a1, represents the pulse amplitude of the first harmonic of the ABP waveform; f1, the 
pulse amplitude of the first harmonic of the FV waveform. The pulse amplitude of first 
harmonics is determined with FFT.  
 
Considering Equation 7.2 for heart rate (ω= 2π ∙ HR), and substituting CVR and Z(ωHR) by 
Equation 7.2a and Equation 7.2b, it results in: 
Equation 7.3 
𝐶𝑃𝑃 =  
𝑎1
𝑠𝑃𝐼
 × √(𝐶𝑉𝑅 ∙ 𝐶𝑎)2 ∙ 𝐻𝑅2 ∙ (2𝜋)2 +  1   (𝑚𝑚𝐻𝑔) (7.3) 
 
 
Where:  
𝑠𝑃𝐼 =
𝑓1
𝐹𝑉
 
 
sPI denotes the spectral pulsatility index. HR is expressed in Hz.  
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Equation 7.3 presents the non-invasive estimator of CPP that can be evaluated on the heart 
beat-by-beat basis. CVR and Ca used in Equation 7.3 can be estimated using mathematical 
transformations of TCD and ABP pulse waveforms measurements based on a model of cerebral 
arterial blood volume changes presented below.  
The amount of arterial blood supplied to the cerebral space by the vascular system during a 
cardiac cycle is partially compensated by the simultaneous outflow of blood through the venous 
system. Both the arterial inflow (CBFa) and venous outflow (CBFv) of cerebral blood have 
a pulsatile character, but their pulse waveform shapes are phase-shifted resulting in detectable 
cerebral blood volume (CBV) changes during a heartbeat. The interaction between pulsatile 
changes in CBFa and CBFv determines the transient, time dependent change in cerebral blood 
volume (CBV) and can be described by the following equation 218: 
Equation 7.4 
∆𝐶𝐵𝑉(𝑡) =  ∫ (𝐶𝐵𝐹𝑎(𝑠) – 𝐶𝐵𝐹𝑣(𝑠))
𝑡
𝑡0
𝑑𝑠 (7.4) 
 
where t0 is the beginning of a single cardiac cycle and s is the variable of integration.  
 
With TCD, venous outflow cannot be monitored continuously (contrary to phase-coded MRI 
219, for instance), thus two models of approximation of CBV are worth consideration: 
 
1. Continuous flow forward model (CFF): it is presumed that venous outflow, being far less 
pulsatile 220 may be substituted by the mean value of arterial CBF. This leads to the formula: 
Equation 7.5 
∆𝐶𝑎𝐵𝑉𝐶𝐹𝐹(𝑡) =  ∫ (𝐶𝐵𝐹𝑎(𝑠) – 𝑚𝑒𝑎𝑛 𝐶𝐵𝐹𝑎)
𝑡
𝑡0
𝑑𝑠 (7.5) 
 
where CaBV represents cerebral arterial blood volume. Units are given in cm
3. 
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2. Pulsatile flow forward model (PFF): in this approach, the pulsatile arterial blood inflow 
inflating and deflating cerebral arteries during each heart cycle is modelled as the difference 
between CBF(t) and cerebral blood flow forward from large arteries to small resistive 
arterioles:  
Equation 7.6 
∆𝐶𝑎𝐵𝑉𝑃𝐹𝐹(𝑡) =  ∫ (𝐶𝐵𝐹𝑎(𝑠) – 
𝐴𝐵𝑃(𝑠)
𝐶𝑉𝑅
)
𝑡
𝑡0
𝑑𝑠 (7.6) 
 
Where CVR is defined as the ratio between mean ABP and FV (Equation 4.3). Units are given 
in cm3. 
 
Equation 7.5 and Equation 7.6 will yield values of CBV per unit of cross-sectional area of the 
insonated vessel. Assuming that the cross-sectional area remains constant, FV can substitute 
CBFa in Equation 7.5 and Equation 7.6.  
Obtained from the presented calculations, both virtual signals CaBVCFF and CaBVPFF have a 
pulsatile component. However, the shape of the CaBVPFF waveform is different, and its 
amplitude is lower than CaBVCFF (amplitudes of first harmonic of CaBVCFF and CaBVPFF for 
the heart frequency are denoted further as C1CFF and C1PFF) – see Figure 7.2. 
 
Then arterial compliances are defined, accordingly: 
Equation 7.7 
𝐶𝑎𝐶𝐹𝐹 =  
𝐶1𝐶𝐹𝐹
𝑎1⁄ (7.7) 
 
Equation 7.8 
𝐶𝑎𝑃𝐹𝐹 =  
𝐶1𝑃𝐹𝐹
𝑎1⁄ (7.8) 
 
Both compliances have units (cm/mmHg), expressed as a value of arterial compliance per unit 
of cross sectional area of the insonated vessel.  
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CVR can be estimated in two ways: 
 
Equation 7.9 
𝐶𝑉𝑅1 =  
 𝐴𝐵𝑃
𝐹𝑉
(7.9) 
 
Equation 7.10 
𝐶𝑉𝑅2 =  𝑎1 𝑓1⁄ (7.10) 
 
CVR2 is an equivalent of the so-called ‘resistance area product’ 221 and is usually lower than 
CVR1, but its advantage is the immunity to inaccuracies related to not zeroing the blood 
pressure transducer for cerebral arterial circulation since it does not rely on mean values for 
ABP and FV.  
Any combination of CVR ∙ Ca (four combinations altogether): CVR1 ∙ CaPFF, CVR2 ∙ CaPFF, 
CVR1 ∙ CaCFF, CVR2 ∙ CaCFF may result in four nCPP estimators. The average of these four 
estimators was called spectral nCPP (nCPPs). 
While estimators using CFF are not affected by time delays between any signals, estimators 
using PFF are: ABP is usually measured from the radial artery distant from the brain, and 
therefore is delayed in comparison to MCA flow velocity signal (Figure 7.2). The delay may 
range from a median ± interquartile range (IQR) of 10 ± 15 ms, according to unpublished 
material analysing 53 healthy volunteers. It may be different between individuals and may vary 
in time. To compensate for this delay, estimators of C1 can be calculated in the spectral domain. 
This considers that the Fourier transform of the integral of the time function f(t) is equal to its 
Fourier transform divided by 𝑗𝜔. For the frequency of heart rate, this will be 𝑗𝜔HR. Under the 
assumption that the phase shift between the first harmonic of ABP(t) and FV(t) signals is small 
(median ± IQR: 13.12 ± 3.59 degrees after adjustment for time delays resulting from the 
distance between the site of ABP measurement and the MCA – unpublished material analysing 
53 healthy volunteers), the frequency domain estimators of C1 can be expressed as: 
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Equation 7.11 
𝐶1𝐶𝐹𝐹 =
𝑓1
𝜔𝐻𝑅
(7.11) 
 
 
Equation 7.12 
𝐶1𝑃𝐹𝐹 =  
(𝑓1 − 𝑎1/𝐶𝑉𝑅)
𝜔𝐻𝑅
(7.12) 
 
 
 
 
Figure 7.2. Example of signals of ABP, ICP, FV and estimators of pulsatile arterial blood volume calculated using 
constant flow forward (CaBVCFF) and pulsatile flow forward (CaBVPFF) methods.  
 
 
 
The time delay between the FV and ABP signals is estimated as a median ± IQR of 10 ± 15 ms (derived from the 
distance between the site of ABP measurement and MCA). The pulse amplitude of CaBVCFF is greater than 
CaBVPFF. 
ABP (mmHg), arterial blood pressure; ICP (mmHg), intracranial pressure; FV (cm/s), cerebral blood flow 
velocity; CaBVCFF (mmHg), estimator of pulsatile arterial blood volume calculated using constant flow forward; 
CaBVPFF (mmHg), estimator of pulsatile arterial blood volume calculated using pulsatile flow forward. 
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Patient population  
Two cohorts of patients from the previously described database of 446 adult TBI patients 
(Section 4.1.2) (median age of patients: 30 years (IQR: 18–78), with 75% being male) were 
analysed in this study.  
The first cohort consisted of patients undergoing an induced rise in ABP producing rises in 
CPP levels (N=16). The second cohort consisted of patients in whom ICP plateau waves were 
identified as sudden and spontaneous increases in ICP (and pulse amplitude of ICP), during 
which CPP and FV dropped with a relatively stable ABP (N=14, in a total of 21 plateau waves 
identified).  
 
 
Clinical monitoring and data collection 
The implemented clinical monitoring included ABP, ICP and FV as described in Section 4.2.1. 
CPP and derived physiological parameters were calculated as described in Section 4.2.3. nCPPs 
was calculated as described above. 
For the patients undergoing induced rises in ABP, one hour of baseline modalities were 
recorded (baseline phase), then CPP was controlled with an infusion of norepinephrine adjusted 
to reach and maintain the desired CPP constant during the recording (plateau phase). Mean 
CPP at baseline and plateau phases were 69±6 mmHg and 92±4 mmHg, respectively. This 
patient cohort has been previously studied by Steiner et al. 222 assessing cerebral autoregulation 
with PET (positron-emission tomography) at different CPP levels.  
For patients presenting ICP plateau waves, the recordings were also divided into baseline 
(before the onset of plateau waves) and plateau (during plateau of plateau waves) phases.  
All parameters were calculated and averaged for both baseline and plateau phases.  
 
 
 Statistical analysis 
The data were tested for normal distribution using the Shapiro-Wilk test and are presented as 
median (IQR). Data distributions were non-parametric. All plateau waves identified were 
treated as independent events. To assess the performance of the proposed method, the 
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correlation coefficient in the time domain (R) was calculated between direct CPP and nCPPs 
for both induced rises in ABP and plateau waves cohorts. R values in the time domain were 
obtained for individual patients and then averaged within each cohort. The Spearman 
correlation coefficient was calculated for mean values between CPP and nCPPs considering the 
difference (delta (∆ - the magnitude of changes)) between the baseline and plateau phases for 
both patient cohorts. The Fisher z-transformation was used to test whether ∆R values between 
CPP and nCPPs were significantly different in the two populations analysed. 
To assess the prediction ability of the model, the area under the of a receiver operating 
characteristic analysis was calculated. To integrate this assessment for both patient cohorts, the 
prediction threshold chosen was determined as the median value of the absolute difference 
(absolute ∆) between the plateau and baseline phases for the two cohorts together to provide a 
consistent statistical assessment. The threshold obtained was ∆CPP ≥23.2 mm Hg. This test 
permits, independently of the direction of changes in CPP, to assess whether nCPPs can predict 
the magnitude of these changes reliably. 
 
 
 
Results 
 
Table 7.1 presents values of the physiological variables and nCPPs estimator assessed. Figure 
7.3 and Figure 7.4 demonstrate examples of changes in ABP, ICP, CPP and nCPPs in the patient 
cohorts undergoing induced ABP increase and ICP plateau waves, respectively. 
The averaged correlation (mean ± SD) in the time domain between CPP and nCPPs for patients 
undergoing induced rises in ABP was 0.95±0.07, and 0.86±0.14 during ICP plateau waves. ∆ 
correlations between mean values of CPP and nCPPs were 0.73 (p=0.002) and 0.78 (p<0.001), 
respectively for induced rises in ABP and ICP plateau waves cohorts (Figure 7.5). The Fisher 
z-transformation did not indicate statistically significant difference between these two ∆ 
correlation coefficients (z=-0.32 (p=0.75)). 
The four estimators forming nCPPs differed in their correlations in the time domain with direct 
CPP during plateau waves. The estimators using CVR2 correlated better with CPP than 
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estimators using CVR1: R=0.49 and R=-0.16, for estimators using CVR1 & CaCFF and CVR1 & 
CaPFF, respectively. 
 
Table 7.1. Values of the physiological variables and nCPPs estimator assessed for measurements at baseline and 
plateau phases. 
 
 Induced rise in ABP (N=16 patients)  Plateau waves (N=21 waves)  
 Baseline Plateau   Baseline Plateau  
ABP 86.92 (91.19-81.08) 110.9 (114.4-107.1)  91.21 (97.97-83.00) 90.77 (94.05-78.00)  
FV 59.03 (69.51-49.23) 72.56 (81.84-53.40)  47.51 (64.92-42.84) 35.87 (60.46-30.70)  
ICP 13.93 (19.00-11.53) 15.19 (20.60-12.70)  25.08 (28.76-16.81) 48.26 (53.86-38.07)  
CPP 73.19 (76.68-68.80) 93.25 (96.93-92.17)  66.35 (74.04-58.24) 41.74 (47.91-35.29)  
nCPPs 82.73 (85.41-78.53) 109.85 (113.15-103.04)   72.82 (83.27-64.40) 61.97 (69.01-54.04)  
       
ABP (mmHg), arterial blood pressure; FV (cm/s), cerebral blood flow velocity; ICP (mmHg), intracranial 
pressure; CPP (mmHg), cerebral perfusion pressure; nCPPs (mmHg), non-invasive cerebral perfusion pressure 
according to the spectral method. 
 
In contrast, estimators using CVR2 & CaCFF and CVR2 & CaPFF presented R=0.79 and R=0.82, 
respectively. Such differences were not observed in the cohort undergoing induced ABP rises 
(R ≥0.80 for all estimators). 
Being the average of the four possible estimators using the proposed model, nCPPs presented 
better correlation in the time domain with CPP in comparison to single estimators in all cases 
but for the estimator using CVR1 & CaCFF in patients undergoing induced ABP rises (R=0.95 
and R=0.96, respectively for nCPPs and estimator using CVR1 & CaCFF). The same findings 
were observed considering ∆ correlations (R=0.73 (p=0.002) and R=0.81 (p=0.0002), 
respectively for nCPPs and estimator using CVR1 & CaCFF).  
ROC analysis of the combined threshold for CPP prediction (∆CPP ≥23.2) in both patient 
cohorts revealed that nCPPs had an AUC of 0.71 (95% confidence interval: 0.58-0.88) (Figure 
7.6). 
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Figure 7.3. Example of individual cases 
(A, B, C) showing the correlation in the 
time domain between nCPPs and CPP 
(R) in patients with induced rises in 
ABP. Baseline and rise in ABP phases 
are distinguishable in the recordings. 
ABP (mmHg), arterial blood pressure; 
ICP (mmHg), intracranial pressure; CPP 
(mmHg), cerebral perfusion pressure; 
nCPPs (mmHg), non-invasive cerebral 
perfusion pressure according to the 
spectral method; R, correlation 
coefficient in the time domain. 
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Figure 7.4. Example of individual 
cases (A, B, C) showing the 
correlation in the time domain 
between nCPPs and CPP (R) in 
patients presenting ICP plateau waves. 
Baseline and plateau phases for these 
rises in ICP (and consequent decrease 
in CPP) are demonstrated in the 
recordings. ABP (mmHg), arterial 
blood pressure; ICP (mmHg), 
intracranial pressure; CPP (mmHg), 
cerebral perfusion pressure; nCPPs 
(mmHg), non-invasive cerebral 
perfusion pressure according to the 
spectral method; R, correlation 
coefficient in the time domain. 
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Figure 7.5. Correlation plots between the magnitude of changes (∆) of both CPP and nCPPs in the induced rises 
in ABP (A) and plateau waves (B) cohorts. In both cases, nCPPs could detect the magnitude of changes in CPP 
reliably (R>0.70). 
 
 
CPP (mmHg), cerebral perfusion pressure; nCPPs (mmHg), non-invasive cerebral perfusion pressure according 
to the spectral method; R, Spearman correlation coefficient; ∆, mean difference between plateau and baseline 
phases. 
 
 
Figure 7.6. Receiver operating characteristic (ROC) curve for prediction of CPP changes using the combined 
threshold of 23.2 mmHg. AUC of 0.711 (95% CI: 0.543-0.878) demonstrates reasonable prediction ability for 
nCPPs.  
 
AUC, area under ROC curve; CPP, cerebral perfusion pressure; nCPPs, non-invasive cerebral perfusion pressure 
according to the spectral method. 
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Discussion 
 
The proposed spectral nCPP method estimates CPP by accounting for changes in pulsatile 
cerebral blood volume based on a simplified hydrodynamic model of CBF and CSF dynamics. 
The spectral feature of the method has some advantages: it creates partial independence from 
the inaccuracy associated with zeroing the ABP transducer at heart level and partially 
eliminates the issue of the time delay between peripheral ABP and FV in the MCA. The 
dynamical model of CSF and cerebral blood circulation proposed by Ursino and Lodi 89,139 has 
also been modified by other authors to incorporate changes in cerebral blood volume and 
adapted to nICP o nCPP estimations. nICPHeldt 
36 described in Section 3.3.3 is one example. 
Similarly to this method, nCPPs produces patient-specific CPP estimates and does not require 
calibration datasets. 
The nCPPs method was evaluated in two different conditions associated with changes in 
cerebral perfusion pressure: I) increases in CPP following a rise in ABP caused by the 
administration of vasopressor; II) spontaneous decrease in CPP caused by cerebral vasodilation 
during ICP plateau waves. In both conditions, nCPPs replicated changes of CPP in the time 
domain reliably (Figure 7.3 and Figure 7.4). However, the estimators forming nCPPs using 
CVR expressed as the ratio between ABP and FV presented weaker or even negative 
correlations with CPP during plateau waves; these were the ones using CVR1 ∙ CaCFF and           
CVR1 ∙ CaPFF, with this remark especially denoted in the latter.  
This could be related to the fact that in cases in which the source of changes in cerebrovascular 
resistance is ICP (like in plateau waves), the ratio between mean ABP and FV (CVR1) cannot 
detect it effectively. Considering a relatively constant ABP and mainly a decrease in the 
diastolic component of FV during plateau waves 141, CVR1 increases, whereas, in reality, 
cerebrovascular resistance decreases due to vasodilation. In contrast, estimators using CVR2 
(ratio between pulse amplitude of ABP and FV) performed better, since it can detect changes 
in FV amplitude caused by ICP increases. Therefore, cerebrovascular resistance decreases in 
this case, which is realistic.  
The magnitude of changes observed in nCPPs also presented strong correlations with direct 
CPP considering both patient populations. This indicates that independently of its degree of 
accuracy, nCPPs was reliable to detect the magnitude of changes in CPP (Figure 7.5). 
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Moreover, nCPPs demonstrated reasonable AUC for prediction of CPP changes ≥23.2 in both 
patient cohorts analysed jointly (AUC = 0.71) (Figure 7.6).  
In the nCPPs model, only CVR2 provides complete independence from ABP transducer zeroing, 
and only the CFF model eliminates the issue of time delay. Consequently, both issues still 
appear in an averaged, partial way in nCPPs.  
The averaging approach applied to produce nCPPs has advantages and disadvantages. It is 
advantageous by approximating the different features of the estimators to yield a method that 
is versatile in several conditions associated with derangements in cerebral haemodynamics. 
This characteristic resulted in a better correlation in the time domain between nCPPs and single 
estimators in the plateau waves cohort. In contrast, in other circumstances, the averaging 
approach may suppress specific characteristics of an estimator. This can be observed in the 
cohort undergoing induced rises in ABP, in which the estimator using CVR1 & CaCFF presented 
a better correlation in comparison to nCPPs.  
Nevertheless, considering the two population cohorts together, in this assessment nCPPs 
generally performed better than single CPP estimators alone.
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8 CONCLUSIONS 
 
 
 
8.1 Accuracy of TCD-based nICP monitoring methods 
 
This section provides general conclusions about the assessment of TCD-based nICP methods 
in a variety of clinical conditions with differing physiological mechanisms associated with ICP 
changes (Chapter 5). 
Among the four methods compared, the black box model (nICPBB) had the best performance 
to estimate ICP in a prospective cohort of TBI patients. However, to replicate changes in ICP 
in the time domain, the method based on pulsatility index (nICPPI) had the best performance. 
A new method based on averaging the best estimators (nICPBB and methods based on diastolic 
FV and critical closing pressure (nICPFVd and nICPCrCP) - nICPAv), demonstrated better 
performance for ICP prediction. However, in other assessments, nICPAv was not considered 
since it did not show any noticeable improvement in comparison to single methods. The overall 
95% confidence interval for ICP prediction presented by TCD-based nICP methods in this 
assessment was estimated around 10 mmHg. 
During infusion tests, ICP changes were estimated with only moderate correlations by the nICP 
methods. nICPPI had the best performance for predicting changes in ∆ICP during infusion test, 
followed by nICPBB. Vasogenic components of ICP appeared to be easier to estimate with 
TCD-based nICP methods than the component related to increased CSF circulation. 
In the assessment considering ICP plateau waves, the nICP methods were remarkably accurate 
to detect relative changes in ICP across time. Furthermore, they presented high performance to 
rule out intracranial hypertension and identify ICP changes related to plateau waves. 
Among the four nICP methods evaluated, nICPBB has demonstrated the overall best 
performances. Table 5.8 summarises the measures of accuracy presented by all methods in 
different clinical conditions. However, the estimation of ICP absolute values is limited at the 
current state of development for all nICP methods. This inaccuracy is suggested to be 
associated with the matter of non-specific nICP calibrations. 
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In respect to ICP accuracy, it is known that even the standard invasive techniques might not 
comply with the specified limits for error 120,215,223, particularly using epidural and 
intraparenchymal microtransducers 215. Thus, it is debatable whether these accuracy 
requirements are realistic for all sorts of ICP monitoring.  In view of this, an important concept 
that should be stressed is ICP not solely “as a number”, once dynamical features of this 
parameter, such as its waveform and relative changes in time, are fundamental for a proper 
assessment of the clinical state of the patient 165.  
Therefore, despite the intrinsic limitations and inaccuracy to predict ICP mean absolute values, 
TCD-based nICP methods may have a potential clinical utility since this technique allows a 
non-invasive assessment of cerebral circulation dynamics as ICP changes in the time domain. 
These features also allow tracking nICP changes in real-time in a variety of clinical settings 
(emergency rooms, ambulatories, operating theatres). This is one of the advantages of 
transcranial Doppler ultrasonography and may become particularly useful as a primary 
assessment tool in centres where ICP monitoring is not routinely applied or unavailable. It may 
also suit patients in whom invasive ICP monitoring may not be clearly indicated (mild closed 
head injury, for example) or contraindicated (coagulopathy, for instance). 
Given these conclusions, hypothesis I cannot be confirmed in all clinical conditions studied 
(like during CSF infusion tests). A finite error of 10 mmHg has been determined for TBI 
patients, in which vasogenic waves of ICP appeared to be reliably replicated by TCD-based 
nICP methods.
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8.2 Feasibility of TCD-based monitoring of nICP and cerebral haemodynamics 
 
The feasibility of nICP monitoring was assessed in conditions in which the knowledge of 
intracranial pressure and cerebral haemodynamics could help explain many of the pathological 
states observed clinically (Chapter 6). 
In the study assessing the presence of interhemispheric pressure gradients, the ability of TCD-
based nICP to identify these patterns could represent a suitable tool in the management of TBI 
patients with closed head injury presenting midline shift. As it has been suggested, the 
interhemispheric nCPP difference showed a significant correlation with midline shift, 
suggesting that in TBI patients with brain's structural asymmetry, CPP is greater on the side of 
brain expansion, acting as the driving force to shift brain structures. 
In patients with acute liver failure, different patterns of cerebral haemodynamics could be 
identified non-invasively during orthotopic liver transplant using a TCD-derived multimodal 
approach englobing nICP, nCPP, and other cerebral haemodynamics parameters. Generally, 
the results indicated an alteration of cerebral autoregulation, normal ICP and decreasing CPP 
during the transplant surgery.  
The assessment of patients undergoing shoulder surgery in the beach-chair position 
demonstrated significant cerebral haemodynamics changes in patients with no indications of 
previous neurological impairment. The findings suggest that this surgical setting caused an 
alteration of cerebral haemodynamics, especially impairment of cerebral blood flow 
autoregulation. Left untreated, a significant reduction in cerebral blood flow may result in brain 
ischaemia and postoperative neurologic damage. 
Overall, these findings confirm hypothesis II and demonstrate the feasibility of TCD-based 
monitoring of nICP and cerebral haemodynamics in a variety of clinical settings. In this 
scenario, multiparameter TCD assessment may provide an early detection of the onset of 
cerebrovascular derangements and potentially guide their clinical management.
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8.3 Assessment of the spectral nCPP method 
 
The novel method for nCPP monitoring proposed in this thesis has been validated in two 
different clinical conditions presenting changes in cerebral perfusion pressure. Such changes 
were associated with pharmacologically-induced rises in ABP resulting in CPP increases, and 
changes related to ICP increases of vasogenic origin (plateau waves of ICP) resulting in CPP 
decrease (Chapter 7). 
In both conditions, the proposed spectral nCPP method could identify changes in CPP across 
time reliably, and the magnitude of these changes expressed in mmHg was reasonable. The 
prediction ability to detect changes in CPP was acceptable.  
In the context of monitoring CPP in the time domain, these features confirm hypothesis III and 
confer reliability to monitoring CPP dynamics with nCPPs. Furthermore, there is a need for 
prospective studies to validate and determine the accuracy of the method in traumatic brain 
injury and other conditions requiring neurocritical care. For this assessment, it is essential that 
the ABP transducer be zeroed at the level of the head (auditory meatus) to provide an accurate 
measurement of CPP.
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9  DIRECTIONS OF FUTURE RESEARCH 
 
 
 
Development of nICP/nCPP monitoring methods 
 
Among the TCD-based methods discussed throughout this thesis, a recurrent issue regarding 
their estimation accuracy was the manner these methods were formed, i.e., whether they were 
derived from specific or general formation datasets. Although, in principle, a model based on 
general formation datasets should be able to englobe most of the pathophysiological events 
occurring in a certain population, the sample size required to form such a model needs to be 
extensively representative. This could represent a major limitation factor since the precision of 
a method would be subjective to its formation sample size. 
This downside could be overcome by the application of model-based methods capable of 
replicating physiological phenomena, such as nCPPs presented previously. Once it does not 
require a formation dataset, the estimates produced by the method are individual-specific. 
Nevertheless, the precision of the method would be subjective to the input parameters assigned 
to the model. From this premise, another issue that arises is which combination of input 
parameters would be best to simulate cerebral pathophysiological events.  
At the current state of development for nICP/nCPP monitoring methods, there is not an ideal 
model. However, with the advancements in computational simulation, mostly applying the 
concept of machine learning, the physiological model-based methods could be considered the 
most promising on this field. Moreover, recent improvements in TCD devices, such as robotic 
probes that allow automated insonation of the middle cerebral artery and auto-correction in 
time may open new perspectives to making long-term nICP/nCPP monitoring achievable.  
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Applications of nICP/nCPP monitoring  
 
Transcranial Doppler ultrasonography has the potential to be used as an alternative diagnostic 
tool for the assessment of cerebral haemodynamics rather than costly and potentially risky 
investigations such as invasive ICP monitoring. Nevertheless, the range of TCD applications 
has been limited mostly to neurocritical care settings. 
In many clinical conditions outside this environment, there is a void for neurologic assessment 
in the unconscious patient. In patients who are not undergoing brain surgery and neurocritical 
care, invasive monitoring that breaches the skull surgically is seldom feasible, and clinicians 
rely on periodic, limited assessments. Even in medical conditions in which the brain is regularly 
and significantly affected, such as hypoxic and metabolic encephalopathies, sepsis, refractory 
status epilepticus, an effective non-invasive monitoring regime has not been established yet. In 
these conditions, it would be ideal to monitor cerebral haemodynamics continuously, applying 
a TCD multiparameter assessment in association with other monitoring modalities like near 
infrared spectroscopy (NIRS), electroencephalography (EEG), optic nerve sheath diameter 
measurement (ONSD).  
Techniques like ONSD measurement, parallelly investigated in the course of this thesis, may 
provide a better estimate of the absolute value of ICP than TCD does 224. Furthermore, the 
combination of ONSD and venous TCD-derived parameters showed an improved accuracy 
than ONSD alone 224. In preliminary unpublished findings, the 95% CI for prediction of ICP 
obtained with the combination of ONSD and venous TCD presented similar values described 
by Ragauskas et al. 225 (< ±9 mmHg), whose non-invasive method has been reported as having 
the closest accuracy to direct ICP. This method is based on a two-depth high-resolution 
transcranial Doppler insonation of the ophthalmic artery and does not require calibration since 
it relies on the equilibrium between blood flow pulsations in the intracranial and extracranial 
segments of the ophthalmic artery 226. However, it can be limited in clinical practice because it 
requires a special two-depth TCD device and highly skilled transcranial Doppler operator with 
the anatomical knowledge to identify the specific location of the intracranial and extracranial 
segments of the ophthalmic artery. On the other hand, ONSD and venous TCD is 
methodologically easy, quick and repeatable 227.  
As demonstrated in this thesis, TCD monitoring can provide a reliable assessment of cerebral 
haemodynamics, including intracranial pressure, cerebral perfusion pressure, cerebral 
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autoregulation. The association of these methods, alongside neurological and cerebral 
oxygenation assessments (EEG and NIRS, respectively) and other predictors of ICP (like 
ONSD and venous TCD), may provide a comprehensive multimodal assessment of the brain 
functions. This approach could guide oriented therapies to patients with suspicion of 
neurological disorders in a variety of clinical settings. 
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